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ABSTRACT 
 
This thesis describes the genetic analysis conducted to investigate 
the cause of six autosomal dominant macular dystrophies (North 
Carolina macular dystrophy, MCDR1; North Carolina-like macular 
dystrophy, MCDR3; North Carolina-like macular dystrophy with 
progressive sensorineural hearing loss, MCDR4; progressive 
bifocal chorioretinal atrophy, PBCRA; bull’s-eye maculopathy, 
MCDR2 and split-hand/foot malformations with associated North 
Carolina macular dystrophy, SHFM and NCMD) and one cone 
dysfunction with associated myopia and dichromacy (Bornholm 
eye disease, BED). The method of using Affymetrix SNP chips was 
tested for its usefulness in conducting genetic analysis on the 
macular disorders. The chips were used to see if disorders 
previously linked to large genomic regions could have their loci 
refined to help determine where the genetic error for each disorder 
lies. The genotyping results reveal the analysis is more informative 
when including genotyping data of affected offspring and their 
parents. MCDR1 analysis without such samples did not refine the 
disease locus. The copy number variation (CNV) analysis 
conducted was novel for the disorders and highlighted interesting 
regions of CNV, particularly in the SHFM and NCMD analysis at 
5p15.33 for which QPCR confirmed loss of one copy of a novel 
microRNA. For MCDR2 analysis, new families were identified as 
carrying the mutation Arg373Cys in exon 10 of the PROM1 gene. 
Genetic analysis conducted on various families with BED has 
revealed the genetic cause of the disorder. Genetic changes 
leading to the amino acid combination of leucine, 
isoleucine/valine, alanine, valine and alanine at residues 153, 
170, 174, 178 and 180, respectively, in the L or M opsin genes 
were consistently found in BED patients and are believed to result 
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in the disease phenotype. Additionally, a family with a BED-
related phenotype was found to carry a novel mutation in exon 2 
of a hybrid M opsin gene that would lead to a Glu41Lys 
substitution. 
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1. THE RETINA 
Structure and Function 
 
1.1 The Eye 
The eye is a complex organ composed of many sections and cell 
types, all of which need to work together to enable good vision. It 
is an area of the human body where destruction of only a few 
cubic millimetres of tissue can have a dramatic impact upon the 
function of the organ and in turn, the lifestyle of an individual. 
The eye can be divided into three main concentric layers: the 
outermost comprises the cornea and sclera; the middle section 
contains the choroid, ciliary body and iris with the innermost 
layer being the retina (Figure 1.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 A schematic overview of the basic eye structures. Image 
taken from: www.allaboutvision.com. 
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1.1.1 The Inner Layer 
The retina is a thin multi-layered structure upon which light must 
be accurately focussed in order to produce a good visual image. As 
seen in Figure 1.2, the retina is composed of three basic layers of 
neural tissue and light must pass through the inner and middle 
layers before it reaches the photoreceptors (rods and cones, the 
light-sensitive cells that convert light images into electrochemical 
signals) in the outer layer. The inner layer of the retina is often 
referred to as the ganglion cell layer (GCL), which is followed by 
the inner nuclear layer (INL), an area which also contains blood 
vessels that form the inner retinal vasculature. The outer nuclear 
layer (ONL) ends with the photoreceptor outer segments, beneath 
which is the retinal pigment epithelium (RPE) followed by Bruch’s 
membrane, the choroid and the sclera.  
 
1.2 The Retina 
 
 
Figure 1.2 General structure of 
the vertebrate retina taken from 
Dyer and Cepko (2001). ONL = 
outer nuclear layer made up of 
photoreceptor cell bodies; INL = 
inner nuclear layer, containing 
bipolar and Müller glial cell 
bodies; and GCL = ganglion cell 
layer, which also contains 
displaced amacrine cell bodies. 
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The role of the retina is to convert images from the eye’s optical 
system into electrical impulses that are sent along the optic nerve 
to the brain to interpret as vision. The light sensitive neural tissue 
of the retina is composed of many cell types with the inner layer of 
the retina (ganglion cell layer, GCL) consisting of neural 
connections between bipolar cell axons and ganglion cell 
dendrites. Some retinal ganglion cells (RGCs) are intrinsically 
photosensitive (ipRGCs) and use melanopsin as a light sensitive 
pigment to transmit monosynaptic projections through the 
retinohypothalamic tract directly to the suprachiasmatic nucleus 
in the brain. These ipRGCs constitute less than 2% of the total 
RGC population yet light information for synchronisation of 
circadian rhythms and pupillary responses are predominantly 
conveyed through these cells (Güler et al., 2008). The ipRGCs also 
receive synaptic input from the photoreceptor networks, thus 
allowing the photoreceptors access to the brain circuits mediating 
non-image visual functions, circadian rhythms and pupillary 
responses (Wong et al., 2007). 
 
Following the GCL is a region containing bipolar, Müller, 
horizontal and amacrine cell bodies, known as the inner nuclear 
layer (INL). Müller cells are radial glia of the neural retina whose 
processes span the three cellular layers of the retina by forming 
an anatomical and functional link between the retinal neurons 
and the blood vessels, vitreous body and sub-retinal space 
(Bringmann et al., 2006). Müller cells are important for the 
maintenance of retinal structure and function and for cone retinal 
cycling (Section 1.2.5). Selective Müller cell destruction causes 
retinal dysplasia, photoreceptor apoptosis and retinal 
degeneration and proliferation of the RPE (Dubois-Dauphin et al., 
2000). Horizontal and amacrine cells make lateral connections 
and modulate the direct signalling pathway from photoreceptors 
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to ganglion cells. They lack any extension resembling an axon and 
have only dendrites, though a number of these are pre-synaptic 
and thus act similarly to axons. The amacrine and bipolar cell 
dendrites form synapses with photoreceptor axons and the 
photosensitive columns of rods and cones then form the outer 
segment of the retina. 
 
1.2.1 Visual Pathways 
The combination of cells signalling from each retinal layer to the 
next form different visual pathways. The vertical pathway is 
formed when a single photoreceptor cell forms a synapse with a 
bipolar cell (a vertical neuron). The dendritic end of the bipolar cell 
receives input from the photoreceptor and the axon terminal is 
then pre-synaptic to a ganglion cell. The dendrites of a single 
ganglion cell integrate several bipolar inputs and generate an 
action potential. However, cone photoreceptors often contact 
several bipolar cells, so in this situation a signal from one cone 
cell goes down several vertical pathways and is known as a 
divergent pathway. Outside the fovea it is common for a number of 
photoreceptor cells to connect to a smaller number of bipolar cells 
which are then pre-synaptic to a single ganglion cell. This is 
known as a convergent pathway and is useful for producing a 
visual image in low light conditions. There are also lateral 
pathways, which are formed in the inner retina by amacrine cells 
connecting vertical pathways thereby allowing bipolar and 
ganglion cells to interact, and in the outer retina by horizontal 
cells making connections between photoreceptors. The light 
information from each visual pathway leaves the retina via the 
axons of ganglion cells that collectively form the optic nerve. 
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1.2.2 Development of the Retina 
In humans, eye formation begins at around 22 days of 
development and is not completed until several months after birth 
(Mann, 1964). During embryogenesis the retina (and the RPE) is 
derived from neural ectoderm whereas the cornea and sclera 
develop from mesoderm and surface ectoderm produces the lens.  
 
 
 
 
 
Figure 1.3 Images taken from Wong et al. (2006) showing the 
basic stages of eye development: a) formation of optic vesicles; b) 
interaction of the surface ectoderm with the optic vesicles 
producing the lens placode; c) formation of the optic cup and lens 
vesicle; d) the RPE and retina are formed and; e) the mature eye. 
 
 
The retina and optic nerve originate as paired optic vesicles 
formed as out-pockets on either side of the forebrain (Figure 1.3a), 
and thus the retina forms part of the central nervous system. 
Inductive processes between the surface ectoderm and optic 
vesicles causes the epithelium to thicken and form a lens placode 
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(Figure 1.3b), the precursor to the lens, which requires SOX2 and 
POU2F1 gene expression (Donner et al., 2007). SOX2 encodes an 
SRY-like (sex-determining region Y) HMG (high-mobility group) 
box transcription factor that mediates its effects by forming 
complexes with specific co-factors and is critical in vertebrate 
development. In humans, a SOX2 mutation has been shown to 
cause anopthalmia, hearing loss and brain anomalies (Hagstrom 
et al., 2005). The study by Donner et al. (2007) identified Oct-1 
(encoded by POU2F1) as a co-factor of Sox2 in mouse lens and 
nasal placode induction. The genetic combination of Sox2 and 
Pou2f1 mutant alleles results in ocular and nasal phenotypes that 
resemble those of the Pax6 null embryos. PAX6 (paired box gene 
6) is one of the most important genes in vertebrate eye 
development, it is a homeobox gene expressed in the eye field at 
the early neurula stage of development and proposed to be at the 
top end of the genetic cascade governing eye development (Lupo et 
al., 2000). Mutations in ey/pax6 (fly homologue, ey = eyeless) 
causes malformation or lack of eyes in Drosophila, mouse and 
humans (Ton et al., 1991; Quiring et al., 1994). According to 
Barishak and Ofri (2007), the PAX6 gene product is expressed 
toward the end of gastrulation in the anterior neural plate and 
then through the stages of the optic vesicle (though it is not 
required for optic vesicle formation), optic cup and later on in the 
retina (in ganglion and amacrine cells). Donner et al. (2007) 
demonstrated that Pou2f1, Sox2 and Pax6 appear to be 
interdependent components of a molecular pathway utilised in 
both lens and nasal placode induction in mice. Formation of 
placodes is common in the development of vertebrate sensory 
structures including the lens, ear and nose, which develop 
through multi-step inductive processes involving formation of a 
neural plate stage pre-placodal region and subsequent formation 
of discrete ectodermal thickenings that are the placodes 
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(Brugmann and Moody, 2005). Links between the formation of the 
sensory structures may be important as demonstrated by one of 
the disorders studied here where an early-onset macular 
dystrophy is associated with progressive sensorineural hearing 
loss; genes involved in both eye and ear development will be 
strong candidates in this investigation. 
 
When the lens placode has begun to form, the optic vesicle 
expands and begins to invaginate to form the optic cup (Figure 
1.3c) and as it does so it creates a fold along its centre known as 
the choroid fissure (Sadler, 1990). This encloses a small amount 
of angiogenic mesenchyme that later forms the hyaloid artery and 
vein which develop into the main artery and vein of the retina 
(Figure 1.3d). As the cup invaginates and folds, two layers arise: 
the inner layer that will become the retinal tunic (including the 
light-sensitive elements), and the outer layer that becomes the 
RPE. Differentiation of retinal cells begins at the primitive zone in 
the centre of the cup of neuroectoderm and gradually extends 
toward the rim. This results in retinal ganglion cells and amacrine 
cells being generated first, followed shortly after by horizontal cells 
that differentiate in the outer retina whilst the photoreceptors are 
formed in overlapping phases (Choy et al., 2002). The vertical 
inner and outer networks are later interconnected when bipolar 
and Müller cells are formed in the last part of retinogenesis and 
connections with ganglion cells are established (Young, 1985). As 
the retina continues to develop there is lateral displacement of the 
inner retinal neurons and glia, which occurs during late foetal to 
early infant stages, to create the foveal depression (Hendrickson 
and Youdelis, 1984). This is the central point on the retina where 
light from the central visual field strikes and is the region with the 
greatest visual acuity due to the fact it contains tightly-packed 
cone photoreceptors. Cones provide us with colour vision but are 
Chapter 1 
     Genetic Analysis of Inherited Retinal Dystrophies 30 
only active in relatively bright light whereas rods enable 
monochromatic vision in low light conditions. The distribution of 
rods and cones within the retina is well known, with cone density 
being greatest at the fovea and decreasing rapidly at any distance 
away from this point. Rods, however, are absent at the fovea but 
are in abundance nearby and their density gradually decreases 
with distance from the fovea. For the high visual acuity found in 
the central retina there is a low ratio of photoreceptors to ganglion 
cells. 
 
1.2.3 Photoreceptors 
The transduction of light into nerve signals sent via the optic 
nerve to the brain takes place in the photoreceptors and both the 
cones and rods that undertake this role consist of the same three 
main parts: an outer segment and inner segment that reflects 
their ciliary origin (Lamb et al., 2007), and a synaptic terminal. 
The outer segment is formed of discs containing photopigments, 
the inner segment contains the nucleus and majority of the 
organelles within the main cell body whilst the synaptic terminal 
contains the synaptic vesicles that store the chemical transmitters 
used in neural communication. The shape of the outer segments 
gave rise to the naming of the two photoreceptor types; rods have 
a long, cylindrical outer segment with many discs whereas cones 
have, by comparison, a short stack of discs that tapers distally 
(Figure 1.4). Due to the greater number of discs containing 
photopigment, rods are over a thousand times more light-sensitive 
than cones and can detect even a single photon of light. The 
connections rods make with the other cells of the retina also 
contribute to their sensitivity (Section 1.2.1) but the result of 
these connections is that the vision provided by the rods is more 
blurred than that from cones. 
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The discs in the outer segments are formed from the folding of the 
photoreceptor membranes. In rods, the discs become completely 
detached from and float within the membrane but in cones the 
discs remain attached to the outer segment membrane. New discs 
are constantly being formed at the base of the outer segments and 
the old discs at the tip of the outer segment are recycled. The RPE 
is responsible for the phagocytosis of the old outer segment tips in 
addition to numerous other roles considered in Section 1.3. 
 
Whilst physiologically distinguishable, the two photoreceptor cell 
types are also functionally distinguishable due to their 
photopigments. The photopigment molecule is formed from a 
light-absorbing portion, or chromophore, and a protein called an 
opsin. Rods contain only the A1 chromophore that when bound to 
the opsin is commonly referred to as rhodopsin, whereas the outer 
segments of cones contain one of three different iodopsins 
(rhodopsin analogs) that best absorb light at a particular range of 
wavelengths; short (S, λmax420nm), medium (M, λmax 535nm) and 
Figure 1.4 A schematic of 
a rod and cone 
photoreceptor cell, taken 
from: 
http://thebrain.mcgill.ca. 
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long (L, λmax 560nm). S-wavelength selective opsin is found in 8-
12% of cones except in the fovea, where they are absent (Curcio et 
al., 1991). These cones are blue sensitive, M cones green sensitive 
and L cones red sensitive and the photopigment in rods is for 
visual purple (λmax 498nm) used in scotopic vision (vision in dark 
conditions). The cone photopigments (chromophore plus opsin) 
have different absorption spectra despite containing the same 
chromophore. The differences in the spectral characteristics are 
dictated by the interactions of specific amino acid residues of the 
opsin with the chromophore, a process known as spectral tuning 
(Section 1.2.4). Whilst the general distribution of rods and cones 
is known, what is less well determined is the layout of the three 
cone types, known as the trichromatic cone mosaic. 
 
The S cone sub-mosaic has been well characterised (Curcio et al., 
1991) but the organisation of L and M cones less so because they 
have no known histochemical differences and their pigments are 
96% identical (Nathans et al., 1986b). Bowmaker et al. (2003) 
reported that L and M cones were found in random patches in the 
human retina, yet there is also evidence suggesting non-random 
arrangements as both Hagstrom et al. (1998) and Bowmaker et al. 
(2003) found the L to M ratio increases in the far periphery of the 
retina. Combining the techniques of high-resolution adaptive 
optics imaging and retinal densitometry, Hofer et al. (2005) 
characterised the S, L and M cone arrangements in eight human 
foveal mosaics. They determined that the normal male L to M ratio 
varies (1.1:1 to 16.5:1) whilst all subjects had nearly identical S 
densities. The L and M cones appear to cluster together but 
otherwise do not seem to have a regular pattern. 
 
In foetal retina there are more S cones than there are in adult 
retina and a significant proportion of cones in foetal retina have 
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been shown to express S and L or M opsin (Cornish et al., 2004). 
The L/M cones appear in the foveal cone mosaic 3 to 4 weeks after 
S cones and by birth are present throughout the retina. There is 
little evidence of significant levels of apoptosis in the L/M cones so 
it is thought that cones destined to express L or M may initially 
and transiently express S before switching to L or M (Cornish et 
al., 2004). 
 
1.2.4 L and M Photopigment Genes 
The S opsin gene is located at 7q32.1, whilst the L and M genes 
are found in a tandem array downstream of a locus control region 
(LCR) at Xq28 (Vollrath et al., 1988). The array consists of one L 
gene followed by one or more downstream M genes (Nathans et al., 
1986b; Macke and Nathans, 1997). Both L and M alleles are 
present in each cone but in the adult retina only one allele is 
expressed (Hagstrom et al., 2000). It is widely believed that 
expression of the array includes only the first two genes in the 
cluster (Winderickx et al., 1992a). The identification of the LCR by 
Nathans et al. (1989) gave insight into why this may be the case; it 
is thought that the proximity of the genes to the LCR influences 
expression. Hayashi et al. (1999) showed that if the transcription 
start sites were ~3.5kb and ~43kb from the LCR they were 
efficiently activated but at ~82kb away they were not. The LCR is 
upstream of the array and required for expression of both L and M 
genes though each gene in the array has its own promoter. The 
head-to-tail array seems to have arisen from a gene duplication 
(Dulai et al., 1999) and the LCR is an enhancer that lies between 
3.1kb and 3.7kb upstream of the translational start site of the 
first gene. Deleting the LCR prevents expression of all the genes in 
the array and results in blue cone monochromacy (Nathans et al., 
1989). The LCR is proposed to act as a stochastic selector that 
chooses which photopigment gene will be expressed in an 
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individual photoreceptor (Smallwood et al. 2002). The model 
proposed by Smallwood et al. (2002) suggests that the L and M 
promoters compete for contact with the LCR and the promoter of 
the randomly chosen gene forms a stable and permanent complex 
with the LCR. This model may be contested though because the 
LCR is present in New World monkeys where only a single gene is 
present (Dulai et al., 1999). 
 
Hennig et al. (2007) reviewed the regulation of photoreceptor 
expression in mice and described how it is mediated by a network 
of photoreceptor transcription factors centred on cone-rod 
homeobox protein (Crx), an Otx-like homeodomain transcription 
factor. The network is cell type-specific and governed by factors 
preferentially expressed by rods (for example: neural retina-
specific leucine zipper protein, Nrl and; nuclear receptor subfamily 
2, group E, member 3, Nr2e3) or cones (for example: thyroid 
hormone receptor β2, Trβ2; retinoid related orphan receptor, Rorβ 
and; retinoid X receptor, Rxrγ). The process also depends on 
general transcription factors and co-factors. Mutations that 
interfere with any of the interactions can cause photoreceptor 
development defects or degeneration (Section 2). Selective 
expression of the cone opsin genes is important for development of 
photoreceptors and for maintaining integrity and function. Crx 
regulates transcription of many photoreceptor-specific genes 
(Furukawa et al., 1997). Nr2e3 interacts with Crx and has 
opposing effects on transcription of rod and cone genes. HEK293 
cells with transient expression of both demonstrated that Nr2e3 
enhances rhodopsin but represses S or M photopigment 
transcription when interacting with Crx. Mutations in human 
NR2E3 cause enhanced S-cone syndrome (ESCS, Haider et al., 
2000).  
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Crx has been shown to interact with co-activators with histone 
acetyltransferase (HAT) activity. Peng and Chen (2007) suggest the 
transcription sequence of events in promoter and enhancer 
regions is as follows: 1. binding of Crx; 2. binding of HATs; 3. 
acetylation of histone H3 (AcH3) and 4. binding of other 
photoreceptor transcription factors (eg Nrl and Nr2e3) and RNA 
polymerase II. In Crx knockout mice, association of HATs and 
AcH3 with the target promoter/enhancer regions is significantly 
decreased, correlating to aberrant opsin transcription and 
photoreceptor dysfunction. Crx mutations are known to cause 
cone-rod dystrophy (CORD), leber congenital amaurosis (LCA) and 
retinitis pigmentosa (RP) (Freund et al., 1997; Freund et al., 1998 
and Rivolta et al., 2001; see also Section 2). 
 
As the L and M gene array appears to have arisen from a gene 
duplication (Dulai et al., 1999), the L and M photopigment genes 
differ by only 2% at the nucleotide level in both exon and intron 
regions and contain repeat units of 39Kb of which ~15Kb is the 
visual pigment gene segment and ~24Kb is intergenic sequence. 
The similarity between L and M repeat units predisposes the 
tandem array to unequal homologous recombination. If crossing 
over occurs within the intergenic region then a gain/loss of one or 
more of the genes results, which accounts for the highly variable 
number of M genes in the normal trichromatic population: 25% 
have two retinal pigment genes in their L and M array, 50% have 
three, 20% carry four and 5% have five or more (Wolf et al., 1999). 
Recombination within the coding regions creates hybrid genes and 
most intragenic crossovers occur within introns (which are highly 
homologous, Shyue et al., 1994) due to their large size relative to 
the exons. These unequal crossovers produce hybrid genes that 
result in common abnormal colour vision disorders in males (Deeb 
et al., 1992). Figure 1.5 displays an example of how variations of 
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the L/M array arise due to crossover events. Some of the arrays 
depicted in Figure 1.5 will lead to a male suffering dichromacy, i.e. 
an absence of a single pigment class. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
True dichromats can be classified as one of three types: 
protanopes, who lack functional L opsin; deuteranopes, who lack 
Figure 1.5 A schematic adapted from Nathans (1999). Red boxes 
indicate the sequence for the L gene and green boxes the sequence 
for M (exons and introns). Numbers 1 and 3 indicate intragenic 
crossover sites and 2 and 4 intergenic sites. Letters A-C represent 
different alleles of the array. The AxB grouping shows the arrays 
formed when unequal recombination occurs between breakpoints 1 
and 3 or 2 and 4 if alleles A and B are present. The bottom grouping 
represents the arrays that may be produced following unequal 
recombination between alleles A and C at breakpoints 1 and 3 or 2 
and 4. The hybrid L/M genes tend to produce an opsin with 
characteristics resembling M whereas the M/L hybrids tend to 
produce an opsin with L characteristics. 
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functional M opsin; and tritanopes, who lack functional S opsin. 
There are also cases of anomalous trichromacy in which patients 
do not completely lack red or green vision, such individuals would 
be protanomolous or deuteranomolous, respectively. Nathans et 
al. (1986a) showed that these protan defects will arise when a 
male has an array consisting of an L/M hybrid gene followed by a 
normal M gene sequence. Such an individual may have complete 
protanopia or be protanomolous depending on how many exons of 
the hybrid are of the L opsin gene. Deutan defects will arise if an 
array consists of an L gene sequence followed by a hybrid M/L 
sequence (see Figure 1.5 for diagrammatic representations of 
these arrays).  
 
The amino acid sequences of L and M cone opsins are ~96% 
identical and share ~42% identity with S-cone opsin and rod 
opsin (Nathans et al., 1986b). There are just 15 amino acid 
differences between L and M opsins (Figure 1.6), half of which are 
within the transmembrane region of the protein and therefore are 
likely to interact with the chromophore. Of these, three 
(Ser180Arg, Tyr277Phe and Thr285Ala) are known to contribute 
greatly to the majority of differences in spectral characteristics 
between the two opsins (Asenjo et al., 1994). If the seven residues 
Ser116Tyr, Ser180Ala, Iso230Thr, Ala233Ser, Tyr277Phe, 
Thr285Ala and Tyr309Phe are changed in the M pigment then the 
absorption spectrum becomes indistinguishable from an L 
pigment spectrum. Ser180Ala is a common polymorphism, males 
with L(Ser180) photopigment are more sensitive to red light than 
those with L(Ala180), as shown by colour-matching experiments 
(Winderickx et al., 1992b). The λmax  of L(Ser180) has been shown in 
vivo to be ~3nm longer than that of L(Ala180) (Sharpe et al., 
1998).  
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When crossing over produces hybrid genes, the extent of the 
protan or deutan defects depends on the difference in the λmax  
between the first two encoded pigments. 
 
When Deeb et al. (1992) confirmed the array findings in 
protanopic and deuteranopic patients, they also reported a 
common point mutation in exon 4, nucleotide 609, that results in 
an amino acid change at position 203 of cysteine to arginine 
(Cys203Arg). Winderickx et al. (1992c) showed that if this 
missense mutation lies in one of the first two M genes of the array 
it leads to severe deuteranomaly. However, the Cys203Arg point 
mutation is not unique to these dichromats as it is present in 2% 
of the Caucasian population with normal colour vision. It is 
thought that unexpressed M genes in these individuals carry the 
mutation.  
 
In summary, the L and M opsin genes are 98% identical at the 
nucleotide level and are present in a tandem array controlled by 
an LCR on the X chromosome. The high homology between both 
the gene and intergenic sequences gives rise to unequal 
recombination between the arrays which results in colour defects 
in males being fairly common. The 364 amino acid products of the 
two genes share a 96 % identity with only 15 amino acids 
differing, three of which contribute to the majority of the 
differences in the spectral characteristics of the two 
photopigments. However, though the three cone types are the 
basis for trichromacy in humans, retinal ganglion cells (RGCs) 
that respond in an opposing fashion following activation of the 
different cone classes, are the basis for colour opponency. This 
theory suggests that the visual system records differences 
between the responses of cone classes rather than each cone 
types individual response. Conway (2009) recently reviewed colour 
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opponency in which cone signals are processed by several classes 
of RGCs (Masland, 2001). Each neuron receives signals from a 
particular area of the retina, which corresponds to its 
visual/receptive field. Colour contrast is achieved from the 
comparison of the relative cone activations in adjacent patches 
across the visual space (Hurlbert & Wolf, 2004; Vladusich, 2007). 
 
1.2.5 Phototransduction 
The first step in the process of the transduction of light energy 
into membrane potential is the absorption of photons by the light-
sensitive pigments in the discs of the photoreceptor outer 
segments. In the process of rod phototransduction this is achieved 
by rhodopsin, which is located in the membranes of rod discs. 
This photopigment contains seven hydrophobic alpha-helical 
transmembrane domains linked by hydrophilic loops (Trumpp-
Kallmeyer et al., 1992). The seven alpha-helical segments form a 
pocket in which the chromophore, 11-cis retinal, sits and 
covalently bonds via a protonated Schiff base linkage to a specific 
lysine residue (Lys296) in helix six (Hargrave, 2001). Following 
light absorption the chromophore changes to the all-trans form, 
which converts the rhodopsin to metarhodopsin. Metarhodopsin I 
(Meta I) is initially formed and contains the protonated Schiff base 
but is quickly converted to metarhodopsin II (Meta II), in which 
the Schiff base is deprotonated and in this form the molecule is 
more sensitive to hydrolysis (Lamb and Pugh, 2004). Meta II is the 
active form that stimulates the heterotrimeric G protein 
transducin. In its inactive state, transducin is bound to guanosine 
diphosphate (GDP) but Meta II catalyses the substitution of 
guanosine triphosphate (GTP) for GDP. This occurs on the 
transducin α subunit, which dissociates from Meta II and the 
other two transducin subunits, β and γ. Meta II catalyses around 
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500 such reactions before it is inactivated by the combined 
actions of rhodopsin kinase and retinal arrestin. 
 
The GTP-linked α subunit of transducin activates cyclic guanosine 
monophosphate (cGMP) phosphodiesterase (PDE) by removal of 
the inhibitory phosphodiesterase γ subunits, allowing the α and β 
PDE subunits to hydrolyse cGMP. cGMP that is present in the rod 
cytoplasm in the absence of light is converted into GMP, which 
reduces the amount of cGMP in the cytosol and causes the cGMP-
gated cation channels on the membrane of the rod cell to close, 
leading to hyperpolarisation of the photoreceptor cell membrane. 
Hyperpolarisation causes calcium channels on the inner segment 
to close and as a result, fewer neurotransmitter molecules are 
released from the synaptic terminal. Thus, information about the 
presence of light is relayed by a decrease in signal to the bipolar 
cells. To return the cell to its dark-adapted state the cGMP must 
be regenerated, this is done in several ways, one of which involves 
retinal guanylate cyclase-1 (retGC1). As intracellular Ca2+ levels 
fall, retGC1 is activated by Ca2+-dependent guanylate cyclase 
activating protein (GCAP) to regenerate cGMP. Mutations in both 
retGC1 and GCAP have been identified and result in dysregulation 
of intracellular Ca2+ and cGMP levels, which is believed to lead to 
cell death (reviewed by Hunt et al., 2010). Mutations in GUCY2D, 
which encodes retGC1, are responsible for around 6% of LCA 
cases (Lotery et al., 2000), with mutations in this gene also 
responsible for cone-rod dystrophy (Kelsell et al., 1998 and Udar 
et al., 2003). These mutations reduce retGC1 sensitivity to 
increased cellular calcium levels, leading to failure of retGC1 to be 
inhibited by GCAP. Mutant GCAP (as in Payne et al., 1998) seems 
able to activate retGC1 in low Ca2+ concentrations but fails to 
inactivate it at high Ca2+ concentrations, resulting in constitutive 
activation of retGC1 in the photoreceptors. 
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The photopigment is rapidly inactivated and restored to the 
responsive state as it cannot signal the arrival of another photon 
of light until the all-trans retinoid is replaced by new 11-cis 
retinal. The isomerised retinoid is removed in a long series of 
reactions called the retinoid cycle (Section 1.3.1). In rods, the all-
trans retinal is released from the opsin and taken out of the cell 
across the extracellular space to the RPE where it is converted to 
11-cis retinal, which can recombine with the opsin. It has been 
suggested that cone visual pigment regeneration occurs outside 
the RPE and that the isomerised retinoid is processed in Müller 
cells (Mata et al., 2002). However, Kanan et al. (2008) recently 
showed in their in vitro studies that a Müller cell line did not 
provide the necessary enzymatic activity to complete the retinoid 
cycle and proposed that cone pigment regeneration still requires 
the RPE. If the cone-specific visual cycle occurs in the Müller cells 
then it may be that inter-photoreceptor retinol binding protein 
(IRBP) is important in cone opsin regeneration (Muniz et al., 
2007). Parker et al. (2009) have provided evidence that IRBP could 
be responsible for transporting the retinoid from Müller cells to 
the cone inner segments where it can be oxidised to 11-cis retinal. 
 
1.3 Retinal Pigment Epithelium 
This is a single layer of cells lined in a regular array beneath the 
rods and cones and its role is to support the photoreceptors in 
various ways. Previously mentioned is the participation of the RPE 
in the light-dependent cycling and re-isomerisation of retinal from 
the all-trans state to the 11-cis state. This is important in the 
regeneration of photolysed visual pigments in the photoreceptor 
outer segments. In addition to this the RPE stores retinyl esters, 
which are needed in the retinoid cycle. Faults in the cycle are 
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known to cause inherited retinal diseases (Thompson and Gal, 
2003; Section 2). 
 
1.3.1 Retinoid Cycle 
This process will be outlined using information taken from the 
comprehensive reviews by Lamb and Pugh (2004), Travis et al. 
(2007) and Kono et al. (2008). The cycle begins with an 11-cis 
retinal chromophore absorbing a photon of light and isomerising 
to all-trans retinal, which activates the phototransduction cascade 
(Section 1.2.5). The all-trans isoform is removed from the 
photoreceptor outer segments in two ways: it can remain non-
covalently bound to the opsin and in this state be reduced by all-
trans retinol dehydrogenase (RDH) with the all-trans retinol 
produced following this reaction being released by the opsin, or: 
the all-trans retinal can be released from the opsin and form a 
condensation product, N-retinylidene-phosphatidylethanolamine 
(N-ret-PE), in the lipid membrane. This product gets flipped by 
ATP-binding cassette transporter (ABCA4) across the membrane 
into the cytoplasm where the all-trans retinal can be released, 
hydrolysed and then reduced by all-trans-RDH. In both pathways 
the reduced alcohol (all-trans retinol, also known as vitamin A) is 
chaperoned across the inter-photoreceptor matrix (IPM) by inter-
photoreceptor retinol binding protein (IRBP) to the RPE. Mutations 
in IRBP are an infrequent cause of RP (Valverde et al., 1998 and 
den Hollander et al., 2009). Within the RPE, vitamin A is 
converted into 11-cis retinaldehyde in the following manner: all-
trans retinol is chaperoned in the cytoplasm by cellular retinol 
binding protein (CRBP) before being esterified by lecithin retinol 
acyl transferase (LRAT). RPE65 chaperones the all-trans retinyl 
ester (which can also be stored) and retinyl ester 
isomerohydrolase then mediates the isomerisation of this 
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molecule to 11-cis retinol and the energy from the hydrolysis of 
the ester bond is thought to drive the isomerisation reaction. The 
protein RPE65 is important for this isomerisation and initially it 
was thought not to have any intrinsic isomerase activity 
(Redmond et al., 1998), however, more recently Nikolaeva et al. 
(2009) have shown it to be an isomerase. Mutations in RPE65 are 
responsible for around 2% of autosomal recessive RP cases and 
16% of LCA cases (Morimura et al., 1998). Following 
isomerisation, the alcohol is oxidised by 11-cis retinol 
dehydrogenase to the aldehyde form (11-cis retinal), a reaction 
accelerated by cellular retinaldehyde binding protein (CRALBP, 
Saari et al, 2001), which also chaperones the 11-cis retinal in the 
RPE cytoplasm. Alternatively, the 11-cis retinol can be esterified 
and stored as 11-cis retinyl esters in the RPE. The 11-cis-retinal 
diffuses across the sub-retinal space to the photoreceptor outer 
segment where it can again bond to an opsin protein to form 
visual pigment. 
 
1.3.2 Other Roles of the RPE 
Another main role of the RPE that has been previously mentioned 
is the engulfment and degradation of distal outer segments to 
counter the constant renewal of the outer segments. Each RPE 
cell contacts 50 to 100 photoreceptor outer segments and engulfs 
a large amount of these shed segments, which constitutes a high 
level of phagocytic activity especially in light of the fact that the 
RPE cells themselves continue throughout life with little or no 
turnover. A significant consequence of this activity is a progressive 
build-up of lipofuscin (a residue of outer segment breakdown) and 
it is thought this molecule could be a factor that predisposes the 
RPE to disease. Increased lipofuscin is thought to reflect increased 
outer segment turnover or the inability of the RPE to process the 
outer segment debris. 
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Cells of the RPE also absorb excess light by way of melanin 
granules and transport oxygen, nutrients and cellular wastes 
between the photoreceptors and the choroid. Separating the RPE 
layer from the blood vessels of the choroid is Bruch’s membrane, a 
thin structure of collagen and elastic fibres. 
 
The choroid is a vascular layer of the eye that provides 
nourishment to the outer layers of the retina and is composed of 
different structures: the choriocapillaris, Haller’s layer, Sattler’s 
layer and the suprachoroid. The choriocapillaris is a densely 
branching capillary network of the choroidal circulation that 
supplies nutrients and oxygen to the photoreceptors. 
 
1.4 Summary 
The retina is formed from various cell types that communicate 
with each other to produce a signal sent via the optic nerve to the 
brain, which produces a visual image. It is important to have a 
basic understanding of the physiology of the eye and the 
molecular biology of the visual process in order to better 
understand how faults in any part of the structure and/or visual 
pathways may lead to impaired vision. In such a small area the 
eye packs in millions of highly sensitive cells that are interacting 
in different ways and not simply sending signals to the brain but 
rather combining, superimposing and collecting a variety of 
information that is then forwarded for processing. If even a few 
cubic millimetres of the retina is damaged it can greatly reduce an 
individuals ability to respond to visual stimuli. Due to the complex 
structure and numerous biological processes occurring in this 
organ, a small error in any part of the visual system may have a 
detrimental effect on the sight of an individual. In this project 
attempts will be made to establish the genetic cause of a number 
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of retinal dystrophies, which will hopefully lead to a better 
understanding of the complex molecular pathways involved in 
retinal function and dysfunction. 
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2. INHERITED RETINAL 
DYSTROPHIES 
An Overview 
 
2.1 Retinal Degeneration 
Inherited retinal dystrophies are a heterogeneous group of 
disorders, which result in degeneration of the retina. This may 
begin with a mutation in a gene that causes a problem in one 
particular cell type that then leads to the malfunctioning of that 
cell. As processes within the cell are disrupted this triggers 
apoptosis and therefore death of the cell. Depending on the 
genetic cause, cell death may be confined to one particular cell 
type, for example in cone dystrophies. In other retinal dystrophies 
the genetic fault will lead to apoptosis of a particular cell type but 
then loss of that cell type will trigger apoptosis of others, as in 
retinitis pigmentosa (RP) where primary loss of rods then leads to 
loss of cones, as cone survival is dependent on rods. The genetic 
cause therefore determines whether vision in the periphery (as in 
RP) or central vision (as in macular and cone dystrophies) is lost. 
Cell death can occur in all layers of the retina, including the 
neuronal cells of the inner and outer retina and the RPE. Some 
disorders involve not only loss of the neuronal cells and RPE but 
also the vasculature and formation of sub-retinal neovascular 
membranes (SRNVM), result in an unstable phenotype. 
 
Inherited retinal dystrophies have been shown to be caused by 
mutations in over 250 different genes (listed online at the retinal 
disease database: http://www.sph.uth.tmc.edu/RetNet/) and 
show a range of inheritance patterns. For example, RP affects 1 in 
3,500 people worldwide and autosomal dominant, autosomal 
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recessive, X-linked and sporadic patterns of inheritance have all 
been reported (Wang et al., 2005). In addition to this, a retinal 
dystrophy that mimics RP has been seen in association with 
mutations of mitochondrial DNA (Holt et al., 1990). RP is a 
degenerative process that primarily affects the rod photoreceptors 
and is characterised by night blindness, progressive loss of 
periphery vision with an eventual complete loss of vision. Central 
vision and macular function are generally preserved until the later 
stages of disease when cone loss occurs. At least 36 genes have 
been associated with this disorder but despite this the genetic 
cause of over 50% of RP cases have yet to be identified. Rhodopsin 
alone has had more than 100 mutations associated with RP and 
mutations in the RHO gene account for around 25% of autosomal 
dominant RP cases in the US. Other genes in which mutations 
have been identified as causing RP are shown in Table 2.1.  
 
The rod-cone dystrophy leber congenital amaurosis (LCA) presents 
from birth or within the first few months of life and generally 
shows an autosomal recessive pattern of inheritance. LCA 
accounts for ~5% of retinal disease cases and is characterised by 
visual loss at birth, minimal or absent ERG, nystagmus and a 
variety of fundus changes. Fifteen genes/loci have so far been 
associated with this disorder and can be seen in Table 2.2. 
 
In cone-rod dystrophies vision loss is caused by initial 
deterioration of cones followed by loss of rods. So far around 
twelve genes have been identified as being involved in this form of 
retinal degeneration and these are shown in Table 2.2. 
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Table 2.1 Genes in which mutations have been identified as 
causing forms of RP. 
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Table 2.2 Genes in which mutations have been identified as 
causing various forms of inherited retinal dystrophy. 
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2.2 Macular Dystrophies 
An interesting group of inherited retinal dystrophies are those that 
specifically affect the macula. This is the area of the eye that 
surrounds the fovea and permits the greatest visual acuity.  It is 
not known why there are disorders that specifically affect this 
region and defining the macula and its functions will help lead to 
a better understanding of this.  
 
Inherited macular diseases lead to central vision loss and atrophy 
of the macula and underlying RPE. There are numerous inherited 
macular dystrophies, many with similar pathology to AMD and 
that show a range of inheritance patterns. The genetic causes of 
macular dystrophies have been reviewed by Michaelides et al. 
(2003a), Voo and Small (2004) and Mellough et al. (2009).  
 
2.2.1     Stargardt Disease 
This is the most common form of hereditary macular degeneration 
and accounts for around 7% of all macular dystrophies with 90-
95% of these presentations in the form of STGD1. There are three 
types of STGD: autosomal recessive STGD1 (Figure 2.1a); 
autosomal dominant STGD-like macular dystrophy STGD2/3 
(Figure 2.1b-c) and; autosomal dominant STGD-like disease 
STGD4. 
 
STGD1 is a recessive form of juvenile macular degeneration and 
was first described by Karl Stargardt in 1909. The disorder is 
characterised by a progressive loss of central vision with onset 
occurring in the first or second decade of life. Fundus 
flavimaculatus (FFM) is a retinal disorder with clinical features 
very similar to those of STGD1 and is considered to be a late-
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onset, slow progressive form of Stargardt’s disease (Noble and 
Carr, 1979; Gelisken and Laey, 1985). 
 
 
 
 
 
 
 
Both STGD1 and FFM are known to be caused by mutations in 
ABCA4, which encodes ATP-binding cassette transporter. This 
plays an important role in the recycling of retinoid and knockout 
mice lacking a functional abca4 gene exhibit abnormalities in their 
visual cycle (Weng et al., 1991). Mutant ABCA4 leads to the 
condensation product N-ret-PE  (Setion1.3.1) remaining inside the 
disc where it begins to form other intermediates. When these discs 
get phagocytosed by the RPE, the intermediates are converted to 
N-retinylidene-N-retinylethanolamine (A2E), a component of 
lipofuscin (Section 1.3.2). Mata et al. (2000) have shown that A2E 
levels are elevated in the RPE of abca4 knockout mice. This 
product has adverse effects (reviewed by Sparrow et al., 2005) 
such as interfering with lysosomal functions (Holtz et al., 1999), 
resulting in failure of the RPE to completely digest phospholipids 
(Finnemann et al., 2002). Over 500 mutations in ABCA4 are 
known to cause Stargardt’s disease and these can occur as 
frameshift, splice-site, deletions/insertions and missense forms. 
Figure 2.1 a) Fundus image taken from Michaelides et al. (2003a) 
of a typical patient with STGD; b) fundus image taken from an 
individual with Stargardt-like dystrophy caused by a Tyr2700X 
mutation in ELOVL4 and c) fluorescein angiography of the same 
individual as in (b). Images (b) and (c) are taken from Maugeri et 
al. (2004). 
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Mutations in ABCA4 are also responsible for autosomal recessive 
RP (Martinez-Mir et al., 1998 and Nasonkin et al., 1998), CORD 
(Cremers et al., 1998 and Maugeri et al., 1998) and FFM (Rozet et 
al., 1998). Michaelides et al. (2007) have also shown that ABCA4 
mutations occur in patients with BEM. 
 
The phenotype of STGD3 is very similar to that of STGD1 and 
based on fundus examination alone it is difficult to distinguish 
between the two types.  However, they do differ at the DNA level 
for whereas variations in ABCA4 result in STGD1, mutations in 
the gene elongation of very long chain fatty acids-like 4 (ELOVL4) 
result in STGD3 (Maugeri et al., 2004). Zhang et al. (2001) 
identified a five base pair deletion (c.797-811delAACTT) in exon 6 
of this gene, which causes a frameshift mutation and premature 
termination of the encoded protein. A second nucleotide variation 
in ELOVL4 associated with STGD3 was identified by Bernstein et 
al. (2001), which was also found to cause butterfly macular 
dystrophy and bull’s-eye maculopathy. This variation consists of 
two single base pair deletions separated by four nucleotides at the 
same location as the 5 bp deletion and which also results in a 
frameshift mutation and truncation of the ELOVL4 protein. In 
rhesus monkey and mouse retina, expression of this protein was 
found exclusively in rod and cone photoreceptors (Zhang et al., 
2001). However, the specific role of this protein in the retina is 
unknown and thus the mechanism by which the deletions cause 
disease is currently unclear (review of STGD3 pathology: 
Vasireddy et al., 2010).   
 
STGD4 exhibits a phenotype very similar to STGD1 and STGD3. 
Kniazeva et al. (1999) characterised this disorder and excluded 
linkage to either of the STGD1 and STGD3 loci and found it 
associated to 4p. Michaelides et al. (2003a) reported on a 
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missense mutation in PROM1 that co-segregates with STGD4, 
mutations in which also cause RP and CORD. PROM1 encodes 
human prominin (mouse)-like 1 protein, a member of the 
prominin family of 5-transmembrane domain proteins that is 
expressed in retinoblastoma cell lines and adult retina (Jászai et 
al., 2007). Further details of this protein will be discussed in 
Section 10 in relation to autosomal dominant Bull’s-eye macular 
dystrophy (MCDR2). 
 
2.2.2     Other Macular Dystrophies 
Other macular dystrophies include the pattern dystrophies, which 
are a group of inherited disorders of the RPE that show yellow, 
orange or grey deposits within and under the RPE at the macula 
in a variety of distributions (Musarella, 2001). Butterfly macular 
dystrophy (BMD) is one form of distribution and mutations in the 
RDS gene are the predominant cause of the disease state with a 
second locus for BMD linked to 5q21.1-q33.2. Most mutations in 
the RDS gene associated with pattern dystrophies are missense 
mutations in the intra-discal D2 loop of the peripherin protein. 
This area is important for the tetrameric assembly of 
peripherin/Rds dimers (Goldberg and Molday, 1996) and 
heterotetrameric complex formation with the homologous protein 
ROM1 (Goldberg et al., 1995). Formation of these dimers is 
required for correct targeting and incorporation into newly formed 
rod outer segment disc membranes (Loewen et al., 2003). 
Mutations in RDS have previously been described to cause 
autosomal dominant RP and CORD but they are also known to 
cause adult vitelliform macular dystrophy (AVMD) and multifocal 
vitelliform macular dystrophy (Wells et al., 1993; Boon et al., 
2007). Multifocal vitelliform macular dystrophy, better known as 
Best disease, is often confused with AVMD. Best disease is 
clinically heterogenous with the most prominent cause being 
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mutations in bestrophin-1 (BEST1/VMD2, Marquardt et al., 1998). 
Numerous mutations in BEST1 have been identified but other 
genes associated with this phenotype are yet to be found. Biallelic 
mutations in BEST1 have been shown to cause autosomal 
recessive bestrophinopathy (Burgess et al., 2008) and mutations 
that disrupt splicing have been shown to cause autosomal 
dominant vitreoretinochoroidopathy (ADVRC, Yardley et al., 2004). 
 
Generally the pattern dystrophies do not cause significant visual 
loss. In contrast to this, the macular disorder Doyne honeycomb 
retinal dystrophy results in patients becoming legally blind, which 
occurs due to macular atrophy and, occasionally, sub-retinal 
neaovascular membrane (SRNVM) development. The small round 
yellow-white deposits that appear under the RPE of the macula 
and around the optic disc that are characteristic of this disorder, 
appear in early adult life. Despite this, good visual acuity is 
maintained until the fifth decade of life, after which, vision may be 
lost due to macular atrophy and subretinal neovascular 
membrane (SRNVM). A single mutation (Arg345Trp) in the gene 
encoding EGF-containing fibulin-like extracellular matrix protein 
1 (EFEMP1) has been identified in individuals exhibiting Doyne 
honeycomb retinal dystrophy (Stone et al., 1999). The mutation 
Arg345Trp was also associated with Malattia Leventinese, which is 
an autosomal dominant macular disorder characterised by yellow-
white drusen deposits that accumulate beneath the RPE. Aberrant 
accumulation of EFEMP1 also underlies drusen formation in AMD 
(Marmorstein et al., 2002). 
 
Other genes in which mutations have been identified as causing 
autosomal dominant macular dystrophies include the previously 
mentioned FSCN2 (Wada et al., 2003), mutations in which also 
cause autosomal dominant RP (Wada et al., 2001).  Similarly, 
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GUCA1B mutations were previously described as causing 
autosomal dominant RP and mutations in this gene have also 
been associated with macular degeneration (Sato et al., 2004). 
 
Sorsby’s fundus dystrophy is a macular dystrophy that results in 
visual loss from SRNVM (Weber et al., 1994b). Mutations in exon 
5 of the tissue inhibitor of metalloproteinase-3 gene (TIMP3) have 
been identified as being responsible for Sorsby’s fundus dystrophy 
(Weber et al., 1994a). 
 
Other autosomal dominant macular dystrophy loci have been 
identified at chromosome 5p15.33-p13.1 (MCDR3), 6q14.1-q16.2 
(MCDR1/PBCRA), 14q11.2 (MCDR4) and 19q13.31-q13.32 
(MCDR5). The first three of these loci will be investigated in this 
project. 
 
2.3 Complex Disorders – Age-Related Macular 
Degeneration 
Of the forms of macular degeneration, AMD is the most common, 
affecting ~30% of adults aged 75 or over in the US (Friedman et 
al., 2004). AMD is a complex disorder meaning it is influenced by 
numerous risk factors including age, cigarette smoking and 
hypertension (Hyman and Neborsky, 2002). Epidemiological 
studies have shown that family members are at increased risk of 
the disease (Smith and Mitchell, 1998) and twin and family-based 
studies provide evidence for a genetic basis (Seddon et al., 2003).  
For complex disorders such as AMD in order to find genetic 
factors relevant to this disorder, twin-based and association 
studies are required. Whereas the dominant and recessive 
disorders previously covered are the result of mutations passed 
down from one generation to the next, the genetic cause 
Chapter 2 
     Genetic Analysis of Inherited Retinal Dystrophies 57 
identification can be identified through linkage studies on affected 
families. For complex disorders such analysis cannot be 
undertaken as a genetic change is not the sole cause of the 
disorder but is instead a contributing factor and so may not occur 
in all affecteds. However, twin and association studies allow for  
mutations to be identified that are contributors to the 
development of the disease state. Many groups have identified risk 
loci in recent years and looked for mutations in genes such 
EFEMP1, RDS, BEST1 and TIMP3, which are known to be involved 
in macular degeneration (Section 2.2.2). No mutations in these 
genes were associated with AMD, as reviewed by Patel et al. 
(2008). Many genes involved in the immune system have been 
implicated in AMD and in particular, complement components. 
The most important genetic associations in AMD involved 
complement factor H (CFH, Hageman et al., 2005). Following the 
association of CFH with AMD, other complement factors were 
investigated. CFB and C2 screenings showed that 74% of AMD 
subjects lacked a protective variant of these genes found in 56% of 
subjects without AMD (Gold et al., 2006). A C3 variant has also 
been associated with AMD by Yates et al. (2007). Other genes 
associated with AMD are listed in Table 2.3.  
 
Table 2.3 Genes associated with AMD. 
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2.4 Systemic Disorders  
Inherited retinal dystrophies can also be seen in combination with 
other inherited disorders. For example, RP may be secondary in 
aetiology and is known to be part of over 30 syndromes (Wang et 
al., 2005) and in such conditions is usually inherited in an 
autosomal recessive manner, as in the case of Usher syndrome 
and Bardet-Biedl syndrome. Usher syndrome is the most common 
form of deaf-blindness and is clinically and genetically 
heterogeneous with eight causative genes identified so far whose 
encoded proteins appear to be part of a dynamic complex present 
in hair cells of the inner ear and in photoreceptor cells of the 
retina (Kremer et al., 2006). Hearing loss for Usher syndrome is 
sensorineural and most severe for high frequencies. Based on the 
age of onset of RP, progression of hearing loss and the severity of 
the symptoms, this syndrome can be identified as one of three 
clinical subtypes (Smith et al., 1994). The genes associated with 
the Usher syndrome subtypes are reviewed by Reiners et al. 
(2006) and largely encode Usher proteins. The Usher proteins are 
essential in the morphogenesis of the stereocilia bundle in hair 
cells and in the calycal processes of photoreceptor cells in addition 
to being important in the synaptic processes of these cell types 
(Kremer et al., 2006). As the Usher interactome is involved in 
pathways common to the inner ear and retina, when it becomes 
disrupted Usher syndrome results. Other disorders that include 
an ocular and hearing phenotype include Stickler and Wolfram 
syndromes. Stickler syndrome is characterised by facial-skeletal 
abnormalities, sensorineural hearing loss, glaucoma, myopia and 
retinal detachment (Bennett and McMurray, 1990). Genes 
identified as causing this disorder include COL11A1, COL9A1 and 
COL2A1 (Richards et al., 1996; van Camp et al., 2006; Hoornaert 
et al., 2010). Wolfram syndrome is characterised by diabetes, 
optic atrophy and deafness (Cremers et al., 1977). The cause of 
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this disorder has been found to be mitochondrial deletions (Rötig 
et al., 1993) but the genes WFS1 and WFS2 have also been 
identified (Rigoli et al., 2010; Ajlouni et al., 2002). 
 
Bardet-Biedl syndrome (BBS) is a rare developmental ciliopathy 
disorder that exhibits a range of clinical presentations, including 
retinal dystrophy, learning difficulties, obesity, polydactyly or 
syndactyly and renal dysgenesis. The genetics of BBS are quite 
complex and though initially identified as a recessive trait it 
appears to be a triallelic disorder, i.e. three mutant alleles at two 
loci are necessary for pathogenicity (Katsanis et al., 2001). More 
recently, Webb et al. (2009) described BBS as an autosomal 
recessive trait, genetically heterogenous ciliopathic condition 
caused by mutations in multiple genes. Other disorders combine 
macular dystrophies with physical abnormalities such as in the 
rare association of macular dystrophy and ectodermal dysplasia 
and ectrodactyly (EEM syndrome) and Sorsby syndrome. This 
latter disorder is not to be confused with Sorsby’s fundus 
dystrophy (Section 2.4.3), for this is a rare, dominantly inherited 
combination of bilateral colobomas and apical dystrophy of the 
hands and feet (Thompson and Baraitser, 1988). It is not yet 
known what the genetic cause of this disorder is but Bacchelli et 
al. (2003) have shown that it is unlikely to be due to mutations in 
ROR2, which cause brachydactyly type B.  
 
Whereas Sorsby syndrome is a dominant disorder in which 
patients exhibit an ocular phenotype in association with 
abnormalities of the hands and feet, EEM shows an autosomal 
recessive mode of inheritance. In 2005, Kjaer et al. reported that 
EEM appears to be the result of distinct homozygous mutations in 
CDH3 (cadherin-3 precursor), a gene also responsible for 
congenital hypotrichosis with juvenile macular dystrophy (HJMD; 
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Indelman et al., 2007). Shimomura et al. (2008) determined CDH3 
to be a p63 target gene important in the development of the 
human limb bud and hair follicles. 
 
2.5 Disorders Investigated in this Project 
Knowing the genetic cause of an inherited disorder not only 
provides a better understanding of function in the retina but also 
clues to the pathology of a disorder. For example, in the case of 
STGD1, deposits in the RPE are visible by retinal imaging yet they 
are not directly due to the gene mutated. ABCA4 mutations 
disrupt the normal function of the ABCA4 protein, which sits in 
the photoreceptor membrane discs. The ineffective ABCA4 causes 
disruption of the retinoid cycle, which leads to build up of 
lipofuscin in the RPE. This accumulation is toxic to the RPE cells 
and triggers apoptosis. Death of the RPE cells leads to death of 
nearby photoreceptors as they rely on the RPE for survival. So in 
the case of STGD1, identifying the genetic cause led to a better 
understanding of the disease pathology and, in particular, 
lipofuscin composition. It is also important to discover the genetic 
cause of disorders in order to develop treatments to either prevent 
the degeneration or alleviate symptoms (for example, anti-vascular 
endothelial growth factor treatments are used to prevent further 
blood vessels forming across the macula in the wet form of AMD). 
But for most inherited disorders the hope is that gene therapies 
can be developed to replace the faulty gene in the affected cell 
type, producing enough functional protein to recover correct 
function in the retina. The retina is a unique environment for gene 
therapy and advancements in this treatment method are 
occurring quickly. Gene therapy currently focuses on using the 
adeno-associated virus (AAV), which infects human cells but does 
not cause disease and results in a very mild immune response. In 
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2007, the first clinical trial of gene therapy using AAV-2 for LCA 
cases with RPE65 mutations began at the UCL Institute for 
Ophthalmology and Moorfields Eye Hospital, with two further 
trials in the US. The results were promising and demonstrated 
that the technique is feasible, safe and can lead to improvement in 
visual function (Bainbridge et al., 2008 and Maguire et al., 2008). 
Current studies focus on ensuring the gene delivery is efficient 
and cell type specific by use of different viral capsids and 
promoters (Allocca et al., 2007). Candidates for gene therapies 
come from investigations into the genetic causes of diseases, as in 
this project. If the genetic problem can be found then we will not 
only gain further insight into the functions of the retina and the 
pathology of the disorder, but also a chance of developing a 
treatment for it. Macular dystrophies affect central vision and 
therefore have a distinct impact on the lives of individuals 
suffering from such disorders. If retina function, and 
subsequently vision, can be restored to patients this would have a 
distinct positive effect on their lives. 
 
This project will investigate the genetic causes of a number of 
macular dystrophies in addition to a cone-based disorder, which 
are detailed below. 
 
2.5.1     North Carolina Macular Dystrophy 
North Carolina macular dystrophy (NCMD/MCDR1) was first 
described over 40 years ago yet the genetic cause continues to 
elude scientists. Unrelated NCMD families have been reported in 
the UK (Reichel et al., 1998), Germany (Pauleikhoff et al., 1997), 
France (Small et al., 1997), Belize (Rabb et al., 1998), America 
(Small et al., 1998) with a suspected NCMD family in Korea (Kim 
et al., 2006). Initial studies reporting the disease used various 
names to describe the disorder as a result of the variable 
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phenotype seen, including; central areolar pigment epithelial 
dystrophy (CAPED; Frank et al., 1974; Fetkenhour et al., 1976; 
Hermsen and Judisch, 1984); central pigment epithelial and 
choroidal degeneration (Leveille et al., 1982) and central retinal 
pigment epithelial dystrophy (Klein and Bresnick, 1982). The 
disorder was first described by Lefler et al. (1971) in the 
descendants of a large Irish family settled in North Carolina in the 
late eighteenth to early nineteenth century. The CAPED families 
identified in other early studies were later revealed to be 
descendants of the three founding brothers of the original North 
Carolina family (Small et al., 1992a) and thus a common name for 
the disorder was developed based on this origin. Small (1998) 
considered 13 unrelated NCMD families of various ethnic origins 
and found no genetic heterogeneity associated with this disorder 
and all reported MCDR1 families have been linked to the same 
region on chromosome 6q16. 
 
MCDR1 shows some clinical and histopathological similarities to 
AMD; it is characterised by non-progressive atrophy of the RPE 
and overlying photoreceptor cells, abnormal accumulation of 
drusen, choroidal neovascularisation and loss of central vision. 
However, NCMD is an autosomal dominant, highly penetrant 
disorder with congenital or infantile onset, whereas AMD is a 
complex disorder that generally develops in the fifth decade of life 
(Section 2.5). The extent of the clinical manifestations observed in 
NCMD varies and forms the basis of the grades that define the 
severity of the phenotype. Small et al. (1992b) outlined three 
grades of NCMD based on fundoscopic appearances: in Grade I 
there are small drusen-like yellow deposits in the central macula 
(Figure 2.2a). Such patients are usually asymptomatic with 
normal or slightly subnormal visual acuity; in Grade II there are 
confluent drusen. Visual acuity is usually near normal unless 
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there is development of subretinal choroidal neovascular 
membranes (SRNVM; Figure 2.2b). Grade III denotes well-
demarcated chorioretinal atrophy with hyper-pigmentation 
bordering the lesion (Figure 2.2c). 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Generally the disease is stable except in individuals who develop 
SRNVM. The disease appears to be early-onset in all cases and 
Rhee et al. (2007) reported on a 3-year old with subfoveal 
neovascularisation that was first identified at 34 weeks with 
bilateral atrophy of the choroid and RPE confined to the macula. 
 
Szlyk et al. (2005) performed comprehensive functional vision 
assessment of five individuals with NCMD and concluded that 
despite the phenotypic variability of this disorder, visual acuity of 
20/200 or better appears to be maintained irrespective of the 
clinical grade of severity in all patients. The group also reported 
that visual acuity does not appear to significantly change over 
time and though the fundus appearance in NCMD is typically 
bilaterally symmetrical, characteristically one eye predominates in 
terms of visual function.  
 
Figure 2.2 Fundus 
images taken from 
Yang et al. (2007): a) 
Grade I MCDR1; b) 
left eye of an MCDR1 
patient with new 
choroidal 
neovascularisation 
(CNV) and c) Grade III 
MCDR1. See text for 
grade descriptions. 
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Many macular dystrophies exhibit an abnormal fundoscopic 
appearance confined to the macula yet present 
electrophysiological, psychophysiological or histophysiological 
evidence of more widespread photoreceptor and RPE dysfunction 
(Scullica and Falsini, 2001). However, MCDR1 
psychophysiological and electrophysiological tests have revealed 
that normal peripheral retinal function is retained (Small, 1998). 
As MCDR1 appears to be macular-specific, the function of the 
gene involved in causing the disease will give insight into macular 
development and function.  
 
Other retinal disorders have been linked to nearby chromosomal 
regions and in the case of progressive bifocal chorioretinal atrophy 
(PBCRA, Section 8), to an overlapping region. PBCRA, another 
developmental macular disorder, has a more severe phenotype 
than MCDR1 but it is possible that different mutations in the 
same gene cause both disorders. A retinal disease with phenotypic 
similarities to MCDR1 is dominant drusen and macular 
dystrophy, which has been linked to 6q14 (Kniazeva et al., 2000) 
but as with MCDR1, no specific genetic change has yet been 
identified. The previous genetic analysis conducted on MCDR1 
families and the protocol used in this project are detailed in 
Chapter 5. 
 
2.5.2     North Carolina-like Macular Dystrophy 
The phenotype of this disorder is very similar to that of MCDR1 
but linkage to 6q was excluded and linkage to 5p determined. So 
far, North Carolina-like macular dystrophy (MCDR3) has only 
been reported in a single family (Figure 2.3) in which the disease 
was characterised as resembling North Carolina macular 
dystrophy. Despite the similarities between the two disorders, the 
MCDR1 locus was excluded and the disorder mapped to  
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chromosome 5 (Michaelides et al., 2003c). The disease is 
characterised by an early age of onset (within the first five years of 
life) and vision is generally good despite the macular abnormalities 
seen, which range from multiple drusen-like deposits to focal 
atrophy and pigmentation (Figure 2.4 a-c). 
 
The disease appears to be non-progressive though one individual 
(V:7) did show an increase in drusen-like deposits and retinal 
pigmentation over a 5-year period but there was no evidence of a 
change in the macular appearance during this time. As with 
MCDR1, the retinal phenotype varied amongst individual family 
members and all three grades of lesion characterised in MCDR1 
were seen in the MCDR3 pedigree (Figure 2.4 a-c). Additionally, 
the visual field loss was not widespread and demonstrated only 
over the central macular lesions, suggesting this dystrophy is also 
localised to the macula. Two significant differences between 
MCDR1 and MCDR3 were apparent: mild abnormalities in colour 
vision in some of the MCDR3 affected individuals and evidence of 
disease progression, though this was only noted in a single case. 
 
Whereas MCDR1 shares aspects of its phenotype with AMD, 
MCDR3 shows some differences to the complex disorder. In 
particular, concentric perifoveal areas of increased 
autofluorescence (AF) were found to correspond to the drusen-like 
deposits (Figure 2.4 a & b), whereas in AMD there is generally 
little association between the drusen and the AF (von Rückmann 
et al., 1997). The mechanism of drusen formation in both MCDR1 
and MCDR3 is currently unclear but it is believed that 
identification of the causative genetic mutations of the two 
disorders will aid our understanding of this process. The genetics 
of MCDR3 are considered in Chapter 6. 
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2.5.3     North Carolina-like Macular Dystrophy with 
Progressive Sensorineural Hearing Loss 
Again this disorder has a very similar phenotype to MCDR1 yet as 
with MCDR3, it does not link to 6q. Also as with the MCDR3 
phenotype, this disorder has currently only been reported in a 
single publication by Francis et al. (2003) studying a four-
generation family (Figure 2.5). This autosomal dominant inherited 
macular dystrophy is described as being clinically similar to 
MCDR1 but affected individuals also exhibit progressive adult-
onset sensorineural hearing loss. The typical pattern of 
sensorineural hearing loss segregating with the ocular phenotype 
is progressive, bilateral, symmetrical and high frequency. 
 
Figure 2.4 All images taken from Michaelides et al. (2003c): a) 
fundus photograph of patient IV:14; b) shows the fundus AF image 
from the same individual as in (a) and demonstrates increased AF 
at the macular that corresponds to the drusen-like deposits visible 
in (a) and c) fundus photograph of patient V:7 showing macular 
RPE atrophy and pigment clumping with surrounding drusen-like 
deposits. 
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Figure 2.5 Four-generation pedigree of a family with autosomal 
dominant macular dystrophy and progressive sensorineural 
hearing loss. Circles indicate patient samples run on the 
Affymetrix 250K Sty I chips. 
 
 
As seen in both MCDR1 and MCDR3 families, the ocular 
phenotype of the MCDR4 disorder varied among different family 
members. Some individuals have fine drusen-like deposits at the 
macula and pigmentary disturbance at the RPE (Figure 2.6a), a 
phenotype consistent with MCDR1 grade 1 appearances. Other 
individuals show a well-demarcated subfoveal area of chorioretinal 
atrophy with pigment hypertrophy bordered by fibrosis (Figure 
2.6b), which is consistent with grade III MCDR1 lesions. As with 
both MCDR1 and MCDR3, the electrophysiological findings of the 
affected MCDR4 individuals were essentially normal, which 
implies the disorder is restricted to the macula region. The clinical 
appearances were non-progressive and evident soon after birth 
whilst the sensorineural hearing loss was progressive and 
typically became significant in the fourth decade of life. 
 
Other retinal degenerations with associated hearing loss have 
been described, with the most common being Usher syndrome in 
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which the hearing defect is associated with retinitis pigmentosa 
(Kimberling and Möller, 1995, Section 2.4). This combination of 
retinal and hearing defects is unsurprising when considering the 
hair cells of the cochlear and retinal photoreceptors show 
structural similarities and have shared gene expression (Kremer et 
al., 2006). In Usher syndrome, both cone and rod photoreceptor 
systems are involved and the ocular disease is progressive, this 
contrasts to MCDR4, which appears to be a non-progressive 
macular-specific disorder with associated deafness. Similar 
disorders have been reported but appear to be caused by a 
mitochondrial defect (Harrison et al., 1997; Souied et al., 1998). 
Identification of the disease-causing gene will not only increase 
our understanding of the mechanisms of macular development 
but also of the ear. The genetics of MCDR4 are considered in 
Chapter 7. 
 
 
Figure 2.6 Fundus images taken from Francis et al. (2003): a) 
from patient III:1, showing drusen-like deposits and retinal 
epithelial atrophy centred on the macula and b) from patient III:3, 
showing subfoveal chorioretinal atrophy with pigment hypertrophy 
and fibrosis at the edge. 
 
2.5.4     Progressive Bifocal Chorioretinal Atrophy 
Progressive bifocal chorioretinal atrophy (PBCRA) was identified in 
a large five generation British family by Kelsell et al. (1995), Figure 
2.7. Genetic linkage analysis was conducted and the PBCRA 
disease locus was subsequently mapped to chromosome 6q, which 
overlaps with the MCDR1 locus. The two disorders are, however, 
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clinically distinct. This congenital chorioretinal dystrophy was first 
reported by Douglas et al. in 1968 and the clinical features were 
described by Godley et al. in 1996. PBCRA is characterised by 
progressive macular and nasal atrophic lesions, nystagmus, 
myopia and poor vision. It has two distinct foci of atrophy: a 
temporal focus present at birth that then enlarges throughout life 
and a nasal focus that develops in the early years of life. Affected 
individuals show a reduction in colour vision and visual acuity 
though sight is never completely lost. Unlike MCDR1 and the 
NCMD-related disorders, PBCRA findings reflect widespread 
abnormality of photoreceptors and RPE as revealed by 
electroretinography (ERG) and electrooculography (EOG). 
Individuals also exhibit poor colour vision, which is a 
characteristic only seen in one of the other NCMD-related 
disorders, MCDR3. So, despite overlapping with the MCDR1 
disease locus the two disorders present different phenotypes and 
therefore if the disorders are allelic, it seems likely that different 
mutations are involved. The genetic analysis previously conducted 
on this disorder will be considered in Chapter 8. 
 
2.5.5     Split-Hand/Split-Foot Malformation with North 
Carolina Macular Dystrophy 
In this project two families will be investigated, one English and 
one French (Figure 2.8), both exhibit a NCMD phenotype with 
additional bilateral macular ‘colobomata’ and skeletal 
abnormalities of the digits. The term macular coloboma, although 
commonly used, is actually a misnomer. Coloboma occur when 
there is a failure during development of the closure of the foetal 
fissure. Macular colobomas are not caused by such defects but 
represent a failure in the development of the fovea or macular 
atrophy. In the French family, some affected members have 
isolated macular ‘colobomata’ whilst others have ‘colobomata’ with  
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digit anomalies (brachydactyly or SHFM). In both families the 
SHFM phenotype is typically variable amongst members of the 
same family whilst the presence of macular colobomata is fairly 
uniform amongst the affected individuals. For the French family 
(9.1b), individuals II:2, II:6 and V:1 exhibit macular coloboma; 
III:1, III:3, IV:1 and IV:3 exhibit coloboma and apical dystrophy 
with III:3 and IV:1 also exhibiting pachyonychia. Individual II:4 
has macular dystrophy. Images in Figure 2.9. 
 
 
a)  
b)  
 
Figure 2.8 SHFM and NCMD pedigrees: a) a three-generation 
English family and b) a five-generation French family. Circled in 
red are samples run on the Affymetrix 250K SNP Chips. 
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Bilateral colobomata have been associated with other forms of 
inherited retinal diseases, such as RP (Parmeggiani et al., 2004) 
and LCA phenotypes (Ozgül et al., 2006). Another association of 
ocular and digit phenotypes has been seen in Sorsby syndrome, a 
rare, dominantly inherited combination of bilateral colobomas and 
apical dystrophy of the hands and feet in the form of 
brachydactyly type B (Thompson and Baraitser, 1988). A mutation 
in ROR2 (receptor tyrosine kinase-like orphan receptor 2) has 
been found to cause brachydactyly type B but it does not cause 
Sorsby syndrome (Bacchelli et al., 2003). In 2002, Giltay et al. 
reported on a patient with iris coloboma in the left eye, choroidal 
coloboma in the right eye and SHFM and showed this did not 
result from a mutation in TP63 (tumour protein p63, mutations in 
Figure 2.9 Top left to right: the 
coloboma of II:2; the retina of II:4 
exhibiting macular dystrophy and; the 
coloboma of III:1. The images to the 
right show the digit phenotype of III:1. 
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which cause SHFM4). Another rare condition combining abnormal 
ocular and digit phenotypes is ectodermal dysplasia, ectrodactyly 
and macular dystrophy (EEM). This is thought to be an autosomal 
recessive disorder in which the ocular findings show extensive 
retinochoroidal atrophy with diffuse retinal pigmentation (Yildirim 
et al., 2006). Mutations in CDH3 (cadherin 3) have been found to 
cause EEM (Kjaer et al., 2005) and hypotrichosis with juvenile 
macular dystrophy (HJMD; Indelman et al., 2007). 
 
Split-hand/split-foot malformations (SHFM, also called 
ectrodactyly) are commonly an autosomal dominant trait with 
reduced penetrance and clinical variability. SHFM is a limb 
deformity affecting the hands and feet and can present with 
syndactyly, median clefts and aplasia/hypoplasia of the 
phalanges, metacarpals and metatarsals. The severity of the 
phenotype varies within single families and ranges from non-
penetrance to syndactyly in mildly affected individuals and a 
“lobster claw” appearance in severely affected individuals. SHFM 
is genetically heterogeneous with five SHFM loci identified so far. 
SHFM1 was linked to 7q21.3 (Crackower et al., 1996), SHFM2 to 
Xq26 (Faiyaz-Ul-Haque et al., 2005), SHFM3 to 10q24 (Ozen et al., 
1999), SHFM4 to 3q27 (Ianakiev et al., 2000) and SHFM5 to 2q31 
(Bijlsma et al., 2005). Another family has been linked to 8q21.11-
q22.3 (Gurnett et al., 2006). To date, only SHFM4 has a gene 
identified carrying a causative mutation: TP63 (Ianakiev et al., 
2000). TP63 (or p63) is a homologue of the cell-cycle regulator 
TP53, which plays a critical role in regulation of the formation and 
differentiation of the apical ectodermal ridge (AER), a critical 
signalling centre that directs outgrowth and patterning of the 
developing limb (Saunders, 1948).  
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DNA rearrangements resulting in copy number variations have 
been shown to cause SHFM3, which appears to be caused by 
over-expression of BTRC (beta-transducin repeat containing) and 
suppressor of fused homolog (Drosophila), SUFU (Lyle et al., 2006). 
Kano et al. (2005) suggested genome rearrangements are a rare 
cause of SHFM and found duplications of LBX1, BTRC, POLL, 
DPCD and a disrupted extra copy of dactylin in SHFM subjects. In 
mice dactylaplasia (Dac) is a semi-dominant trait that 
phenotypically resembles SHFM and mutant alleles of the mouse 
Dac gene cause the disorder (Chai, 1981). It may be that a similar 
situation is occurring in the SHFM with associated NCMD 
disorder whereby an increase or decease in copy number is 
leading to over or under expression of an important gene. Previous 
genetic analysis will be considered in Chapter 9.  
 
2.5.6     Bull’s-Eye Macular Dystrophy 
Michaelides et al. (2003b) reported and characterised bull’s-eye 
macular dystrophy, which they mapped to 4p15.2-p16.3. Though 
the term ‘bull’s-eye maculopathy’ was first used in the description 
of chloroquine retinopathy (Kearns and Hollenhorst, 1966), bull’s-
eye lesions have also been reported as features of cone-rod 
dystrophy and other macular dystrophies (Kurz-Levin et al., 
2002). MCDR2 is an autosomal dominant form of bull’s-eye 
maculopathy in which sufferers typically show annular RPE 
atrophy and central sparing has been suggested to correspond to 
lipofuscin accumulations in the RPE. The family characterised by 
Michaelides et al. (2003b) displayed concentric areas of increased 
AF in the macula (Figure 2.10b) prior to showing ophthalmoscopic 
evidence of retinal atrophy.  
 
As with the other macular dystrophies being investigated, this 
disease shows an early age of onset with sufferers exhibiting a 
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red-speckled macular appearance that later develops into the 
typical bull’s-eye maculopathy. In most individuals the disease is 
confined to the macular region but electrophysiological evidence 
in older individuals suggests the disease causes more widespread 
retinal dysfunction in later stages. 
 
 
 
 
 
 
Figure 2.10 Images taken from Michaelides et al. (2003b): a) 
fluorescin angiography from an affected individual showing 
localized masking of the choroidal fluorescence in the perifoveal 
area; b) fundus autofluorescence of the same individual as in a) 
showing bull’s-eye type lesion comprising of decreased perifoveal 
autofluorescence bordered peripherally and centrally by increased 
autofluorescnece and c) fundus photograph of another affected 
individual showing bull’s-eye maculopathy with a well-demarcated 
are of RPE and temporal optic disc pallor. 
 
A mutation in human prominin (mouse)-like-1 has been identified 
as causing MCDR2 and this will be detailed in Chapter 10. 
 
2.5.7     Bornholm Eye Disease 
The final disorder being investigated in this project is the cone 
dysfunction Bornholm eye disease (BED). This is an early-onset, 
non-progressive, X-linked disorder in which affected individuals 
exhibit cone dysfunction and a range of ophthalmologic features, 
including: myopia, astigmatism, optic nerve head hypoplasia, 
thinning of the RPE and visible choroidal vasculature. The 
associated myopia is a severe form and was linked to Xq28 and 
designated the MYP1 locus. Patients have an abnormal cone ERG, 
reflecting the cone dysfunction aspect of the disorder. A unique 
feature of this cone dysfunction compared to others is that all 
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affected individuals are dichromats and families have been 
described exhibiting protanopia (Young et al., 2004; Michaelides 
et al., 2005) and deuteranopia (Haim et al., 1988). 
 
Haim et al. (1988) first described this disorder in a study of a large 
Danish family from the island of Bornholm with X-linked infantile 
myopia that also showed astigmatism, impaired vision, hypoplasia 
of the optic nerve heads and deuteranopia. Schwartz et al. (1990) 
confirmed linkage to Xq28 and named the disorder Bornholm eye 
disease and added the clinical signs of ambylopia, reduced ERG 
flicker function and non-specific pigment abnormalities to the 
diagnosis. Young et al. (2004) reported on a second family 
exhibiting the same range of clinical signs. This family were of 
Danish descent but rather than being deuteranopic, all affected 
males were protanopic; this family also linked to Xq27-q28. 
Michaelides et al. (2005) then reported on four British families 
with an X-linked cone dysfunction associated with myopia and 
protanopia. As the L and M cone opsin genes are present in a 
tandem array at the Xq28 linked region, this group conducted 
molecular analysis on the L/M arrays of these families. Two 
families were found to have a hybrid L/M gene, which is a 
common cause of dichromacy but would not explain the cone 
dysfunction. A third family had the exon 4 mutation Cys203Arg, 
which is known to cause cone dysfunction if present in one of the 
first two genes in the array (Winderickx et al, 1992c, Section 
1.2.4). The Cys203Arg mutation abolishes opsin function and 
results in early degeneration of photoreceptors with loss of cone 
function and colour deficiency (Carroll et al., 2009). The 
possibility of variations in the L or M opsin genes as the cause of 
BED was therefore pursued. Further considerations of this are 
contained in Chapter 11. 
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2.6 Aims and Objectives 
For all the macular dystrophies except MCDR2, the aim of this 
project is to determine the genetic basis for disease. For this 
purpose, it was decided that the Affymetrix SNP chips would be 
used to examine haplotypes and copy number variation. Given 
that all the disorders except one have been previously linked, this 
new method was favoured over traditional linkage analysis as it 
has the potential of providing new insights into the nature of the 
disease mutation (see Section 4.1). The data obtained should 
provide a refinement of the disease regions and guide us to the 
primary candidate genes. 
 
For MCDR2, the aim is to identify new families with PROM1 
mutations with additional individuals exhibiting the bull’s-eye 
phenotype also to be screened. For families in which a mutation is 
identified, their allele for the marker D4S1601 will be determined 
for comparison to previously linked families with PROM1 
mutations. 
 
For Bornholm eye disease, two factors indicate the involvement of 
the X-linked opsin genes: the mapping of the disease locus to 
Xq28 (the location of the M and L opsin gene array) and the 
presence of dichromacy in all individuals with this disorder. The 
aim therefore is to determine whether sequence and/or 
organisation changes in the L and M opsin genes in affected 
families are responsible for the disorder. 
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3. MATERIALS & METHODS 
Reagents Used and Methods Applied 
 
3.1 Polymerase Chain Reaction Protocols 
3.1.1      BIOTaq 
Reactions were conducted using BIOTaq DNA Polymerase (Bioline, 
BIO-21040) and contained 1µl genomic DNA (50-100ng, or to a 
specific concentration as stated in chapters). 1µl of each of the 
forward and reverse primers were added from stock solutions of 
10µM, with 1µl dNTP mix (10mM stock each), 2.5µl NH4 (10x 
stock), 1.5µl MgCl2 (50mM stock), 0.5µl BIOTaq DNA polymerase 
(5U/µl stock) and made up to a total 25µl reaction volume with 
molecular biology grade H2O. Amplifications were conducted in a 
Techne TC-412 PCR machine using the standard cycles of an 
initial denaturation at 95oC for 3 minutes, followed by 35 cycles of 
denaturation at 94oC for 45 seconds, primer annealing for 45 
seconds was conducted at specific temperatures for each primer 
set (given in the disease chapters), followed by a 1 minute 
extension at 72oC. A final extension at 72oC for 7 minutes was 
conducted. Any variations to these cycles are stated in the disease 
chapters.  
 
Gradient PCRs 
For the majority of primer sets, initial gradient PCRs were 
conducted in a Techne Touchgene Gradient PCR machine to 
determine the optimum annealing temperature for each primer 
set. BIOTaq or GoTaq (Section 3.1.2) protocols with control 
genomic DNA were conducted across ten different annealing 
temperatures: 55.4oC, 56.1oC, 57.2oC, 58.6oC, 59.5oC, 60.3oC, 
61.3oC, 62.6oC, 63.9oC and 64.6oC. Figure 3.1 highlights the 
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usefulness of this method and shows the increase of amplicon 
production with an increase in temperature and the reduction of 
production of unwanted amplicons from non-specific primer 
binding.  
 
                               Temperature increase  
 
 
Figure 3.1 Gel image showing PCR products run on a 1% gel for 
gradient PCRs using varying annealing temperatures listed in the 
text. 
 
Gel Electrophoresis 
Amplicon size determined the percentage of agarose (Sigma-
Aldrich, normal: A9539; low-melt: A9414) used for electrophoresis 
gels. The agarose was dissolved in 2M Tris-acetate, 100mM 
Na2EDTA (ethylenediamine tetra-acetic acid) buffer (TAE buffer, 
50x stock diluted to 1x; National Diagnostics, EC-872). Fragments 
<500bp were run on a 2% gel; 500–1,000bp fragments run on a 
1% gel and amplicons >1,000bp were run on a 0.5% gel. For very 
small fragments (<500bp), low-melt agarose gels were used. Gels 
contained 1µl ethidium bromide (10mg/ml) for every 20mls of gel 
(final concentration of 500ng/ml). Gels were viewed on a BioDoc-It 
UV Transilluminator. 
 
Desired 
amplicon 
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Gel Extraction 
GoTaq Green reactions always required this form of PCR cleanup 
due to the green buffer and this protocol was used for cleanup of 
all PCR products prior to sequencing unless otherwise stated. The 
desired amplicons were excised from the agarose gel and the DNA 
extracted using the QIAquick Gel Extraction Kit (QIAGEN, 28706) 
with the extraction protocol for a microcentrifuge followed. This 
involved adding three gel volumes of buffer QG (solubilisation and 
binding buffer; QIAGEN, 19063) per one volume of gel (100mg of 
gel was given as equivalent to 100µl of buffer). The gel slices were 
incubated in the buffer at 50oC for 10-15 minutes or until the gel 
had dissolved. One gel volume of isopropanol was then added and 
the mixtures vortexed before being transferred to QIAquick spin 
column. The samples were centrifuged for 1 minute, 13,000rpm 
and the flow-through discarded. 0.5ml Buffer QG was then added 
to each column and centrifuged for 1 minute, 13,000rpm. The 
flow-through was again discarded and 0.75ml Buffer PE (wash 
buffer; QIAGEN, 19065) added to the columns and left to stand for 
5 minutes before being centrifuged for 1 minute, 13,000rpm. The 
flow-through was discarded and the empty column spun for a 
further minute at 13,000rpm. The column was then placed in a 
clean tube and the DNA eluted in 30µl EB Buffer (10mM Tris-Cl, 
pH 8.5) by being left to stand for 1 minute in the buffer before a 
final spin at 13,000rpm for 1 minute. The purified DNA was then 
used in sequencing reactions or for cloning into plasmids (Section 
3.3.1).  
 
Montage Cleanup of PCR Products 
For PCRs not conducted with GoTaq Green, reactions that 
produced only a single amplicon could be purified with Montage 
Mutliscreen PCR µ96 filter plates (Millipore, LSKMPCR10). Each 
PCR was made up to a volume of 100µl with molecular biology 
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grade H2O and the total volume transferred to the purification 
plate (one reaction per well). A vacuum was applied to the plate 
(600mbar) for 10 minutes or until the wells were dry and then a 
further 25µl of molecular biology grade H2O was added to the 
wells and the vacuum applied for 3 minutes (or until wells were 
dry). The vacuum was removed and the underside of the plate 
blotted dry. 20µl of molecular biology grade H2O was added to 
each well and the plate was covered and shaken for 10 minutes 
using a vortex machine at 1,000rpm. The remaining volume was 
then transferred from the plate for storage at 4 - -20oC. 
 
Sequencing 
DNA was added at different volumes depending on the PCR 
cleanup procedure used. If directly sequenced from PCR products 
then 3µl were used, 4µl from gel extracted products and 3µl from 
Montage purified products and purified plasmid. Sequencing was 
conducted using the Big Dye Terminator v3.1 Cycle Sequencing 
Kit (ABI, 4337456). 1µl of the forward or reverse primer was added 
to the DNA (10µM stock) with 0.5µl Big Dye (5x) and 1.5µl 
Sequencing Buffer. Reactions were made up to 10µl with 
molecular biology grade H2O. The reaction cycles included an 
initial denaturation at 96oC for 1 minute followed by 25 cycles of 
96oC for 10 seconds, 50oC for 5 seconds and then 60oC for 4 
minutes. Products were then cleaned (below) and analysed in an 
ABI Prism 3730 DNA Analyser (Applied Biosystems). 
 
Standard Sequencing Cleanup 
Following the sequencing reaction, 10µl of molecular biology grade 
H2O was added to the 10µl of sequencing products. To this, 0.5µl 
EDTA (0.5M, pH 8.0) was added with 2µl Sodium Acetate (3M, pH 
5.2) and 50µl 100% ethanol. Samples were vortexed, wrapped in 
foil and incubated at room temperature for 15 minutes. The 
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samples were then spun at 13,000 rpm for 30 minutes and the 
eluate carefully removed and discarded. 70µl 70% ethanol was 
then added and the samples spun at 13,000 rpm for 15 minutes. 
The eluate was discarded as before and samples dried at 65oC for 
at least 5 minutes. The samples were then resuspended in 11µl 
HiDi Formamide (Applied BioSystems, 4440753) prior to analysis 
in an ABI Prism 3730 DNA Analyser (Applied Biosystems).  
 
Montage Sequencing Cleanup 
For this method, the Montage SEQ96 Sequencing Reaction 
Cleanup Kit was used (Millipore, LSKS09604). Following the 
sequencing reactions, 25µl Injection Solution was added to each  
sample and the total volume (35µl) was transferred to the cleanup 
plate. A vacuum (600mbar) was applied to the wells for 3 minutes 
(or until the wells were dry). A further 25µl Injection Solution was 
added and the vacuum applied for 4 minutes. The vacuum was 
removed and the underside of the plate blotted dry. 25µl Injection 
Solution was then added to each well and the plate covered and 
shaken on a vortex at 1,000rpm for 10 minutes. The remaining 
volume was transferred to a sequencing plate for analysis in an 
ABI Prism 3730 DNA Analyser (Applied Biosystems). 
 
3.1.2      GoTaq 
This protocol used GoTaq Green DNA Polymerase (Promega, 
M3175). Reactions contained 1µl genomic DNA (50-100ng, or a 
specific concentration as stated in chapters). 1µl of each of the 
forward and reverse primers were added from stock solutions of 
10µM with 1µl dNTP mix (10mM stock of each), 10µl Green Buffer 
(5x stock), 0.25µl GoTaq DNA polymerase (5U/µl stock) and made 
up to a 50µl reaction volume with molecular biology grade H2O. 
Amplifications were conducted using the same cycles as for the 
BIOTaq Protocol (Section 3.1.1). Any variations to these cycles are 
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stated in the disease chapters. Appropriate agarose gels were 
prepared for electrophoresis as described in Section 3.1.1. PCR 
products were always gel extracted prior to sequencing. 
 
3.1.3      KOD Hot Start 
Reactions were conducted using the KOD Hot Start Polymerase 
(MERCK, 71086) and contained 1µl genomic DNA diluted (50-
100ng or to a specific concentration as stated in chapters). 1.5µl 
of each of the forward and reverse primers were added from stock 
solutions of 10µM with 5µl dNTP mix (2mM stock of each), 3µl 
MgSO4 (25mM stock), 5µl Buffer (10x stock) and 1µl KOD DNA 
polymerase (1U/µl stock). Reactions were made up to 50µl with 
molecular biology grade H2O. PCR cycles consisted of an initial 
denaturation at 95oC for 2 minutes, followed by 35 cycles of 95oC 
for 20 seconds and annealing at 62oC (unless otherwise stated in 
disease chapters) for 10 seconds. The extension was conducted at 
70oC with the time varying depending on the amplicon length, for 
<500bp 10 seconds per kilobase, for 500-1,000bp 15s/kb, for 
1,000-3,000bp 20s/kb and for products >3,000bp 25s/kb timings 
were used. Appropriate agarose gels were prepared for 
electrophoresis as described in Section 3.1.1 and sequences 
cleaned prior to analysing.  
 
3.1.4      BIOXACT Long 
Reactions were conducted using the BIOXACT Long recommended 
protocol (Bioline, BIO-21049). 1µl genomic DNA (50-100ng) was 
used with 5µl OptiBuffer (10x stock), 2.5µl MgCl2 (50mM stock), 
1µl dNTP (100mM stock of each), 1µl each of the forward and 
reverse primers (10µM stock) and 1µl BIOXACT DNA polymerase 
(4U/µl). Reactions were made up to a 50µl final volume with 
molecular biology grade H2O. For amplification of L and M gene 
exons 3 to 5 (Section 11), the following reagents were used: 5µl 
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OptiBuffer (10x stock), 1µl MgCl2 (50mM stock), 0.5µl dNTPs 
(100mM each stock), 2.5µl Hi-Spec Additive, 1µl 50-100ng DNA, 
0.3µl of each the forward and reverse primers (100µM stock), 1µl 
BIOXACT (4U/µl stock) and made up to a 50µl final volume with 
molecular biology grade H2O. BIOXACT cycles began with an 
initial denaturation at 95oC for 5 minutes, followed by 35 cycles of 
95oC for 30 seconds, annealing at 62oC for 1 minute with 
extension at 68oC for 4 minutes and a final extension at 68oC for 
10 minutes. Appropriate agarose gels were prepared for 
electrophoresis as described in Section 3.1.1 and the products 
cleaned prior to sequencing. 
 
3.1.5      Extensor 
Reactions were conducted using the Extensor PCR Master Mix 2 
(Thermo Scientific, AB-0793/A). 1µl DNA (50-100ng) was used 
with 12.5µl Extensor Master Mix (2x stock), 2µl of each of the 
forward and reverse primers (10µM stock) and made up to 20µl 
with molecular biology grade H2O. Cycles involved an initial 
denaturation at 94oC for 2 minutes followed by 10 cycles of 94oC 
for 10 seconds, annealing at 64oC (unless otherwise stated in the 
disease chapters) for 30 seconds and extension at 68oC for 1 
minute for products up to 1kb and 2 minutes for products up to 
3kb. These cycles were followed by 20 cycles of 94oC for 20 
seconds, annealing at 64oC (unless otherwise stated) for 30 
seconds and extension at 68oC for 1 or 2 minutes depending on 
the product length. A final extension at 68oC was run for 7 
minutes. Appropriate agarose gels were prepared for 
electrophoresis as described in Section 3.1.1. 
 
3.1.6      Long Range PCR 
This protocol was taken from Oda et al. (2003) and used only for 
the amplification of first and downstream genes in the L and M X 
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chromosome array. Reactions were conducted in 0.2ml tubes and 
prepared on ice. Mixtures were not vortexed but carefully mixed 
by minimal pipetting. Cyclers were pre-heated. Reactions were 
carried out using the 5PRIME PCR Extender System (5PRIME, 
2900158) and contained 10-50ng genomic DNA, 1.25µl dNTP 
(10mM stock of each), 1µl of each primer (10µM stock), 2.5µl 
Tuning Buffer (10x stock), 0.2µl 5PRIME Polymerase (5U/µl stock) 
and reactions made up to 25µl with molecular biology grade H2O. 
The cycling schedules for the first gene reactions involved initial 
denaturation at 93oC for 3 minutes followed by 10 cycles of 93oC 
for 15 seconds, 62oC for 30 seconds and 68oC for 15 minutes. 
This was followed by 18 cycles of 93oC for 15 seconds, 62oC for 30 
seconds and 68oC for 15 minutes with 20 second increments for 
each cycle. For the downstream gene amplifications, cycling was 
carried out at 93oC for 3 minutes, followed by 10 cycles of 93oC for 
15 seconds then 68oC for 15 minutes. These were followed by 18 
cycles of 93oC for 15 seconds then 68oC for 15 minutes with 20 
second increments per cycle. The large fragments were analysed 
on a 0.5% agarose gel and the PCR products used in subsequent 
BIOTaq reactions (see Section 11.4.3). 
 
3.1.7      SYBR Green Quantitative PCR 
Triplicate reactions for each sample were conducted using the 
Power SYBR Green PCR Master Mix (Applied Biosystems, 
4367659). Genomic DNA was purified (Section 3.2.1) and 10ng 
used per single reaction. 0.625µl of each primer (5µM stock) was 
added to the DNA with 6.25µl Power SYBR Green Master Mix (2x 
stock) and 4µl molecular biology grade H2O. The final reaction 
volume was 12.5µl and transferred to a BIO-RAD Hard-Shell 96 
microplate (BIO-RAD, HSA-9601). Cycles were conducted in a 
BIO-RAD C1000 Thermal Cycler and involved a 95oC initial 
denaturation for 10 minutes followed by 40 cycles of 95oC for 15 
Chapter 3 
     Genetic Analysis of Inherited Retinal Dystrophies 87 
seconds and 62oC for 1 minute. A melt curve of 95oC for 15 
seconds and 60oC for 15 seconds was added to the cycles to 
ensure specificity of primer binding.  
 
3.1.8      TaqMan QPCR 
Reactions were conducted following the protocol from Neitz and 
Neitz (2000) and used to amplify exon 5 of the L and M opsin 
genes. A single primer set hybridised to both L and M gene 
sequences and two probes were used, one specific for L and 
tagged at the 5’ end with 6FAM and the other probe specific for M 
and tagged at the 5’ end with JOE. Both probes were tagged at the 
3’ end with the quencher TAMARA. Primers and probes are listed 
in Table 11.1, Section 11.4.3. Reactions for each sample were run 
in triplicate with each single reaction containing 10ng of purified 
DNA (Section 3.2.1), 0.75µl L probe (4.6µM stock), 1.25µl M probe 
(5µM stock), 0.9µl of each of the forward and reverse primers 
(25µM stock) and 12.5µl TaqMan Gene Expression Master Mix 
(Applied BioSystems, 4369016). Reactions were made up to a final 
volume of 25µl with molecular biology grade H2O and transferred 
to BIO-RAD Hard-Shell 96 microplate (BIO-RAD, HSA-9601). 
Cycles were conducted in a BIO-RAD C1000 Thermal Cycler and 
the cycling schedule involved an initial incubation at 50oC for 2 
minutes followed by denaturation at 95oC for 10 minutes. This 
was followed by 3 cycles of 95oC for 30 seconds and 67oC for 1 
minute then 27 cycles of 95oC for 15 seconds and 67oC for 1 
minute. 
 
3.1.9       Genotyping of D4S1601 
BIOTaq reactions were conducted to amplify the marker D4S1601 
but using half the normal protocol primer concentration, 10ng of 
DNA and an annealing temperature of 56oC. The forward primer 
was labelled at the 5’ end with 6FAM. On completion of the PCR 
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cycles, 0.5µl of the PCR product was added to 0.5µl 500 LIZ Size 
Standard (Applied BioSystems, 4366589) and 9µl of HiDi 
Formamide (Applied BioSystems, 4440753). The mixture was 
heated at 95oC for 5 minutes before placing on ice for 2 minutes. 
The samples were then analysed in an ABI Prism 3730 DNA 
Analyser (Applied Biosystems). 
 
3.1.10     Digestion of PCR Product 
The protocol published by Ueyama et al. (2003) was attempted to 
determine the ratio of L to M opsin gene promoters. GoTaq PCRs 
were conducted to amplify the promoter regions from the same 
primer set (Table 11.1, Section 11.4.3). The products were gel 
extracted with 30µl of the eluted product used in the digestion. 5µl 
of NEB Buffer 4 (10x stock; New England BioLabs, B7004S) was 
added to the extracted DNA with 1.5µl Bsr FI (10U/µl stock; New 
England BioLabs, R0562S) and 13.5µl molecular biology grade 
H2O. The reactions were incubated at 37oC for one hour before 
adding 2.5µl 10% sodium dodecyl sulphate (SDS) to each sample 
prior loading on a 3% low-melt agarose gel. Gels were stained with 
TAE buffer with SYBR Green I 10,000x concentrate in DMSO 
(dimethyl sulfoxide, 1µl for every 10ml buffer; Invitrogen, S7563). 
Products from the first gene promoter were expected to give 137bp 
and 32bp bands and those from the downstream promoters were 
expected to give 97bp, 40bp and 32bp bands. The ratio of the 
137bp and 97bp fragments were intended to be used to determine 
the ratio of L to M promoters.    
 
3.2 Affymetrix Protocols 
3.2.1      DNA Preparation 
0.1 volumes of 3M Sodium Acetate were added to stock samples of 
genomic DNA. 2.5 volumes of 100% ethanol were then added to 
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each sample and mixtures vortexed and either left to precipitate 
overnight at -20oC or for one hour at -80oC. Samples were then 
spun at 4oC, 12,000rpm for 20 minutes. The supernatant was 
carefully aspirated and discarded. 1ml of cold 70% ethanol was 
then added and the samples spun at 4oC, 12,000rpm for 10 
minutes. The supernatant was again carefully aspirated and 
samples left to air-dry for an hour. Each sample was then 
dissolved in 10µl EB buffer. The concentration of each sample was 
determined using a Nanodrop 2000 Spectrophotometer (Thermo 
Scientific). For the Affymetrix protocols, 250ng of DNA was 
required. 
 
3.2.2      50K Xba I Protocol 
For this method, the GeneChip Human Mapping 50K Xba Assay 
Kit (Affymetrix, 900521) was used. The 100K low-throughput 
protocol provided by Affymetrix was adhered to with the basic 
steps included here. The 250ng of purified DNA was added to 2µl 
Buffer D (10x stock; Promega, R004A), 2µl Bovine Serum Albumin 
Acetylated (1mg/ml stock; Promega, R396D), 1µl Xba I (12U/µl 
stock; Promega, R618A) and made up to 20µl with molecular 
biology grade H2O. The DNA was digested at 37oC for 120 
minutes, followed by enzyme inactivation at 70oC for 20 minutes. 
Adaptors were then ligated to the Xba I sticky ends of the DNA in 
a reaction containing 1.25µl Adaptor Xba I (5µM stock; Affymetrix, 
900410), 2.5µl T4 DNA ligase buffer with 10mM ATP (10x stock; 
New England BioLabs, B0202S), 0.625µl T4 DNA ligase (400U/µl 
stock; New England BioLabs, M0202S), 0.625µl molecular biology 
grade H2O and the 20µl of digestion mixture. Ligations were 
carried out for 120 minutes at 16oC with an enzyme inactivation 
step of 20 minutes at 70oC. 75µl molecular biology grade H2O was 
then added to each ligation sample and 10µl of each diluted 
ligation used in a PCR reaction, three reactions per sample. The 
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Platinum Pfx DNA Polymerase was used for the PCRs (2.5U/µl 
stock; Invitrogen, 11708-021).  Each single reaction contained: 
10µl Pfx Buffer (10x stock), 10µl PCR Enhancer (10x stock), 2µl 
MgSO4 (50mM stock), 12µl dNTPs (2.5mM stock of each), 10µl 
Primer 001 (Affymetrix, 900409), 2µl Platinum Pfx polymerase and 
10µl diluted ligation and was made up to 100µl with molecular 
biology grade H2O. Mixtures were briefly vortexed and spun at 
2,000rpm for one minute. Cycles involved initial denaturation at 
94oC for 3 minutes followed by 30 cycles of 94oC for 15 seconds, 
60oC for 30 seconds and 68oC for 60 seconds. A final extension at 
68oC for 7 minutes was then run. PCR products were analysed on 
a 2% agarose gel and successful PCR products purified. The three 
PCR reactions for each single sample were combined for 
purification into one well of a QIAGEN MinElute 96 UF Plate 
(QIAGEN, 1019566). A vacuum of 600mbar was applied to the 
plate and when the wells were dry, 50µl molecular biology grade 
H2O was added and the vacuum again applied until the wells were 
dry. This wash step was repeated twice more. 40µl EB Buffer was  
then added to each well and the plate sealed and shaken for 5 
minutes at room temperature. The eluate from each well was 
transferred to a fresh tube and the concentration of each  sample 
quantified using a Nanodrop. 40µg DNA was required for the 
fragmentation process, which was made up to a volume of 45µl in 
EB buffer. The GeneChip Fragmentation Reagent (2.5U/µl stock; 
Affymetrix 900131) was diluted to 0.04U/µl in molecular biology 
grade H2O and Fragmentation Buffer (10x stock with a final 
concentration of 1x; Affymetrix, 900422). 5µl of this mixture was 
then added to the 45µl of purified DNA and fragmentation 
conducted at 37oC for 35 minutes followed by enzyme inactivation 
at 95oC for 15 minutes. The fragmentation products were then 
viewed on a 4% TAE agarose gel. Successful fragmented products 
were labelled with the GeneChip DNA Labelling Reagent (7.5mM 
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stock; Affymetrix 900484). Per one reaction, 14µl Terminal 
deoxynucleotidyl Transferase (TdT) Buffer (5x stock; Affymetrix 
901022), 2µl Labelling Reagent and 3.5µl TdT (30U/µl stock; 
Affymetrix, 901023) were added to the fragmented products. The 
hybridisation of the labelling reagent was conducted at 37oC for 2 
hours followed by enzyme inactivation at 95oC for 15 minutes. 
Samples were then sent to the UCL Wolfson Institute for 
hybridisation to the array.    
 
3.2.3      250K Sty I Protocol 
For this method the GeneChip Mapping 250K Sty Assay Kit was 
used (Affymetrix, 900765). The 500K low-throughput protocol 
provided by Affymetrix was adhered to but the basic steps are 
included here. The 250ng of purified DNA was added to 2µl NEB 
Buffer 3 (10x stock; New England BioLabs, B7003S), 2µl Bovine 
Serum Albumin Acetylated (1mg/ml stock; Promega, R396D), 1µl 
Sty I (10U/µl stock; New Enlgand BioLabs, R0500S) and made up 
to 19.75µl with molecular biology grade H2O. The DNA was 
digested at 37oC for 120 minutes, followed by enzyme inactivation 
at 65oC for 20 minutes. Adaptors were ligated to the Sty I sticky 
ends of the DNA in a reaction containing: 0.75µl Adaptor Sty I 
(50µM stock; Affymetrix, 900597), 2.5µl T4 DNA ligase buffer with 
10mM ATP (10x stock; New England BioLabs, B0202S), 2µl T4 
DNA ligase (400U/µl stock; New England BioLabs, M0202S) and 
the digestion mixture. Ligations were carried out for 180 minutes 
at 16oC with an enzyme inactivation step of 20 minutes at 70oC. 
75µl molecular biology grade H2O was then added to each ligation 
sample and 10µl of each diluted ligation used in a PCR reaction, 
with three reactions per sample. The Clontech Titanium DNA 
Amplification Kit was used for the PCRs (Clontech, 639240). Each 
single reaction contained 10µl Titanium Taq Buffer (10x stock), 
20µl G-C Melt (5M stock), 14µl dNTPs (2.5mM stock of each), 4.5µl 
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Primer 002 (100µM stock; Affymetrix, 900595), 2µl Titanium Taq 
Polymerase (50x stock) and made up to 100µl with molecular 
biology grade H2O. Mixtures were briefly vortexed and spun at 
2,000rpm for one minute. Cycles involved initial denaturation at 
94oC for 3 minutes followed by 30 cycles of 94oC for 30 seconds, 
60oC for 30 seconds and 65oC for 15 seconds. A final extension at 
68oC for 7 minutes was then run. PCR products were analysed on 
a 2% agarose gel and if successful PCRs were evident the products 
were purified. For purification, 8µl 0.1M EDTA were added to each 
PCR reaction and samples briefly vortexed and spun. The three 
PCR reactions for each single sample were combined for 
purification into one well of a QIAGEN MinElute 96 UF Plate 
(QIAGEN, 1019566). A vacuum of 600mbar was applied to the 
plate and when the wells were dry, 50µl molecular biology grade 
H2O was added and the vacuum again applied until the wells were 
dry. This wash step was repeated twice more. 45µl Recovery 
Buffer (RB; Clontech, 636976) was then added to each well and 
the plate sealed and shaken for 10 minutes at room temperature. 
The eluate from each well was transferred to a fresh tube and the 
concentration of each sample quantified using a Nanodrop. 90µg 
DNA was required for the fragmentation process, which was made 
up to a volume of 45µl in RB buffer. The GeneChip Fragmentation 
Reagent (2.5U/µl stock; Affymetrix 900131) was diluted to 
0.05U/µl in molecular biology grade H2O and Fragmentation 
Buffer (10x stock with a final concentration of 1x; Affymetrix, 
900422). 5µl of this mixture was then added to the 45µl of purified 
DNA and fragmentation conducted at 37oC for 35 minutes 
followed by enzyme inactivation at 95oC for 15 minutes. The 
fragmentation products were then viewed on a 4% TAE agarose 
gel. Successful fragmented products were labelled with the DNA 
Labelling Reagent (30mM stock; Affymetrix 900778). Per one 
reaction, 14µl TdT Buffer (5x stock; Affymetrix 901022), 2µl 
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Labelling Reagent and 3.5µl TdT (Affymetrix, 901023) were added 
to the fragmented products. The hybridisation of the labelling 
reagent was conducted at 37oC for 4 hours followed by enzyme 
inactivation at 95oC for 15 minutes. Samples were then sent to 
the UCL Wolfson Institute for hybridisation to the array. 
 
3.3 Cloning 
3.3.1      Ligation 
The ligation of PCR fragments for cloning were conducted using 
5.5µl of gel extracted insert (Section 3.1.1), 0.5µl pGEM-T Easy 
Vector System (Promega, A1360), 1µl T4 DNA ligase buffer with 
10mM ATP (10x stock; New England BioLabs, B0202S), 1µl T4 
DNA ligase (400U/µl stock; New England BioLabs, M0202S) and 
made up to 10µl with molecular biology grade H2O. Reactions 
were incubated at 4oC for at least 16 hours. 
 
3.3.2      Transformation 
JM109 Competent Cells (>108cfu/µg; Promega, L2001) were 
thawed on ice and used for cloning pGEM-T vectors. 25µl aliquots 
were prepared and 5µl of the pGEM-T ligation mixture added to 
the competent cells by gentle pipetting and swirling. Cells were 
kept on ice for 30 minutes before being heat-shocked at 42oC for 1 
minute and 30 seconds. Cells were then placed back on ice for 2 
minutes. 200µl Super Optimal broth with Catabolite repression 
(S.O.C) medium (Invitrogen, 15544-034) was added to each tube 
of cells and mixed by pipetting. The mixture was transferred to a 
15ml Falcon tube and incubated in a shaker at 37oC for 1 hour. 
The cells were then poured and spread on agar plates containing 
1.5% agar (Sigma-Aldrich, A1296), 1% tryptone (Sigma-Aldrich, 
T7293), 0.5% yeast extract (Sigma-Aldrich, Y1625), 1% NaCl, 
ampicillin (sodium salt, final concentration 100µg/ml; 
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Calbiochem, 171254), 5-bromo-4-chloro-3-indolyl-beta-D-
galactoside (X-Gal, final concentration of 80µg/ml; Calbiochem, 
71077) and isopropyl β-D-1-thiogalactopyranoside dioxane-free, 
high purity (IPTG, final concentration of 0.5mM; Calbiochem, 
420322) and left to dry for 30 minutes. Plates were then incubated 
at 37oC for 16 hours and isolated colonies selected via the 
blue/white screening method (with white colonies containing the 
insert).  Cells from each single colony were incubated in 4ml of 
Luria broth (LB; Sigma-Aldrich, L3522) with ampicillin (100µg/ml 
final concentration) at 37oC in a shaker for 16 hours. Following 
incubation the cells were spun for 10 minutes, 3,500rpm at 4oC. 
The supernatant was discarded and the pellet frozen prior to 
extracting the plasmids.  
 
3.3.3 Plasmid Extraction 
Plasmids were extracted from the collected JM109 cells using the 
GenElute Plasmid Miniprep Kit (Sigma-Aldrich, PLN350). The 
protocol provided with the kit was followed with cells resuspended 
in 200µl Resuspension Solution then transferred to a 1.5ml tube. 
200µl of Lysis Solution was added to each resuspension and the 
contents mixed by inversion of the tubes. 350µl 
Neutralisation/Binding Solution was then added and again mixed 
by inversion of the tubes, which were then spun at 13,000rpm for 
10 minutes. The GenElute Binding Columns were prepared and 
the clear lysates transferred to the columns, which were spun at 
13,000rpm for 1 minute. The flow-through was discarded and 
500µl Optional Wash Buffer applied to each column and spun at 
13,000rpm for 1 minute and the flow-through discarded. 750µl 
Wash Solution was then added to each column and spun at 
13,000rpm for 1 minute and the flow-through discarded. The 
empty columns were spun once more for 2 minutes before being 
transferred to a fresh tube. 50µl of Elution Solution was then 
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added to each column and spun at 13,000rpm for 1 minute. 
Plasmids could then be used in sequencing reactions (Section 
3.1.1).    
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4. COMPUTATIONAL METHODS 
 
4.1 Linkage Analysis 
To find the causes of inherited disorders, various methods can be 
used. For autosomal dominant disorders linkage analysis using 
markers can be conducted to identify the disease locus within the 
genome, whereas for more complex disorders such as AMD, twin, 
population and association studies are required. Twin studies 
allow for genetic and environmental factors important to the 
disease state to be investigated, as do population studies, and 
combined they provide detailed information on contributory 
factors of complex disorders (AMD Section 2.3). This project 
investigates autosomal dominant disorders for which traditional 
linkage analysis has already been conducted and located large 
disease regions. Linkage analysis has long been used to identify 
the region of the genome in which the genetic fault causing the 
disease state lies. Following identification of the disease region, 
candidate genes can be selected and their coding exons screened 
for mutations. Linkage analysis involves using DNA markers, such 
as restriction fragment length polymorphisms (RFLPs), 
microsatellite markers or SNPs, to establish a link between them 
and the disease locus. RFLP markers involve amplifying specific 
fragments of the genome and then digesting the amplicon with a 
particular restriction enzyme. The resulting products of the digest 
identify the marker haplotype by the combination of digest 
fragments produced, which is generally represented as a number. 
For microsatellite markers, the region surrounding the marker is 
used to design PCR primers, which amplify the marker and the 
allele is scored by product length. The different fragments are 
separated and analysed using GeneMapper Software (Applied 
Biosystems), which provides the haplotype identification based on 
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the fragment length. The more variations possible for a marker the 
more informative it can be in linkage analysis.   
 
When a family with an autosomal dominant disorder is identified, 
initial linkage analysis needs to use markers from over the entire 
genome in order to find those that link to the disease. This 
analysis obtains a LOD score, which represents the chance of a 
particular marker being linked to the disease locus. The LOD 
score is a logarithm (base 10) of odds score and compares the 
likelihood of two loci being linked to the likelihood of observing 
such a thing by chance. For this reason, a LOD score of 3.0 or 
greater is deemed to represent significant linkage as it shows the 
odds are 1,000:1 that the linkage observed did not occur by 
chance.  
 
Linkage analysis depends on the occurrence of recombination 
events. Recombination can occur between two strands of DNA 
during meiosis in which the strands align before being separated 
into different cells. When similar DNA sequences align there is a 
chance the maternal and paternal strands may switch equivalent 
sections of DNA. Alleles are defined as unlinked when they display 
50% recombination, as described by Mendel’s law of independent 
assortment. The recombination frequency (RF,Θ), is the frequency 
at which a single crossover will occur between two genes during 
meiosis. If there is a 1% RF (i.e. 1 in 100 chance of 
recombination), this represents genes being 1 centimorgan (cM) 
apart. Therefore, when two genes are close together they do not 
assort independently and are linked.  
 
For the disorders MCDR1, MCDR2, MCDR3, MCDR4 and PBCRA, 
previous linkage analysis has been conducted using microsatellite 
markers across all chromosomes to link the disorders to 
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particular areas of the genome (loci). For MCDR1, this has been 
done by many research groups (Section 5) and was recently 
refined by Yang et al. (2007). But for all five macular disorders the 
regions contain numerous genes as possible candidates, 
particularly MCDR3 and MCDR4. As the disorders have previously 
been linked, it is unlikely that study of the same families with 
microsatellites will refine the disease loci. Single nucleotide 
polymorphisms (SNPs) are a relatively new form of marker and 
occur much more frequently over loci than do microsatellites. 
However, they are not as informative as microsatellites as only two 
alleles generally exist. But, given their frequency in the genome, 
SNP analysis will be used in this project to see if their frequency 
across the loci will provide informative data that will help refine 
the previously linked disease regions.  
 
4.2 Use of the Affymetrix Genotyping Console 
The Affymetrix data can be used in two ways: the first makes use 
of the data that provide genotype calls at approximately 250,000 
or 50,000 SNPs (depending on the chip) throughout the genome. 
By comparing the genotypes of affected individuals at the disease 
loci, it should be possible to determine which alleles are common 
to affecteds in the disease region. A limitation of the Affymetrix 
method of analysis is that the Genotyping Console software 
cannot determine the phase of alleles. If allele A is present it 
provides the output AA and if alleles B is present it provides the 
output BB and when both are detected it provides the output AB. 
However, it cannot tell which alleles are on which chromosome. 
This means that in order to determine haplotype either unaffected 
family members or parent-offspring pairs need to be analysed. In 
this project affected parent-offspring will generally be analysed 
and their genotypes compared to other family members. If within 
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the disease region there are SNPs at which the affected individuals 
contain a different allele then these SNPs can be excluded as it 
would be expected that affected individuals would have similar 
alleles segregating with the disease. For example, if at a particular 
SNP four samples have the genotype AA and two the genotype BB 
then an “Exclude” output can be given because amongst the 
affected individuals there is not a consistent allele. However, if 
consistent differences are seen this may be evidence of different 
haplotypes. If excludes can be made this will refine the disease 
regions and hopefully highlight candidate genes. 
 
The second use of the Affymetrix technology is that it can identify 
copy number variations (CNV) in the sample genomes. This is 
important as gene duplications and/or deletions may be 
associated with the disease states and the gene chips allow 
identification of microdeletions/duplications. For this analysis, 
data from affected individuals are compared to data from the 
International HapMap Project (International HapMap Consortium, 
2003). This collection represents “normal” sample data for 
individuals of selected ethnic origin and is used as reference data 
for the CNV calculations that determine copy number state 
changes in the genomes of test samples. Some sites of the genome 
are known to vary in copy number (Redon et al., 2006; Kidd et al., 
2008; Itsara et al., 2009) and the Affymetrix Genotyping Console 
detects when a sample CNV overlaps with a known variation site. 
The Genotyping Console integrates information from the database 
of genomic variants (DGV), which is also available on Ensembl so 
any CNVs identified can be compared at these sites to identify any 
that are unique to the affected samples. 
 
A switch was made from the 250K to the 50K GeneChips during 
this project because it was evident after using the 250K chips that 
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many of the SNPs were uninformative due to apparent 
interference from neighbouring SNPs, resulting in numerous 
NoCall outputs at a 0.1 confidence, a NoCall indicating the 
console cannot call the genotype under the given parameters 
(Section 4.3). 
 
Affymetrix supplies detailed explanations of the methods of their 
calculations and analysis (www.affymetrix.com). The process of 
the analysis conducted in this project is outlined below. 
 
4.3 Genotype Analysis 
Hybridisation of the sample DNA to the chip was carried out by 
the UCL Wolfson Institute and the chip signals were translated 
into intensity data that could then be analysed in the Affymetrix 
Genotyping Console. The chip data are first input through various 
quality control (QC) calculations to determine the general quality 
of the data, the output of which reflects how useful the data will 
be. 
 
4.3.1 Genotype Calls 
A QC Call Rate is generated that estimates the overall quality of a 
sample based on the BRLMM algorithm. The overall call rate for 
each sample is given and derived from the individual call rate of 
each SNP across the chip. Affymetrix state that an overall call rate 
of >=93% is a good indication that the chip data will be useful. 
However, the correlation between the QC call rate and genotyping 
performance is not perfect and it is important to remember that a 
sample may pass the QC yet still have a sub-optimal genotyping 
performance. Other checks to be made at this point include the 
confirmation of the console-determined gender of each sample 
with the actual gender. This gender analysis provides gender calls 
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estimated from the number of heterozygous calls (the percentage 
of AB genotype calls) for SNPs on the X chromosome.  
 
The confidence of a call is more important than the call itself as it 
reflects how certain the Genotyping Console is that the genotype 
(call) given is the actual genotype at a particular SNP. The 
confidence is the maximum score at which the algorithm will 
make a genotype call. The lower the confidence value the more 
trustworthy the data because the chance of the determined 
genotype being a miscall is reduced. Calls with a confidence value 
greater than the user-defined threshold are given a NoCall output. 
The analysis on the 250K chips had to be run at a confidence of 
both 0.5 and 0.1, which is not ideal. It was found that by reducing 
the confidence to 0.1 the number of informative SNP calls was 
reduced by nearly 50% for many samples. In Figure 4.1a, the 
difference in the number of NoCalls given at a confidence of 0.1 
compared to 0.5 at the same SNPs is evident. It is for this reason 
that the subsequent batch of samples was run on 50K Xba I 
GeneChips. Though there are five times fewer SNPs, the data were 
very reliable with over 90% of calls made at a confidence level of 
0.1 (Figure 4.1b).  
 
The console genotyping analysis produces a large amount of data 
for each SNP that must be exported chromosome by chromosome 
to Microsoft Excel under specific parameters before different 
samples can be aligned. By doing this, the genotypes at each 
specific SNP on a chromosome and within a linked disease region 
can be compared and analysed using basic excel equations. 
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Figure 4.1 Excel images highlighting the NoCalls (blue) received 
from the Affymetrix Genotyping Console: a) the increase in 
NoCalls received from the 250K microarrays when changing from 
a confidence of 0.5 to 0.1 is evident and b) shows some data 
received at 0.1 confidence using the 50K microarrays. 
 
 
4.3.2 Trio Data 
Mendel Check 
Where trio data are available (affected and unaffected parents plus 
affected offspring) the samples are checked for Mendelian 
NoCall 
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inheritance i.e. to ensure that the offspring has inherited one 
allele from each parent. A calculation for this was developed as an 
Excel Macro by Dr. Andrew Webster, which looks at a row of 
genotypes and assumes the first two are the parent genotypes and 
those following are from the offspring. It then tests each offspring 
genotype to ensure each of the alleles is inherited from a separate 
parent. The outputs given are either MenOK, indicating the 
genotypes are consistent with Mendelian inheritance, or Error_N, 
indicating an error in N (number of) offspring (Figure 4.2). Any 
errors in the Mendel check are likely to be miscalls but may also 
arise from hemizygosity of one allele, resulting in an apparent 
homozygous call. For example, if the affected parent is AA, the 
unaffected parent is BB but the single affected offspring is AA the 
Mendel check will produce an Error_1 output. The Genotyping 
Console does not differentiate how many alleles are present. If it 
detects alleles A and B, it will provide the ouput AB but if B is not 
detected the output will be given as AA whether there are two A 
alleles or not. This means that runs of apparent homozygous calls 
may be representative of a deletion and the Mendel check allows 
for identification of these regions. Typically a single error will be 
detected on one chromosome and the likely cause will be a 
miscall, hence it is important to use calls at a confidence of 0.1. 
Alternatively, it may be indicative of the offspring losing the allele 
from one parent (resulting in hemizygosity) and deletions may 
therefore be identified from this analysis. 
 
Final Call 
With trio data, the dominantly inherited allele associated with the 
disorder can be deduced by a second Macro equation, ADTriad 
(Figure 4.2). This uses information from the unaffected parent to 
assign the allele of the affected parent inherited by the offspring, 
such as in a case where the affected child and the affected parent 
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are both AB but the unaffected parent is BB. From this it can be 
determined that the SNP inherited with the dominant disease is A. 
In this example, the output for the affected child is listed under 
‘Paternal Allele’ and given as AA but it is important to remember 
this does not represent the SNP alleles but rather the allele 
inherited from the affected parent. The Error_N calls from the 
Mendel check can then be corrected to AB (if they are isolated and 
therefore likely to be a miscall) and combined with the column of 
‘Paternal Alleles’ to give the ‘Final Call’ of the affected offspring 
(Figure 4.2).  It is important to do this analysis and run unaffected 
samples when possible because the Affymetrix chip cannot 
determine phase, i.e. the order of alleles for each chromosome. 
Thus the only way to determine which alleles are inherited 
between affecteds is to compare them to the unaffected parent as 
described above. 
 
4.3.3 Autosomal Dominant Allele of Affecteds 
Following the Mendel check and correction of Final Calls, the 
genotypes of all affected individuals for a particular disease type 
can be compared side-by-side and another Macro equation, AD 
(autosomal dominant), used to determine the allele inherited 
across each SNP amongst affecteds and to exclude SNPs where 
the genotypes differ. An Exclude output is given when, for 
example, four samples from affected individuals have the genotype 
AA but two are BB. The exclude output is given because amongst 
affected individuals there is no consistent allele and it is expected 
for affected individuals to have common SNPs segregating with the 
disease. For this reason, where differences are encountered it is 
judged acceptable to exclude regions of DNA where the genotypes 
of affected individuals differ.  If there are consistent differences 
within a known disease region it may be indicative of different 
disease haplotypes. 
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Where trio data are available for a disease state and the allele of 
the affected parent inherited by the affected offspring has been 
determined and corrected as described above, then this column of 
alleles can be aligned with the AD exclusion data from all samples 
of the same disease group for comparison. The AD exclusion 
column can then be corrected because if at a particular SNP a 
consistent allele has not been determined (i.e. given the output 
Figure 4.2 Excel image identifying a single error in Mendelian 
inheritance in Patient III (Patient I is the affected parent and Patient 
VI the unaffected parent of Patient III), the equation ADTriad then 
incorrectly calls the allele from the affected parent as “A” (red 
column) but this is then corrected to AB in the following calculation 
(green column). This assumes the single error is due to a miscall 
rather than being an actual deletion. Additionally, when both the 
affected parent and the affected child have the genotype AB, the 
allele inherited from the affected parent can be determined if the 
genotype of the unaffected parent is homozygous (Section 4.2.3). 
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AB) but the Final Call data from the trio analysis have provided an 
output of AA (meaning A is the allele inherited from an affected 
parent), then the exclusion data can be changed to AA. 
 
4.4 Copy Number Analysis 
In addition to the genotyping analysis, the Affymetrix Genotyping 
Console can be used to investigate copy number variations in the 
sample genomes. For this analysis the test samples are compared 
to 90/270 HapMap reference samples (the number depends on 
the chip being used). The results are then compared to the DGV to 
highlight which CNVs are found in “normal” individuals and 
therefore highlight which may be unique to the disease. 
 
The initial QC analysis reveals whether the data are in or out of 
bounds; if out of bounds the Genotyping Console analysis is 
suggesting the CNVs have not been identified under the desired 
parameters. This in/out of bounds QC is determined from the 
interquartile range values (IQRs) given for each chromosome 
(following the CNV calculations) and should be highly similar 
across a sample with the overall sample level IQR comparable to 
the individual chromosomal IQRs. If any of the values are above 
the user-defined threshold, then the sample is given an out of 
bounds output. The IQR is a measure of the dispersion/spread of 
the data and represents the central 50% values. It is not affected 
by outliers (see below) or extreme values and is therefore a robust 
measure of dispersion.  
 
The 5-state Hidden Markov Model (HMM) is used for the CNV 
analysis where the output 0 indicates a homozygous deletion, 1 
indicates a heterozygous deletion, 2 represents a normal copy 
number state, 3 a single copy gain and 4 represents an 
amplification. Various thresholds can be adjusted to analyse the 
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data in the best way, such as with Genomic Smoothing and 
Transition Decay. Smoothing adjusts the noise and if less 
smoothing is applied, then the variance (standard deviation, SD) 
of the CN states should be increased. The SD represents the 
underlying variance or dispersion in CN state. Transition decay is 
the expected correlation between adjacent SNPs because the copy 
number of one SNP is partially dependent on the neighbouring 
SNPs and weighted based on the difference between them. If the 
transition decay is reduced (i.e. the influence of the neighbouring 
SNPs) from the default of 10Mb to 1Mb then if a particular SNP 
has a calculated CNV of 1, the probability of the flanking SNPs 
also having a CNV of 1 is much lower. If a SNP has a CN state of 3 
when all surrounding it are 2, then this SNP can be corrected to 2 
using the ‘Re-adjust outliers’ option. In this project the general 
allele specific copy number with genomic smoothing was set at 
0.5Mb with the transition decay at 10Mb and outliers re-adjusted 
at 1000bp.      
 
It is important to consider the possibility of a CNV as causing a 
disease state because a microdeletion/duplication within or close 
to the disease locus may be responsible (Kohler and Cutler, 2007). 
Deletions in VPS13B have been shown to cause Cohen syndrome, 
an autosomal recessive disorder characterised by many features, 
including: retinal dystrophy, mental retardation, truncal obesity 
and facial dysmorphism (Balikova et al., 2009). 
 
4.5 QPCR Analysis 
In this project, quantitative polymerase chain reactions were 
conducted to investigate copy number variations in genomic DNA 
samples using a BIO-RAD C1000 Thermal Cycler. QPCR is a 
typical PCR reaction except an additional probe (TaqMan) or dye 
(SYBR Green) is added that allows detection of the amplified 
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product following each round of PCR. In SYBR Green reactions, 
the normal PCR components are used but with the additional dye 
SYBR Green. This dye binds to double-stranded DNA so that in 
each amplification cycle the dye binds to the new product. This 
method does have issues however, as it also encourages non-
specific binding of SYBR Green. The dye will bind to any double-
stranded DNA present in the reaction mixture, such as if the 
primers bind non-specifically, form primer-dimers or if the DNA 
template forms secondary structures. The TaqMan method avoids 
these issues as it is highly specific and the signal produced is 
based only on amplicon formation in each round of PCR. This 
method requires the design of a probe (in addition to primers) that 
binds within the amplified fragment. The probe contains a dye and 
a quencher and this latter part prevents the dye emitting 
fluorescence whilst in its normal state. However, once the probe is 
bound to the template fragment being amplified, the polymerase 
enzyme works its way along template forming the new strand and 
as it reaches the probe it begins digesting it. As the 5’ end of the 
probe is digested the quencher is released, this means it no longer 
suppresses the dye and so fluorescence is given off. As 
fluorescence is only released as a new strand is amplified, the 
signal detected is directly proportional to the amount of product. 
 
The fluorescence data generated during a QPCR can be used to 
compare samples by looking at the PCR cycles (Ct) necessary to 
achieve a given level fluorescence. Ct is proportional to the initial 
amount of target in the sample and the relative concentration of 
one target compared to another is reflected in the difference in 
cycle number (delta-Ct) necessary to achieve the same level of 
fluorescence. The Ct value is taken from the exponential phase of 
the reaction. The initial cycles of QPCR provide a low signal that is 
usually too weak to register above background until after at least 
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15 cycles. During the exponential phase, fluorescence doubles at 
each cycle. After around 35 cycles the fluorescence reaches a 
plateau, which indicates saturation of the reaction. 
 
Delta-Ct is calculated by deducting the Ct of a reference target 
region from the Ct of the target region. A delta-Ct of 0 represents a 
ratio of one between the target and reference sample. Using a 
“normal” DNA sample control as well as test samples provides a 
reference for calculating delta-delta-Ct. This is done by deducting 
the delta-Ct for the control DNA sample from the delta-Ct of the 
test sample. This is the analysis process used in this project. 
ANOVA (analysis of variance) was used to compare the control 
sample values to the test group. When a significant difference was 
achieved, two-tailed t-tests were conducted between the control 
and individual test samples to determine the significant difference 
between the selected samples.  
 
The reference gene for CNV analysis can be a housekeeping gene 
for which it would be expected that every individual would 
maintain two copies. GAPDH was chosen for this (Figure 4.3) but 
in future it would be best to find a different housekeeping 
reference gene as Redon et al. (2006) showed that one of 270 
HapMap samples showed a gain/loss at the GAPDH genomic 
region in the DGV genome build 37 (Figure 4.4). However, just one 
of 270 would suggest this CNV is uncommon. 
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Figure 4.3 Image showing the GAPDH primers were designed to 
bind in exon 8. 
 
 
4.6 Other Computational Analysis 
A number of criteria can be set for the identification of candidate 
genes within a disease region. The genes within the disease region 
for the different disease states can be compared to see if they have 
similar functions or are members of the same gene/protein family. 
Given the similarity between the phenotypes of the disorders 
under investigation, it is possible that genes of similar function 
may be causing the disease states. Details of the expression of 
candidate genes is also important in prioritising the screening of 
candidate genes, for example, many of the disorders are early-
onset with phenotypic manifestations for the majority being 
localised to the macula. Thus, when conducting bioinformatics 
analysis of candidate genes, the list may be refined by focussing 
on those expressed in the retina and during development. For 
MCDR4, genes expressed in both the retina and ear will be of key 
interest. 
 
The sites Ensembl (http://www.ensembl.org/index.html), DGV 
(http://projects.tcag.ca/variation/), NEIBank 
(http://neibank.nei.nih.gov/EyeSAGE/index.shtml) and NCBI 
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(http://www.ncbi.nlm.nih.gov/) were extensively used in this 
project for bioinformatics analysis. These sites were used to 
investigate SNP location and information and candidate gene 
investigations. The software Geneious (Drummond et al., 2010) 
was also used extensively and throughout the project much time 
was spent investigating candidates and using these databases in 
addition to the Affymetrix Genotyping Console. 
 
 
 
Figure 4.4 Image taken from the DGV genome build 37 showing 
the GAPDH CNV identified by Redon et al. (2006). 
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5. NORTH CAROLINA MACULAR 
DYSTROPHY (NCMD/MCDR1) 
 
5.1 MCDR1 Genetic Analysis 
The disorder is well known amongst scientists and 
ophthalmologists due to all the years it has been known about yet 
the genetic cause remains elusive. It is a non-heterogeneous 
disorder with all families tested linking to the same locus on 6q 
(Small, 1998). Interestingly, in recent years two new disorders, 
MCDR3 and MCDR4, have been identified with an almost identical 
ocular phenotype yet they do not link to 6q. It may be that similar 
genes are involved or that the genes affected in each disorder are 
involved in the same process/function/pathway. It is also of 
interest that PBCRA links to an overlapping region on 6q so it is 
possible that the same gene is affected in both conditions but in 
different ways. Either way, discovering the cause of MCDR1 will 
provide a better understanding of macular function and 
dysfunction. 
 
The phenotype of MCDR1 is described in Section 2.5.1 but briefly: 
patients have a stable condition that varies between members of 
the same family in its severity. The phenotype is only unstable if 
there is formation of SRNVM in Grade III MCDR1. Patients lose 
central vision and though visual acuity can be good, with Grades 
II and III vision is poor and cannot be recovered. If a mutation can 
be identified in a particular gene then the possibility of gene 
therapy arises. If a CNV increase appears to be causing the 
disease state then it will be more difficult to find effective 
treatment, whereas a loss of a gene can also be treated with gene 
therapy. 
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MCDR1 was originally mapped by Small et al. (1992b) to 
chromosome 6q16 and the disease locus named by the Human 
Genome Organisation as MCDR1 (MC = macular, D = dystrophy, 
R = retinal, 1 = first macular degeneration to be mapped). Small 
(1998) and Small et al. (1999) later reported on the various 
linkage studies that have been conducted with NCMD families and 
produced Figure 5.1 in summation of these investigations. 
Haplotype analysis revealed four families from the USA shared the 
same haplotype whilst families from Belize, Britain, France and 
another two from America appeared to have separate haplotypes, 
suggesting independent mutations arose in these families. The 
MCDR1 locus was determined to lie between the markers D6S249 
and D6S1671. 
 
More recently, the disease region has been refined by Yang et al. 
(2007) using six families exhibiting the NCMD phenotype and in 
which the disorder was linked to the MCDR1 locus. This group 
refined the disease interval to a 1.8 million bp region from 6q16.1 
to 6q16.2 between markers D6S1716 and D6S1671. Eleven of the 
genes annotated at the time within this region (eight of which are 
indicated in Table 5.1) were analysed by mutation screening 
within the coding regions yet no mutations were found. D6S1716 
lies between the first two annotations listed in Table 5.1 whilst 
D6S1671 lies just after the last annotation in the table. The 
highest scoring marker within this region was D6S1717, which 
lies ~100kb upstream of C6orf168. Whilst detailed linkage 
analysis has been conducted on numerous MCDR1 families and 
CDS within the locus screened for mutations, CNV analysis has 
never been reported and will be conducted in this project. 
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Initially it was intended to conduct Affymetrix analysis using DNA 
from several members of the original British MCDR1 family 
(Figure 5.2) reported on by Reichel et al. (1998). However, 
permission to use these samples was not obtained until very near 
the end of the project. At this point it was discovered that the DNA 
quality of the majority of samples was poor due to the length of 
time in storage and sadly it was not good enough for Affymetrix 
processing. Due to limited resources it was initially deemed 
worthwhile to analyse as many affecteds from different families as 
possible as opposed to parent-offspring pairs from half the 
number of families. The samples indicated in Figures 5.2 and 5.3 
were analysed for CNV analysis and though the samples chosen 
would not allow for haplotype determination, it was thought that 
comparisons of the genotypes would still reveal shared regions of 
similarities. 
 
Each of the families (Figure 5.3a-h) were of European origin but 
were small, containing only one or two affected members. For this 
Figure 5.1 Ideogram of 
chromosome 6 showing the 
location of markers and 
distances between them in 
centiMorgans. The location 
of the MCDR1 gene as 
determined by various 
family studies is shown by 
the shaded bars. Taken 
from Small et al. (1999). 
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reason it was not appropriate to conduct linkage analysis as a 
number of subjects separated by at least 10 meioses are required 
to obtain significant LOD scores. As MCDR1 is a non-
heterogeneous disorder and MCDR3 and MCDR4 are extremely 
rare with just a single family identified for each, it is highly likely 
that these NCMD families do indeed link to 6q and so analysis of 
data focused on this region. 
 
From the original British MCDR1 family, two samples were of good 
enough quality to process on the Affymetrix chips, an unaffected 
parent and affected offspring (indicated in Figure 5.2) from whom 
the disease genotype for this family could be determined. 
 
 
 
Figure 5.2 The original British MCDR1 family as reported on by 
Reichel et al. (1996). The individuals circled in green are those 
analysed on the Affymetrix 50K Sty I chips. Individuals highlighted 
in black are known affected members. 
 
 
 
a) 
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b)
 
 
c)
 
 
d)
 
Chapter 5 
     Genetic Analysis of Inherited Retinal Dystrophies 117 
 
 
 
e)  f)  
 
g)  
 
h)  
Figure 5.3a-h Pedigrees of MCDR1 families with known affected 
members highlighted in black and individuals whose DNA was 
analysed on the Affymetrix 50K Sty I SNP chips are highlighted in 
green. 
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5.2 Candidate Genes 
Despite Yang et al. (2007) screening the exons and sequencing the 
cDNAs of the genes within the MCDR1 locus (Table 5.1) in 
patients with NCMD and finding no abnormalities, these remain 
candidate disease genes as mutations may exist in promoter 
regions, at splice sites or within introns. It may also be that 
deletions of exons were missed due to the sequencing strategy. 
 
Table 5.1 Annotations within the MCDR1 disease region of the 
human genome build 37. *cDNA screened by Yang et al. (2007). 
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5.2.1       SFRS18 
Of the genes listed in Table 5.1, SFRS18 is the only one reported 
to be expressed in the retina and RPE/choroid (NEIBank 
database). It encodes the serine-arginine-rich-splicing regulatory 
protein 130 (SRrp130). Zimowska et al. (2003) reported this to be 
a novel 130 kDa nuclear protein consisting of 805 amino acid 
residues with multiple serine-arginine (SR) repeats that co-
localises with Pnn in a human corneal epithelial cell line. Pnn 
encodes pinin, a phosphoprotein thought to play a key role in the 
establishment and maintenance of corneal epithelial adhesion (Shi 
et al., 2000). SRrp130 exhibits an SR-rich carboxy-terminus, 
which caused the authors of the study to speculate the 
involvement of SRrp130 in pre-mRNA biogenesis through 
interactions with SR-rich proteins. SRrp86 is known to be 
involved in activation and inhibition of splicing (Barnard and 
Patton, 2000) and the C-terminus of SRrp130 shows significant 
homology to SRrp86. There have been no reports to date of a role 
of this gene in retinal function or development but NEIBank 
Database lists it as having expression in the retina. As it may play 
a role in splicing, it is possible that NCMD is caused by a novel 
faulty splicing mechanism due to a mutation in this gene. Various 
mutations affecting splicing have been found to cause RP (Section 
2) so it is plausible to consider such a mechanism for macular 
dystrophy. 
 
5.2.2      POU3F2 
POU domain class 3, transcription factor 2 gene (POU3F2, also 
known as BRN2, brain-specific homeobox/POU domain protein 2) 
belongs to a large family of transcription factors that bind to an 
octameric DNA sequence with the class III POU genes expressed 
predominantly in the central nervous system. POU3F2 is involved 
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in embryonic neuronal development and Cobrinik et al. (2006) 
reported that the protein product of this gene binds to promoters 
of characteristic retinal progenitor cells (RPCs) and is down-
regulated by retinoblastoma protein (Rb). During retinal 
development it is expressed in intermediate and late RPCs as well 
as in post-mitotic cells. As this gene has been identified as being 
active during the development of the retina, it may be a stronger 
candidate than SFRS18 for NCMD. It is likely to bind to promoters 
for many retinal genes, for example, GeneCards indicates the 
ABCA4 promoter has a POU3F2 site 
(http://www.genecards.org/cgi-bin/carddisp.pl?gene=ABCA4). If 
it is important for the expression of retinal genes then a mutation 
could clearly have a crucial impact on the functioning of the 
retina. 
 
5.2.3      FBXL4 
The F-box/leucine-rich repeat protein 4 (encoded by FBXL4) is a 
component of modular E3 ubiquitin protein ligases, which 
function in phosphorylation-dependent ubiquitination. The fly 
homologue, dFbxl4, is dependent upon fly calmodulin-binding 
transcription activator (dCAMTA) for expression and together they 
facilitate rhodopsin deactivation (Han et al., 2006). It is suggested 
that dFbxl4-mediated ubiquitination of rhodopsin may abolish 
rhodopsin-Gq interaction and so deactivate the light receptor in 
Drosophila. Loss of dCAMTA/dFbxl4 function causes rhodopsin to 
undergo light-dependent down-regulation. Thus, it appears that in 
flies, dFbxl4 is important for sensitivity and termination of the 
light receptor. The importance of dFbxl4 in Drosophila 
phototransduction may suggest a similar role of FBXL4 in human 
retina. If the human homologue does play a similar role in the 
human retina then this is a good candidate gene for NCMD. 
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5.2.4      Other Candidate Genes 
Neither CCNC nor the methyltransferase COQ3 have been reported 
to be involved in retina-specific functions or development so they 
would not appear to be good candidates for NCMD. Similarly, 
PRDM13 is not a high priority candidate gene in NCMD but it has 
been considered as a candidate tumour suppressor gene 
(Behrends et al., 2003). MCHR2 is a G-protein-coupled receptor 
activated by melanin concentrating hormone and is involved in 
appetite regulation (Hill et al., 2001). This gene is an intriguing 
candidate as there is no orthologue present in mice and, as mice 
lack a macula, it is possible the MCHR2 gene has an as yet 
unknown role in macular function. Dr Ambreen Kalhoro has 
previously screened the coding exons of this gene in MCDR1 
patients but failed to find a mutation (unpublished data). 
 
5.3 Methods Applied 
5.3.1      Affymetrix 50K Xba I Protocol 
The DNA samples were prepared for processing over the 
Affymetrix 50K Xba I chip, as described in Section 3.2.2. 
Hybridisation to the chips was conducted by the UCL Wolfson 
Institute.  
 
5.3.2    Candidate Screening 
FBXL4  
Gradient BIOTaq PCRs were conducted for all primers (see Section 
3.1.1) and PCRs then carried out at optimal temperatures for each 
primer set using the BIOTaq protocol. Primers and annealing 
temperatures are shown in Table 5.2. 
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Table 5.2 FBXL4 primers and annealing temperatures. 
 
 
 
 
 
SIM1 
Gradient BIOTaq PCRs were conducted for all primer sets (Section 
3.1.1) and PCRs then carried out at optimal annealing 
temperatures for each primer set. The BIOTaq protocol was 
followed and amplification products used directly in sequencing 
reactions unless otherwise stated (Table 5.3). 
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Table 5.3 SIM1 primers and annealing temperatures. 
 
 
 
 
Novel Putative mRNA Transcript 
Two predicted exons of a putative, incomplete mRNA transcript 
were screened using the BIOTaq protocol. An annealing 
temperature of 56oC was used for both exons and the sequences 
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were cleaned using the Montage method (Section 3.1.1) prior to 
analysing. Primers are listed in Table 5.4. 
Table 5.4 Primers used for the amplification of a novel putative 
mRNA transcript. 
 
 
 
POU3F2 
Numerous attempts to screen POU3F2 were made yet all failed. 
Four different polymerase enzymes were tried and numerous 
primers designed (Figure 5.4 and Table 5.5). Manually designed 
primers were used in addition to software-designed primers. 
Attempts were made to amplify the entire length of the gene in 
addition to amplifying it in sections. None of these attempts were 
able to provide sequencing data. 
 
 
 
 
 
Figure 5.4 Image showing the positions of primers designed and 
used in attempts to amplify POU3F2. 
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Table 5.5 Primers used in attempts to screen POU3F2. Names of 
primers match those annotated in Figure 5.3 from left to right. 
 
 
 
 
5.4 Results 
5.4.1 Affymetrix Data 
An affected individual from each of nine unrelated families was 
selected for screening in order to analyse genotypes at the MCDR1 
disease interval between D6S1716 and D6S1671. An unaffected 
member of the original MCDR1 family (Reichel et al., 1998) and 
her affected offspring were analysed for genotype comparison. The 
aims of this work were to ascertain whether the families possess 
disease regions with common alleles and to determine whether 
there is any evidence for chromosomal deletion or duplication 
within the MCDR1 region. 
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Genotyping Analysis 
The Affymetrix Genotyping Console determined all samples to be 
of good quality (90 - 96% QC rate), indicating the genotyping 
results generated would be reliable.  
 
The data from the original British MCDR1 family members were 
used to determine a MCDR1 genotype at the 6q locus. This is the 
only family in this study that has been linked to chromosome 6q 
(Reichel et al., 1998). The genotypes from the unaffected subject 
were compared to those of the affected offspring and the allele 
inherited from the affected parent deduced (as described in 
Section 4.3.2), producing the disease genotype for this family 
(Figure 5.5). Where AB is given, this indicates that the disease 
allele could not be determined. The genotype for the original 
British MCDR1 family was then aligned against the other nine 
MCDR1 sample data for comparison (Figure 5.6). It should be 
noted that in this comparison the disease genotype for the original 
MCDR1 family identifies the disease alleles A or B as AA or BB, 
respectively. 
 
A consequence with not running unaffecteds from each family is 
that it does not allow the determination of phase for the unrelated 
families. The Affymetrix Console provides calls only for the alleles 
it detects, it cannot identify which allele is from the maternal or 
paternal chromosome and therefore the haplotypes cannot be 
determined without analysing both parent and offspring samples. 
For this reason, running either one parent of each affected or an 
unaffected sample for each family would have been ideal. 
However, this was only done for the original British family. For the 
new families it was initially deemed worthwhile with limited 
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resources to analyse affecteds from as many families as possible 
rather than parent-offspring pairs from fewer families. Parent-
offspring data would have determined haplotypes but instead only 
comparison of the genotypes within the disease locus could be 
conducted. It was realised during the analysis process that the 
choice of samples for analysis was ill-judged. Figure 5.6 shows the 
comparison between the MCDR1 6q genotype of the original 
British family to the same region in affected samples from 
unrelated families.   
 
 
 
 
Figure 5.5 Excel sheet extract showing the Mendel and ADTriad 
comparisons between the original British family unaffected parent 
and affected offspring. A Dummy Affected parent is added for the 
Macro equations to function. The determined disease genotype of 
the affected offspring is boxed in red. 
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Though the comparisons of the unrelated families are not ideal, 
when aligned with the genotype of the orginal British family, there 
are apparent regions of common alleles within the disease locus 
(Figure 5.6). For example, around the highest scoring 
microsatellite marker D6S1717 are the greatest number of shared 
alleles between all samples. The genes within this region are: 
POU3F2, FBXL4, USP45, CCNC and PRDM13. However, this 
approach is not ideal. Not knowing the phase of each allele means 
it cannot be known which allele is on the disease chromosome. 
There are many SNPs for which AB calls are provided and it may 
be that even though all samples appear to have a common allele, 
for some samples the shared allele may not be part of the disease 
haplotype.  
 
Another issue arising from the approach taken is that SNPs on the 
Affymetrix chips tend to be common SNPs and so the similarities 
identified by comparing the ten unrelated MCDR1 families may be 
seen by comparing any 10 unrelated samples. To highlight this, 
the genotypes of 10 randomly selected HapMap samples were 
aligned and compared at the 6q locus in the same manner as for 
the MCDR1 samples in Figure 5.6. These are ten unrelated 
families as in the MCDR1 analysis and comparing the alleles 
across the 6q locus produces a very similar exclusion pattern as 
seen from the MCDR1 sample comparisons (Figure 5.7).  
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Copy Number Analysis 
The 50K chip data is not ideal for CNV analysis as the 250K and 
SNP 6.0 chips provide greater analysing capacities and more 
reliable outputs. Despite this the data set was compared to 90 
normal samples (HapMap) to give an indication of possible regions 
of CNV in each sample that could then be compared and 
investigated further. The quality of the sample data were adequate 
for the analysis, with all sample data determined to be in-bounds. 
All CNVs were compared to the DGV for identification of novel 
CNVs.  
 
For all samples, the analysis indicated that every chromosome 
contained a number of CNVs. This contrasted with the analysis of 
sample HapMap data and the analyses from other components of 
the project where CNV analysis was conducted using 250K data. 
The 50K chip would appear to be identifying spurious CNVs 
within the genome. Though all families in this analysis have not 
been linked to the MCDR1 locus, it is likely that they are MCDR1 
families and therefore a common variation would be expected. 
However, none of the CNVs identified were found in all families, as 
shown in Table 5.6.  This suggests that all the NCMD families do 
not share a common CNV but given the reliability of the data, the 
CNV discovered in seven of the ten families across POU3F2 and 
FBXL4 should be investigated further. 
 
 
Table 5.6 CNVs not found in the DGV but common to the families 
analysed. 
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5.4.2 Candidate Screening 
Though previous screens of patient cDNA have revealed no 
mutations, the cause of disease could be a splice variant of a 
particular gene, a point mutation within a gene, deletion of a 
whole exon, a non-coding RNA or a CNV. The genes determined as 
best candidates within the MCDR1 locus were chosen for 
screening from genomic DNA with primers designed upstream of 
the exons to include splice sites. POU3F2 was identified as a 
possible candidate with numerous primers designed and PCR 
conditions attempted but all failed. 
 
FBXL4 
Yang et al. (2007) identified this gene as a possible candidate for 
MCDR1 but when the coding exons were screened from isolated 
cDNA no mutations were identified. The function of this gene in 
Drosophila highlighted it as a good candidate for both MCDR1 and 
PBCRA and it was selected for screening in these families (Section 
8.5.1). Despite identifying SNPs within the coding exons, none 
were unique to affected individuals. The variations identified are 
shown in Table 5.7. Attempts to screen the promoter and exon 1 
region failed, which was also the case for control samples. As for 
POU3F2, numerous primers were designed and PCR conditions 
attempted but all failed. 
 
 
Table 5.7 SNPs identified in FBXL4 in 10 MCDR1 samples. 
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Figure 5.8 Example sequencing data showing the FBXL4 exon 5 
variation in sample WB.  
 
 
SIM1 
Despite this gene being downstream of the disease region refined 
by Yang et al. (2007), it was identified as a good candidate for 
PBCRA as part of this project and given the overlap in loci was 
included for screening in the NCMD families. The promoter and all 
exons were successfully sequenced including introns and the 
SNPs identified are summarised in Table 5.8.  
 
Table 5.8 SNPs identified SIM1 in MCDR1 samples. 
 
 
 
 
 
 
Figure 5.9 Example sequencing data showing the SIM1 exon 9 
from sample PB showing two nucleotide variations. 
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Within intron 8 of the SIM1 gene is a putative novel mRNA 
transcript yet to be fully annotated or characterised. Despite the 
ORFs being incompletely identified, attempts to screen them were 
made. The Affymetrix 50K SNP rs3778033 (Figure 5.5) is located 
between the two deduced ORFs of this gene. No variations in the 
predicted sequences were identified. 
 
5.5 Discussion 
5.5.1      Genotyping Analysis 
The analysis conducted for this disorder involved Affymetrix SNP 
chip analysis largely restricted to affected individuals from 
unrelated families. Parent-offspring data were achieved for just 
one family (the original British MCDR1 family) whereas from nine 
others just one affected member was analysed. This meant it was 
not possible to determine the phase of alleles and thereby derive 
haplotype data for the NCMD families. Despite this, comparisons 
were attempted between the genotype deduced from the original 
British samples and the genotypes of the nine other families. By 
comparing the genotypes of affecteds from unrelated families to 
the genotype of the original British MCDR1 family, it was 
anticipated that similarities in genotype might be identified at the 
MCDR1 locus that would highlight key candidate genes. 
Unfortunately this approach was largely unsuccessful; parent-
offspring data should have been obtained for all families so that 
haplotypes could be compared across the disease region. Though 
genotype comparisons were attempted they generated very limited 
information as it is not known whether the apparent consistent 
alleles shared between all families are on the chromosome 
inherited from the affected parent. Another issue with the 
approach taken is that such differences between genotypes may 
occur from a comparison of any ten unrelated individuals. This 
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was shown to be the case when ten random HapMap genotypes at 
the MCDR1 locus were compared and a similar pattern of allele 
similarity produced. Overall therefore, determining haplotypes 
across all families would potentially have yielded more useful 
information. 
 
Due to the size of the nine unlinked families, linkage has not been 
possible so the disease gene may map to a different locus such as 
MCDR3, which has an almost identical phenotype but links to 
chromosome 5p. However, MCDR3 is very rare with just a single 
family identified (Michaelides et al., 2003c), whereas there are 
numerous MCDR1 families worldwide (Section 2.5.1). Based on 
this it seems likely that all nine families are MCDR1 families. It is 
also a possibility that some families may be phenocopies, meaning 
they show MCDR1 characteristics but their genotypes differ with 
environmental conditions being responsible for the phenotype. 
This is a possibility for a couple of the families shown in Figure 
5.3c, d & h, where an affected parent is missing. 
 
A further issue with attempting SNP analysis rather than using 
traditional markers is that linkage cannot be conducted as each 
SNP marker has just two polymorphisms whereas microsatellites 
can have many more and therefore SNPs are much less 
informative. Many samples from large families would need to be 
analysed for linkage analysis to be informative using SNP 
technology. However, it was known that linkage would not be 
possible in this analysis (also due to the size of the families) and 
that the analysis would rely on the genotype comparisons. In 
hindsight it would have been useful to conduct microsatellite 
marker analysis with markers from previous studies used to 
define the MCDR1 locus as this would have indicated whether the 
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disease chromosome in the different families has a common 
origin.  
 
5.5.2      Copy Number Analysis 
The analysis carried out on the NCMD family 50K data identified a 
very large number of CNVs in all samples across all chromosomes. 
The number is in excess of those seen from other samples in this 
project analysed on the 250K chips, which suggests that many 
may be invalid. None were conserved across all MCDR1 families at 
the disease locus but a CN state of 3 identified in seven of the ten 
samples across POU3F2 and FBXL4 could be of interest and 
should be further investigated to confirm or refute the presence in 
all samples. 
 
5.5.3      Candidate Gene Analysis 
Though Yang et al. (2007) screened various genes within the 
MCDR1 locus, these genes had not been screened in the families 
in this project. Based on the possible roles and significance of the 
expressed proteins in the retina and developmental process, some 
were screened in this project. Splice site and promoter screening 
were also attempted. But for POU3F2 and exon 1 of FBXL4, 
screening attempts failed. Numerous primers were designed using 
both manual and computer-generated methods (POU3F2 shown in 
Figure 5.4 and Table 5.5 and FBXL4 failed primers in Appendix I 
Figure 13.1 and Table 13.1) and various PCR conditions and 
polymerases were tried yet still the reactions failed to give the 
desired product. This can happen when, despite much effort to 
prevent it, primers can bind non-specifically. For example, 
POU3F2 is not only GC rich (which makes amplification difficult 
as the polymerase falls away) but the gene is also similar to 
related members, which encourages non-specific primer binding. 
If further attempts were made to screen the genes/exons, it would 
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be worthwhile increasing the primer concentrations to encourage 
more to bind to the desired region. It would also be worthwhile to 
attempt touch-down and reverse touch-down PCR methods. The 
touch-down method involves using initial stringent conditions 
which are then relaxed as the correct product is formed to speed 
up the efficiency and yield. The reverse touch-down method might 
be more appropriate in this situation with initial PCR conditions 
relaxed to amplify all possible products, including non-specific 
regions, then gradually increasing the stringency of the reaction to 
encourage amplification of only the desired fragment. It may also 
be possible to identify restriction sites within the gene then digest 
the genomic DNA with specific enzymes and use the digest 
mixture as a template for PCR with primers designed to bind the 
specific overhang sites of the desired genetic region. 
 
POU3F2 is worth screening in both these MCDR1 families and the 
PBCRA family because it has been shown to be involved in 
embryonic neuronal development and Cobrinik et al. (2006) 
reported that the protein product of this gene binds to promoters 
of retinal progenitor cells. This also makes an intriguing candidate 
because a binding site for this transcription factor exists on one of 
the promoter regions for the MCDR3 candidate CCT5.   
 
In Drosophila, dFbxl4 appears to be important for sensitivity and 
termination of the light receptor (Han et al., 2006). If there is a 
similar role of FBXL4 in the human retina as dFbxl4 has in 
Drosophila, then this would be a good candidate for MCDR1. It is 
also interesting because the related member FBXL7, which is 
listed as being expressed in the retina on the NEIBank database, 
was highlighted as an MCDR3 candidate (Section 6.6.1). POU3F2 
and FBXL4 make good candidates and though Yang et al. (2007) 
screened them, by screening cDNAs they would not have included 
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splice site or promoter regions therefore it is still possible that 
mutations in either of these genes may still cause MCDR1. FBXL4 
was screened in MCDR1 samples and despite identifying 
variations in the exon sequences (including splice sites) none were 
unique to affected individuals.  
 
Of the other genes in the MCDR1 locus, only SFRS18 has been 
reported to be expressed in the retina and RPE/choroid. The 
expressed product SRrp130 has been shown to co-localise with 
pinin in a human corneal epithelial cell line (Zimowska et al., 
2003). Though there have been no reports of SRrp130 function in 
the retina, given its expression pattern it may play an important 
role in splicing in both the retina and RPE. 
 
Cyclin C (encoded by CCNC), coenzyme Q3 homolog 
methyltransferase (encoded by COQ3) and PR domain containing 
13 (encoded by PRDM13) are less likely candidates for MCDR1. 
They are neither listed as being expressed in the retina or 
RPE/choroid nor do they have published data on roles in the eye. 
Ubiquitin-specific protease 45 (USP45) cDNA is listed in Unigene 
as being extracted from eye tissue and related ubiquitin-specific 
proteases have been identified with retina and RPE/choroid 
expression in NEIBank databases. Ubiquitin-specific proteases 
have been shown to be important in cell death in the Drosophila 
retina (Copeland et al., 2007) therefore USP45 may have an as yet 
unidentified role in the human retina. Interestingly, mutations in 
proteins involved in ubiquitination have been found to result in 
retinal dystrophy. For example, mutations in KLHL7 are known to 
cause autosomal dominant RP (Friedman et al., 2009; Section 
2.1.1). The other interesting candidate is the uncharacterised 
C6orf168, which may also have a role in the development or 
correct functioning of the retina that has yet to be determined. 
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Prior to this project, MCHR2 coding exons were screened in 
original MCDR1 family members by Dr A. Kalhoro with no 
mutations found. This gene has previously been associated with 
appetite regulation (Hill et al., 2001) but was judged an interesting 
candidate because of the genes at the 6q locus there is no mouse 
ortholog for this gene and as mice lack a macula it was thought 
possible that there is a specific role for this gene in macular 
function.  
 
Though outside of the locus refined by Yang et al. (2007), the 
genes SIM1 and ASCC3 should not be disregarded as candidates. 
Single-minded homolog 1 (encoded by SIM1) haploinsufficiency 
has been linked to obesity (Hung et al., 2007) and Bonaglia et al. 
(2008) have shown it is also the likely cause of obesity in a Prada-
Willi-like phenotype, in which one characteristic is eye/vision 
abnormalities (including retinitis pigmentosa in one case). The 
Drosophila sim gene is a master regulator of neurogenesis and 
Holder et al. (2000) showed that mouse Sim1 is expressed in the 
developing kidney and central nervous system and is essential for 
supraoptic and paraventricular nuclei of the hypothalamus 
formation. Roles of SIM1 specifically in the eye have not been 
reported but it was screened as a candidate for PBCRA and 
therefore screened in the MCDR1 families as well. Variations were 
identified though none were in coding exons nor were variations 
found consistently across the MCDR1 families. They were 
therefore not likely to be responsible for the disease state, 
excluding SIM1 mutations as the cause of MCDR1. 
 
Though activating signal co-integrater 1 complex subunit 3 is not 
listed in the NEIBank retina and RPE/choroid databases, Unigene 
lists it as present in eye tissue and ASCC3-like 1 is reported as 
being expressed in the retina and RPE/choroid. ASCC3 is of the 
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RNA helicase family but there are no publications on specific roles 
of this gene in the retina and, combined with previous linkage 
data that excludes this gene, this seems an unlikely candidate. 
 
5.5.4      Summary 
This analysis has highlighted that if using Affymetrix SNP chip 
genotyping analysis to aid in refining a disease locus, it is 
essential to analyse parent-offspring data and/or unaffected 
samples in order to determine haplotypes for comparison. The 
CNV analysis from the SNP chips revealed no consistent regions of 
CNVs in all families that might be important in the disease state. 
However, a CN state of 3 identified in seven of ten families may be 
of interest.  It would appear that the primary candidates within 
the locus are POU3F2, FBXL4, SFRS18, USP45 and C6orf168. 
Even though the coding exons of the FBXL4 gene (including splice 
sites) have been screened revealing no mutations in ten NCMD 
families, there could still be an error in the promoter sequence of 
this gene, which has yet to be screened. Screening of SIM1 
provided no evidence of errors that would cause disease, 
suggesting the above genes highlighted that lie within the region 
refined by Yang et al. (2007) remain the MCDR1 candidates. 
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6. NORTH CAROLINA-LIKE MACULAR 
DYSTROPHY (MCDR3) 
 
6.1 MCDR3 Genetic Analysis 
The phenotype of this disorder is very similar to that of MCDR1 
(Section 2.5.2) yet it does not link to the 6q locus and instead 
linkage has been found to 5p. The only phenotypic differences 
between MCDR1 and MCDR3 are mild abnormalities in colour 
vision in some of the MCDR3 affected individuals and evidence of 
MCDR3 disease progression, though this was only noted in a 
single case (Michaelides et al. 2003c). So far the pedigree depicted 
in Figure 6.1 is the only reported MCDR3 family in a single study 
publication characterising and mapping this disease. Michaelides 
et al. (2003c) used microsatellite markers to scan 50% of the 
genome and excluded linkage of MCDR3 to the MCDR1 locus in 
addition to other sites of the genome linked to other inherited 
retinal disorders (CORD6, CORD7, CORD8, GCAP, STGD1, STGD3 
and STGD4). Significant linkage to chromosome 5p15.33-p14.3 
was established and critical recombination events observed in 
affected member IV:9 and unaffected member V:2 at the 
centromeric end defined the locus as between flanking markers 
D5S1981 and D5S2031 (a 19.5Mb region). The markers used in 
the study and maximum lod scores at θ=0 are shown in Table 6.1. 
This is a very large locus containing many potential candidate 
genes and it is hoped that by generating SNP data from MCDR3 
samples the disease region can be refined and the number of 
candidate genes reduced. It was thought that this might be 
possible by comparing genotype data from affected members of 
the family as Miyazawa et al. (2007) have shown genotyping data 
from such samples can be informative. As this family has already  
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been linked the affecteds were analysed in order to compare 
similarities and differences in alleles between samples to help 
refine the locus. Though the Affymetrix Console cannot determine 
phase of alleles (as described in Section 4.2) and unaffected 
members of the MCDR3 family were not analysed, the sample 
cohort comprised of affected offspring plus affected parent and so 
the inherited disease alleles could be determined.    
 
Table 6.1 Markers used in the study by Michaelides et al. (2003c) 
to determine the MCDR3 locus. 
 
 
 
6.2 Methods Applied 
6.2.1      Affymetrix Protocols 
Xba I 50K 
Four samples, highlighted in green in Figure 6.1, were prepared 
for processing over the Affymetrix 50K Xba I chip, as described in 
Section 3.2.2.  
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Sty I 250K 
Five samples, highlighted in red in Figure 6.1, were prepared for 
processing over the Affymetrix 250K Sty I chip, as described in 
Section 3.2.3.  
 
6.2.2      Candidate Screening 
LPCAT1 
Gradient BIOTaq PCRs were conducted for all primer sets (Section 
3.1.1) and PCRs then carried out at the optimal annealing 
temperature for each primer set. The BIOTaq protocol was used 
and amplification products were purified and sequenced using the 
montage protocol unless otherwise stated (Table 6.2). 
 
6.3 Results 
6.3.1 Affymetrix Data 
Genotyping Analysis 
DNA from five members of the family depicted in Figure 6.1 
(circled in red) were processed and run over 250K Sty I SNP chips. 
The individuals circled in green were additionally analysed on 50K 
Xba I chips. This was done as a comparison to the 250K data and 
although the 250K data provided more NoCall outputs than the 
50K data, given the volume of SNPs that could be used for the 
genotyping analysis (despite abandoning those with NoCalls) it 
appears to have been a more useful chip. It would be valuable to 
process samples from extended family members in order to look at 
genotypes of members separated by several meioses events, which 
should help exclude further SNPs within the mapped region and 
refine the locus.  
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Table 6.2 Primers and annealing temperatures for LPCAT1 exons. 
 
 
 
 
The disorder was originally linked between flanking markers 
D5S1981 and D5S2031, which denotes a large disease region of 
over 19 million bases. It was thought that the presence of 
thousands of SNPs within this linked region would be able to 
Chapter 6 
     Genetic Analysis of Inherited Retinal Dystrophies 146 
provide informative comparisons between the samples analysed.  
However, there was just a single exclude seen within the locus 
(running from SNPs: rs6555608, the first SNP on chromosome 5, 
to rs681129, position 18,105,325). In contrast, numerous 
excludes were seen beyond this locus (Figure 6.2), suggesting 
these mark the end of the disease locus, which is consistent with 
the previous linkage data. The exclude within the disease region 
was seen at rs2934551 (2,877,017), which lies near the marker 
D5S417. This marker was used in the original linkage study and 
achieved a maximum LOD score of 1.93 whilst the markers 
centromeric to it obtained significant LOD scores and defined the 
locus. As the genotyping data presented here were extracted at 0.1 
confidence the single exclude within the MCDR3 locus is not likely 
to be a miscall, and although it is just a single marker, combined 
with the previous marker analysis it may suggest that the disease 
region lies beyond this point.  
 
 
 
 
Figure 6.2 Excel sheet showing the group of excludes present at 
the centromeric end of the linked MCDR3 region. Only a single 
exclude output was given prior to this region. 
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The allele associated with the disease haplotype at rs2934551 for 
V:7 and V:8 is B (IV:14 is given a NoCall but given that both 
offspring of this individual are BB he must also have the B allele), 
whereas IV:9 is AA. Given that the mother of IV:9 (III:4) is AB, this 
suggests that a crossover may have occurred at this point in 
individual IV:9 (Table 6.3), indicating that the disease region lies 
beyond this SNP. It is difficult to be confident of a crossover from 
this SNP data because there are only two alleles and the 
Affymetrix data cannot determine which is from which parent. 
However, for each offspring analysed so too was an affected parent 
meaning the alleles inherited from the affected parent can be 
determined. Table 6.3 shows how the data position the possible 
crossover in IV:9. The purple alleles represent those that could be 
inherited from the affected parent. A crossover at rs2934551 
would place the disease region beyond this SNP. Example data 
from rs2934551 (2,877,017) to rs681129 (18,105,325) are shown 
in Figure 6.3a and 6.3b (all SNP data from this region are shown 
in Appendix III). 
 
 
Table 6.3 Data depicting a possible crossover event in IV:9. Purple 
alleles represent the disease haplotype of the affecteds.  
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Throughout the disease region the subjects shared alleles that 
were of low frequency, suggesting these alleles segregated with 
disease. Table 6.4 identifies these SNPs, which seem to group 
around the sites of markers from the published study. The 
scattering of low frequency alleles across the linked disease region 
adds further evidence to the large section of chromosome 5 
segregating with the disease state. 
 
Table 6.4 A selection of SNPs at which the MCDR3 family 
members all exhibited a low frequency allele.  
 
 
 
The 50K trio data could not be used for exclusion analysis due to 
the nature of the relationships between the subjects processed. 
This is because it is not possible to conduct two-point linkage 
between parents and offspring with SNP data due to the lack of 
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meioses and marker information (only two alleles). The three 
affected samples (highlighted in Figure 6.1) achieved a good QC 
rate of >94% but the unaffected achieved only 87%. Despite this, 
few NoCalls were evident at 0.1 confidence. The data were used to 
search for errors in Mendelian inheritance but no notable regions 
of error were identified.  
 
 
 
a)  
 
SNPs that 
lie within 
gene 
regions 
Figure 6.3a Excel extract showing example SNP data within the 
MCDR3 locus. 
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b)  
 
 
 
 
 
Copy Number Analysis 
All sample data from the 250K chip were in bounds except for one 
(V:8), which was given an out of bounds output based on the X 
chromosome IQR. The analysis was run despite this and 
investigations of CNVs conducted. 
 
All chromosomes were analysed for copy number variations and 
those common to all samples are shown in Table 6.5. Three of the 
five MCDR3 samples had a copy number state of 1 (indicating a 
heterozygous deletion at the associated SNP) within the linked 
SNPs that 
lie within 
gene 
regions 
Figure 6.3b Excel extract showing example SNP data within the 
MCDR3 locus. 
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disease region at 5p15.33 but this is a known region of CNV and 
not seen in all samples and so is unlikely to be significant. 
 
Table 6.5 CNVs common to all MCDR3 samples. 
 
 
 
The only CNV seen in all samples but not in a region of known 
CNV was at 18q12.1. This would result in a gain of one copy of 
CDH2, which encodes cadherin 2, type 1 also known as N-
cadherin (neuronal). 
 
6.3.2 Candidate Gene Screening 
It was hoped that the Affymetrix data would produce more 
exclusions and a more refined 5p locus. This was not achieved, 
although the region may have been reduced due to the presence of 
one exclude within the disease region. As the genotyping data did 
little to refine the locus, an extensive search of the genes within 
the locus was conducted to indicate which may be key candidates 
for screening. 
 
There are over 60 characterised genes within the disease region 
and numerous other annotated genes, processed transcripts, 
pseudogenes and ncRNAs. Of the characterised annotated genes, 
the majority are listed on Unigene with their cDNA being found in 
eye tissue. According to the NEIBank database only two are 
expressed in both the retina and RPE/choroid: SDHA and LPCAT1 
and only this latter gene has published data providing evidence of 
a role in retina with Friedman et al. (2010) showing that loss of 
LPCAT1 leads to photoreceptor degeneration in rd11 mice. Cheng 
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et al. (2009) have also shown evidence of the importance of 
LPCAT1 in catalysing the inactivation of inflammatory lipids in the 
retina of diabetc mice. 
 
LPCAT1 
Coincidentally, LPCAT1 was identified by another group from 
Montpellier, France (http://www.inmfrance.com/1_equipe1.php) 
as having a role in lipid metabolism that may regulate isomerase 
activity in the retina and based on its expression it makes a good 
candidate for retinal disease. This group were studying cellular 
and animal models for the investigation of the molecular 
mechanisms of regulation of the isomerisation of vitamin A. As a 
result of this work they discovered a new protein involved in lipid 
metabolism that may regulate isomerase activity and following 
identification of this also have evidence of LPCAT1 expression in 
the retina and RPE. They hypothesised a role of the protein 
LPCAT1 in the regulatory mechanism of isomerase activity. This 
group subsequently contacted our own to suggest screening of the 
gene. Loss of this gene has been reported to lead to photoreceptor 
degeneration in rd11 mice (Friedman et al., 2010) and the 
genotyping and linkage analysis for the MCDR3 family did not 
exclude it as a candidate. The 14 coding exons (including splice 
sites and sections of introns) and promoter region of this gene 
were screened in two selected affecteds (IV:12 and V:8) and one 
unaffected (V:3) from the family in Figure 6.1, with the majority of 
exons exhibiting no changes. The results are summarised in Table 
6.6. 
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Table 6.6 Summary of SNPs identified in MCDR3 samples when 
screening LPCAT1. 
 
 
 
 
 
Following the identification of the non-synonymous SNP in exon 3  
of V:8, which is a known SNP rs28715640 and results in a 
Thr125Ala substitution (Figure 6.4), other family members were 
screened to see if the SNP was present but it was not. Similarly, 
all family members were screened for the non-synonymous SNP 
rs3542723 in exon 13, which results in a Met427Thr missense 
mutation (Figure 6.5). Nine affecteds possessed the low frequency 
G allele but this was also seen in six of eight unaffected members, 
indicating it is not important to the disease state. 
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Figure 6.4 Above image shows a nucleotide trace for V:8 LPCAT1 
exon 3 with variations seen at rs28715640 (left) and rs3733796 
(right). The bottom image shows the amino acid change that 
results from having the A allele at rs28715640 (Thr125Ala). 
 
 
 
 
 
 
Figure 6.5 Above image shows a nucleotide trace for IV:12 LPCAT1 
exon 13 with a variation seen at rs3542723 (T/C). The bottom 
image shows the amino acid change that results from having the 
C allele (Met427Thr). 
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6.3.3 Bioinformatic Screening of Candidate Genes 
No further genes were screened during this project but extensive 
analysis of further candidates was conducted. Within the original 
linked region are over 60 characterised genes and numerous other 
annotations. Of the characterised genes, a large number are listed 
on Unigene with their cDNA being isolated from eye tissue. 
Despite this, just two are listed on NEIBank as being expressed in 
both retina and RPE/choroid: LPCAT1 and SDHA. LPCAT1 has 
already been considered but SDHA encodes succinate 
dehydrogenase complex subunit A, which is part of the 
mitochondrial respiratory chain. Optic atrophy 1 (OPA1) and 
Leber hereditary optic neuropathy (LHON) are both caused by 
defects in mitochondrial proteins (Delettre et al., 2000; Wallace et 
al., 1988), which makes SDHA an interesting candidate.  
 
Six of the characterised genes that lie within the original MCDR3 
locus are listed on the NEIBank retina database: CCDC127, 
MED10, CCT5, DAP, ANKH and BASP1. BASP1, encoding brain 
abundant membrane attached signal protein 1, is a brain-soluble 
protein shown to be abundantly expressed in the RPE and choroid 
(Booji et al., 2010) and is a known promoter of neuronal growth 
(Mosevitsky, 2005). MED10 encodes Mediator complex subunit 10. 
Whilst no specific role for this has been identified in retina, the 
mediator complex is known to be important for transcriptional 
regulation. Dürr et al. (2006) investigated whether the subunits of 
the mediator complex have different functions in zebrafish retinal 
development and suggested that the subunit composition of the 
complex does contribute to the control of differentiation in the 
vertebrate central nervous system. However, the general 
requirement of the mediator complex throughout the body 
suggests it may not be the best candidate as more systemic 
associations might also be expected from a fault in this complex. 
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Though this is not necessarily the case, as shown by mutations in 
splicing factor genes that cause autosomal dominant RP (Section 
2.1).  
 
CCT5 encodes chaperonin containing TCP1 (T-complex protein 1) 
subunit 5. This is a member of the chaperonin containing TCP1 
complex, which assists in the folding of proteins and recently 
Posokhova et al. (2011) have shown that in mouse photoreceptors 
with CCT5 suppression there is outersegment malformation and 
features of RP. Interestingly, regulatory transcription factor 
binding sites in the CCT5 promoter region include those for 
POU3F2 (a candidate for MCDR1). This could therefore be a very 
interesting candidate because if CCT5 is mutated in MCDR3 and 
POU3F2 is mutated in MCDR1, POU3F2 may fail to correctly 
activate CCT5 transcription. In this example, both disorders would 
be lacking the same protein, providing a link in genotype to match 
the similarity in phenotype. The nearest marker to CCT5 used in 
the linkage study by Michaelides et al. (2003c) is D5S630, which 
achieved the highest LOD score of 3.61. It was hoped that this 
gene could be screened in this project but given the number of 
projects on the go there was found to be no time to do so. It is felt 
that in hindsight it would have been best to reduce the number of 
disorders being investigated in order to achieve more significant 
information on a selected two or three. 
 
The less likely candidates from the list of six genes found in the 
NEIBank retina database are DAP, which encodes death-
associated protein and acts as a positive mediator of programmed 
cell death, and ANKH. This latter gene encodes ankylosis 
progressive homolog (mouse) and no retina-specific functions have 
been identified for either. 
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A further five of the genes in the MCDR3 locus are listed in the  
NEIBank RPE/choroid database: PCDC6, KIAA0947, ADCY2 
FAM105B and FBXL7.  This latter gene is an interesting candidate 
because the related member, FBXL4, is a candidate for MCDR1 
and given the similarities between the two disorders, mutations in 
genes from the same family could cause the diseases and explain 
the similarities in phenotype. Whilst expression of FBXL7 has 
been found in the RPE/choroid, there is no published data on 
particular roles of this gene in the eye. FAM105B encodes family 
with sequence similarity 105, member B but little is known about 
the protein. Though there is no specific information on the protein 
product, a protein family database (PFAM, Finn et al., 2010) 
sequence search reveals a highly conserved peptidase C65 domain 
that is specific to ubiquitin isopeptidases. Despite the lack of 
information on this gene it cannot be ignored as a candidate. 
ADCY2 also makes a less likely candidate but not one to be 
excluded. It encodes adenylate cyclase type 2 (brain), a 
membrane-associated enzyme that is Ca2+/calmodulin insensitive 
and catalyses the formation of the secondary messenger cyclic 
adenosine monophosphate (cAMP). Nicol et al. (2006) investigated 
the roles of adenylate cyclases in the development of retinal 
projections and identified Adcy2 in the developing retinal ganglion 
cell layer in the barrelless mouse strain. Based on this evidence, 
this gene may have a role in the normal development of the 
human retina. 
 
Other genes that lie within the 5p15.33-p14.3 region that are not 
listed on NEIBank databases yet have been shown to be important 
in the retina are: IRX4 (Jin et al., 2003); TERT (Lau et al., 2007); 
SEMA5A (Goldberg et al., 2004) and TRIO (Newsome et al., 2000). 
IRX4 was shown by Jin et al. (2003) to regulate Slit1, the product 
of which guides the growth of retinal axons and research in 
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Drosophila also identified a role for Trio in photoreceptor axon 
extension (Newsome et al., 2000). Telomerase reverse 
transcriptase (TERT) was suggested by Lau et al. (2007) to have a 
role other than telomere maintenance in the vertebrate central 
nervous system. Cloning and characterisation of TERT in 
zebrafish also provided evidence that TERT activity in the retina 
has other functions (Lau et al., 2008). SEMA5A makes an 
interesting candidate not only because it lies downstream of the 
high-scoring marker D5S630 from the original mapping study, 
but also because it has been shown to inhibit axon growth in 
retinal ganglion cells (Goldberg et al., 2004) and helps ensheath 
retinal axons during optic nerve development (Oster et al., 2005). 
Interestingly, mutations in the related member SEMA4A have been 
shown to cause retinitis pigmentosa and cone-rod dystrophy (Abid 
et al., 2006).  
 
Of these candidates, CCDC127, SDHA, PCDC6, TERT, LPCAT1 and 
IRX4 lie prior to the single exclude generated in the MCDR3 AD 
genotyping analysis. KIAA0947, MED10, ADCY2, SEMA5A, CCT5, 
DAP, TRIO, FAM105B, ANKH, FBXL7 and BASP1 occur after the 
exclude. So, if including the whole original disease region, primary 
candidates are suggested to be: SDHA, CCT5, BASP1 and 
SEMA5A. LPCAT1 was screened in this project but no disease-
causing mutations were identified. The genotyping data suggests 
the disease region lies after rs2934551, and so the primary 
candidates are suggested to be: CCT5, SEMA5A, BASP1, TRIO and 
FBXL7. 
 
6.4 Discussion 
6.4.1 Genotyping Analysis 
The 250K genotyping analysis confirms the previous mapping 
data that linked MCDR3 to 5p15.33-p14.3 between flanking 
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markers D5S1981 and D5S2031 (Michaelides et al., 2003c). From 
the first SNP on chromosome 5 (at 5p15.33) down to rs681129 
(18,105,325) there was just a single excluded SNP. In contrast, 
numerous excludes were seen beyond this point (Figure 6.2) and 
across the rest of chromosome 5. This suggests a large region 
between 5p15.33-p14.3 segregates with disease, including a 
number of low frequency alleles (Table 6.4) and the Affymetrix 
genotyping analysis has been able to refine the disease locus. 
Linkage analysis was not conducted as it would be uninformative 
with such data because normally, for significance to be achieved, 
at least ten meioses must exist between samples which does not 
occur in the data set used here (Figure 6.1). In addition to this, 
SNP data are not overly informative, relying on just two alleles, 
whereas traditional markers can have numerous genotypes.  
 
Unlike with the MCDR1 genotyping analysis, the problem of 
determining phase was not an issue here because affected parents 
of affected offspring were analysed, enabling the determination of 
the inherited disease allele. The alleles were compared amongst all 
affecteds to identify those consistent in all affecteds. Where there 
were alleles that were inconsistent, the SNPs could be excluded as 
affecteds from the same family would be expected to carry the 
same haplotype at the disease locus. As it turned out the 
Affymetrix genotying data was not as informative as had been 
hoped as only a single excluded SNP was present within the 
disease region at rs2934551 (2,877,017). As this was excluded 
from data extracted at 0.1 confidence it is unlikely to be a miscall. 
It is possible that this exclude is indicative of a crossover in 
individual IV:9 (Table 6.3). This excluded SNP also lies near the 
marker D5S417, which was used in the original linkage study and 
achieved a maximum LOD score of 1.93, whilst markers 
centromeric to it obtained significant scores. As significant linkage 
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was only seen after rs2934551 this may also be evidence that the 
disease region lies beyond this excluded SNP. If this is the case 
then it refines the locus and reduces the number of candidate 
genes. 
 
It was expected that comparison of the 250K genotyping data 
would provide many more excludes and further refine the disease 
locus. Indeed when looking at similar samples from a single 
MCDR4 family, numerous excludes were made across all 
chromosomes and the linked disease locus, but this did not occur 
here. As the genotyping data did little to refine the MCDR3 locus, 
an extensive search of the genes within the locus was conducted 
to identify the best candidates.  
 
6.4.2 Bioinformatic Searching for Candidate Genes 
As the screening of many candidate genes was outside the remit of 
this project, extensive searching of the candidates within the 
disease region was conducted in order to identify the primary 
candidates for future screening projects. The bioinformatic 
screening identified CCT5, SEMA5A, BASP1, TRIO and FBXL7 as 
the primary MCDR3 candidates. 
 
6.4.3 Copy Number Analysis 
All chromosomes were analysed for CNVs in all samples and those 
seen consistently in all samples were identified. Though a CNV 
was identified in the disease locus at 5p15.33, this was not 
common to all samples and resided in a known CNV spot, 
therefore making it unlikely to be important in the disease state. 
 
Just two regions were identified where all samples shared a CNV, 
these were at 15q11.2 at a known region of CNV and at 18q12.1. 
This latter region is not a known region of CNV and would result 
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in an extra copy of CDH2. N-cadherin has been found in 
retinoblastoma and normal neural tissue (van Aken et al., 2002). 
It has been shown to be important in the patterning of Drosophila 
retina through cellular surface mechanisms (Hayashi and 
Carthew, 2004). Though this gene may play a similar role in the 
human retina, having an extra copy is unlikely to be significant in 
the MCDR3 phenotype given that the disorder links to 5p. 
 
6.4.4      Summary 
The Affymetrix analysis suggests that MCDR3 is not caused by a 
copy number variation at the chromosome 5 locus. The 
genotyping analysis appears to have refined the MCDR3 locus to a 
16.5Mb region and extensive bioinformatic analysis has been 
conducted to identify the best candidates within the locus. The 
disease does not seem to be caused by mutations in LPCAT1. The 
primary candidate is suggested to be CCT5. 
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7. NORTH CAROLINA-LIKE MACULAR 
DYSTROPHY AND PROGRESSIVE 
SENSORINEURAL HEARING LOSS 
(MCDR4) 
 
7.1 MCDR4 Genetic Analysis 
This disorder has a very similar ocular phenotype to MCDR1 but 
does not link to 6q and has an additional feature of progressive 
sensorineural hearing loss. The phenotype, outlined in Section 
2.5.3, has only been described in a single family (Francis et al., 
2003, Figure 7.1). As for MCDR3, 50% of the genome was 
screened in members of this family using microsatellite markers 
and candidate regions mapped to other inherited retinal diseases 
were also excluded in the analysis, including: ABCA4, STGD4, 
CORD7, GCAP, ELOVL4 and TIMP3. 
 
 
Figure 7.1 Four-generation pedigree of a family with autosomal 
dominant macular dystrophy and progressive sensorineural 
hearing loss. Red circles indicate patient samples run on the 
Affymetrix 250K Sty I chips. 
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Unfortunately with the family depicted in Figure 7.1 being the 
only one currently known to have this disorder, it was difficult to 
obtain statistically significant linkage data. However, following 
screening of around 50% of the genome, a maximum positive LOD 
score of 2.92 was obtained with the marker D14S261 (14q11.2), 
Table 7.1. Given the small family, this is likely to be as significant 
a LOD score as could be achieved and therefore indicates the 
disease locus. The authors of the study conducted a search of 
online databases of genes within the linked region but at the time 
found none to be expressed in both the retina and cochlear.  
  
In this project the aim is to refine the 14q disease locus in this 
family and identify candidate genes or possible disease-causing 
CNVs. As with the MCDR1 and MCDR3 investigations, the 
approach to refining the disease-causing region was based on 
microarray SNP analysis. As for the MCDR3 analysis, it was felt 
that by comparing genotypes of affected individuals across the 
disease locus, SNPs where there was no consistent allele could be 
excluded and therefore refine the disease region by highlighting 
regions of shared genotypes. By running the affected parent of 
affected offspring the disease haplotype could be determined. 
 
Table 7.1 MCDR4 markers used to link the disease to 
chromosome 14. 
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7.2 Methods Applied 
7.2.1      Affymetrix 250K Protocol 
Six samples, highlighted in red in Figure 7.1, were prepared for 
processing over the Affymetrix 250K Sty I chip, as described in 
Section 3.2.3.  
 
7.2.2      Candidate Screening 
NOVA1 
Gradient GoTaq PCRs were conducted for all primer sets (Section 
3.1) and PCRs were then carried out at the optimal annealing 
temperature for each primer set. The GoTaq protocol (Section 
3.1.2) was used and amplification products were gel-extracted and 
sequenced (Table 7.2). Exon 6 failed to amplify despite attempts 
with GoTaq, Extensor and BIOXACT Long protocols (Section 3.1, 
primers shown in Appendix IV). 
 
 
Table 7.2 Primers and annealing temperatures for NOVA1 exons. 
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7.3 Results 
7.3.1 Affymetrix Data 
Genotyping Analysis 
All samples achieved a QC of >96% and genotypes were extracted 
at 0.1 confidence. The MCDR4 AD genotypes were generated for 
chromosome 14 and whereas MCDR3 AD genotypes for the 
chromosome 5p locus produced just one exclude within the 
disease region, across chromosome 14 (and indeed the other 
chromosomes, examples in Appendix V), the MCDR4 AD produced 
many exclude outputs. This indicated inconsistent alleles were 
present between affected individuals of the same family and so 
could be excluded from the disease locus as they would be 
expected to have the same haplotype at the disease interval.  This 
is what was hoped would be achieved before beginning the 
analysis but was not seen across the large MCDR3 locus. Between 
excludes on chromosome 14, the longest run of contiguous SNPs 
with shared alleles overlapped with the marker D14S261 and may 
define the MCDR4 locus (Figure 7.2). 
 
The region runs between excludes at rs11623837 (20,762,066) 
and rs4981261 (21,060,447) and contains the genes: TTC5, 
PARP2, TEP1, CCNB1IP1, KLHL33, OSGEP, APEX1, TMEM55B, PNP 
and RNASE10, 9, 11 and 12; the ncRNAs RNaseP_nuc, 5SrRNA, 
SNORA79 and SNORD126; and the protein coding annotations 
AL355075.1 and AL163195.1 (shown in Figure 7.2). Given that 
the disorder has been linked to 14q with the marker D14S261, 
these data refine the region around the marker and suggest the 
locus is in the ~300kb region shown in Figure 7.2. SNPs near the 
marker D14S1023 were excluded (Figure 7.3), which correlates 
with the marker data from the original study. 
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Figure 7.2 Excel sheet extract showing the longest run of 
contiguous shared alleles at 14q11.2 between MCDR4 affecteds, 
this overlaps with the original high-scoring marker D14S261. 
 
 
 
 
 
Figure 7.3 Excel sheet extract showing exclude sites around the 
D14S1023. 
 
 
The gene RPGRIP1 (RP GTPase regulator interacting protein 1), 
mutations in which have been found to cause recessive LCA 
(Dryja et al., 2001) and recessive cone-rod dystrophy (Hameed et 
al., 2003), lies at the 14q11.2 locus and the region around this 
gene was not excluded by the MCDR4 AD analysis (Figure 7.4). 
This gene lies between excludes at rs10483251 (21,671,277) and 
rs10135215 (21,947,857). In this region are the annotations: 
SNPs that 
lie within 
gene 
regions 
SNPs 
closest 
to 
original 
markers 
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AL157687, HNRNPC, RPGRIP1, SUPT16H, CHD8, two snoU16-53 
and RP11-689J19.1. The marker D4S283 lies within excluded 
SNPs close to one another but is not actually excluded itself, 
which again seems consistent with previous marker analysis (data 
not shown). 
 
Also at 14q11.2 is NRL, mutations in which cause autosomal 
dominant RP (Bessant et al., 1999). This region appeared to be 
excluded by the MCDR4 AD, Figure 7.5. 
 
 
 
 
 
 
 
Figure 7.5 Excel extract showing exclusions around the genomic 
region for NRL. 
 
 
Another long run of contiguous SNPs at 14q in which all samples 
shared alleles was between excludes at rs2332676 (26,654,330) 
and rs12435522 (27,179,913). This region contains only NOVA1 
Figure 7.4 The MCDR4 AD does not exclude the genomic region 
for RPGRIP1. 
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and the protein coding annotations AL132716.1 and AL132716.2, 
shown in Figure 7.6. 
 
 
 
Figure 7.6 Excel image showing the region for NOVA1 is not 
excluded by the MCDR4 AD. 
 
There were few SNPs at which individual genotypes were 
heterozygous and therefore looking for rare alleles that segregate 
with the disease state was difficult. Two were identified near the 
marker D14S261, rs1243684 (A=0.153, G=0.847) and rs1087395 
(T=0.275, C=0.725), Table 7.3.  
 
Table 7.3 A selection of SNPs at which the MCDR4 family 
members exhibited a low frequency allele. 
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Copy Number Analysis 
The copy number analysis data quality were determined to be in-
bounds for all samples and all chromosomes were analysed for 
structure variations. All CNVs were checked against the DGV to 
eliminate those that were detected in regions of known CNV.  
There were few examples of CNVs being shared in all affecteds and 
all were in known regions of CNV. These are shown in Table 7.4. 
 
Table 7.4 CNVs to all MCDR4 samples. 
 
 
 
 
7.3.2 Candidate Screening 
NOVA1 
This gene was chosen to be screened due to its expression in the 
cochlear and potential role in neurological pathways. The coding 
exons were screened from genomic DNA but attempts to amplify 
exon 6 failed (this occurred in control DNA samples as well). 
GoTaq gradients, Extensor Mix and BIOXACT Long PCR methods 
were used in addition to splitting the exon 6 sequence into three 
small amplicons but all failed to amplifiy. No variations were 
identified in the other exons of samples screened. There appear to 
be different splice variants of NOVA1, in one variant of the gene, 
exons 1, 2, 3, 4 and 6 encode the product, whereas another uses 
exons 1, 2, 3 4 and 5. For the first variant, exon 6 provides 50% of 
the coding sequence, so this exon needs to be fully screened 
before NOVA1 can be excluded as a candidate. 
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7.4 Discussion 
7.4.1 Genotyping Analysis 
Analysing affected parents and their affected offspring of the 
MCDR4 family in Figure 7.1 allowed for identification of the 
disease alleles across the 14q locus. Runs of alleles shared 
between all affecteds would be expected in members of the same 
family at the disease locus. Where the disease allele was not 
consistent the SNPs could be excluded with long runs of 
consecutive shared alleles indicative of a shared haplotype and  
possible disease locus. Whereas with the MCDR3 analysis these 
allele comparisons did little to refine the disease locus, a similar 
sample cohort from the MCDR4 family provided many exclusion 
areas. These were seen across all chromosomes, including 
chromosome 14. The AD genotypes for chromosome 14 produced 
numerous exclude outputs across the whole chromosome. This 
indicated differences between the alleles of samples and the longer 
runs of shared alleles between SNPs would more likely represent 
the disease locus. Between excludes, the largest run of SNPs at 
which all samples shared a common allele overlapped with the 
marker D14S261 (Figure 7.2) and covered around 300kb. 
 
Other genes associated with retinal disease have been linked to 
14q11.2: NRL and RPGRIP1. NRL (neural retina leucine zipper) 
appears to be excluded as a candidate by the MCDR4 AD analysis 
as the affected members carry different alleles over this region. In 
contrast, RPGRIP1 was not excluded by the genotype comparison 
analysis. Mutations in retinits pigmentosa GTPase regulator 
interacting protein 1 (RPGRIP1) were identified in LCA patients 
(Dryja et al., 2001) and CORD families (Hameed et al., 2003). 
Though the AD analysis does not exclude the RPGRIP1 region on 
14q11.2, this gene is considered to be tissue-specific and only 
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expressed in the rod and cone photoreceptors of the retina. 
MCDR4 has an NCMD phenotype with associated sensorineural 
progressive hearing loss. It would therefore be expected that the 
gene responsible for the disorder will be expressed in both retinal 
and cochlear cells, suggesting RPGRIP1 is not a likely candidate. 
 
7.4.2 Bioinformatic Searching for Candidate Genes 
Within the run of SNPs overlapping the marker D14S261 are 
thirteen characterised genes, two protein coding annotations and 
four ncRNAs. Of the genes, CCNB1IP1 and TEP1 are listed on 
Unigene as having their cDNA extracted from both eye and ear 
tissue. TTC5, PARP2, KLHL33, OSGEP, APEX1, TMEM55B and PNP 
cDNAs were found in eye tissue (ear samples not tested). In both 
the NEIBank cochlear and RPE/choroid databases is CCNB1IP1, 
whilst OSGEP is listed in the retina and RPE/choroid databases 
and TMEM55B in the retina (with the related TMEM55A in 
cochlear) database. Other genes highlighted at 14q11.2 but not in 
the region around D14S261 include: HNRNPC, which is near 
RPGRIP1 and listed as being expressed in the RPE/choroid, retina 
and cochlear and NOVA1, which NEIBank lists only in the 
cochlear database. Though NOVA1 (neuro-oncological ventral 
antigen 1) has no listed expression in the retina, Unigene lists 
cDNA of NOVA1 as being isolated from eye and, in particular, ear 
tissue. It is expressed in the central nervous system and is 
associated with the autoimmune disease paraneoplastic 
opsoclonusmyoclonus ataxia (POMA) (Buckanovich et al., 1993). 
Though no role for this gene has been specifically associated with 
retinal or cochlear function, given its expression pattern and that 
it is expressed in neurons it is plausible to consider that a 
mutation in this gene may cause problems in neurons of the 
retina and in the ear. The coding exons of this gene were screened 
in members of the MCDR4 family but no variations were 
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identified. Unfortunately there was incomplete screening of exon 1 
and attempts to screen exon 6 failed so this gene cannot be 
excluded as a candidate. Numerous attempts were made to screen 
these exons with various primers designed, different reaction 
conditions and reagents used yet the attempts failed. Future 
techniques could be tried as described in Section 5.5.3.  
 
Good candidates that lie within the long run of contiguous SNPs  
across D14S261 at which the MCDR4 samples share common 
alleles, include CCNB1IP1, OSGEP and TMEM55B. There is no 
published data on cyclin b1-interacting protein (CCNB1IP1) roles 
in the retina but cyclin b1 involvement in retinal development has 
been reported (Barton and Levine, 2008). OSGEP is an unlikely 
candidate as it encodes O-sialoglycoprotein endopeptidase, with a 
general function that is not tissue-specific. TMEM55B is a more 
interesting candidate as it encodes transmembrane protein 55B, 
expression of which was detected in the retina with the related 
member TMEM55A expression detected in the cochlear. Recently 
TMEM216 mutations have been shown to cause ciliopathies 
(Valente et al., 2010). Though the roles of TMEM55B are 
unknown, expression of the related members in the retina and ear 
are intriguing because the sensory cells of both have cilia 
structures. If like TMEM216, TMEM55B is expressed in the ciliary 
structures, it is possible a mutation may also cause a ciliopathy 
and therefore a retinal and cochlear phenotype. 
 
Other genes highlighted at 14q11.2 by the AD genotyping analysis 
that are listed in Unigene as being detected in eye tissue include: 
TEP1, TTC5, PARP2, KLHL33, APEX1 and PNP. TEP1 is an 
interesting candidate as it encodes telomerase associated protein 
1 and its activity is mediated by TERT, the gene for which was 
identified as a candidate for MCDR3 (Section 6.6.3). TTC5 encodes 
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tetratricopeptide repeat domain 5 and though there is little 
information on the roles of this product, AIPL1 (mutations in 
which cause LCA and CORD, Sohocki et al., 2000) was shown by 
Hidalgo-de-Quintana et al. (2008) to have a tetratricopeptide 
domain, mutations in which compromised the interactions with 
chaperones. Based on this it seems possible that TTC5 has a role 
in forming chaperone complexes for proteins important in the 
retina/ear. Interestingly, the MCDR3 candidate CCT5 has a 
chaperonin function and contains a transcription factor site for 
POU3F2 binding (a candidate for MCDR1). Given the similarities in 
phenotypes of MCDR1, MCDR3 and MCDR4, genes whose 
functions link together like this are of great interest and make 
intriguing candidates. The MCDR4 candidate PARP2 also has a 
promoter region for binding POU3F2 but encodes poly(ADP-ribose) 
polymerase 2, which seems an unlikely candidate for MCDR4 
given the general function of the protein. This is also the case for 
PNP, which encodes purine nucleotide phosphorylase. 
 
The roles of kelch-like 33 (Drosophila), encoded by KLHL33, are 
unknown which makes it difficult to consider as a candidate.  
However, mutations in kelch-like 7, a member of the BTB (broad-
complex, tramtrack, bric-a-brac) kelch superfamily, have been 
found to result in autosomal dominant RP (Friedman et al., 2009). 
Finally, apurinic endonuclease (APEX1) seems a better candidate 
as it appears to be associated with differentiation in the retina. 
Chiarini et al. (2000) studied expression in the retina of 
developing rats and found levels of APEX1 appeared to increase in 
differentiating cells but in apoptotic cells it was absent. 
 
From the chromosome 14 Affymetrix AD genotyping analysis of 
the MCDR4 family members, the main candidates are suggested 
to be: TEP1, TTC5, TMEM55B, CCNB1IP1 and NOVA1. 
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7.4.3 Copy Number Analysis 
The CNV analysis of all chromosomes in all samples revealed few 
regions where all samples shared a common CNV. A CNV was 
identified in five of six samples at the disease linked 14q11.2 but 
as this occurred at the polymorphic TRAC (T cell receptor alpha 
constant) region and not in all samples it is unlikely o be disease-
associated. The only other two CNVs shared by all samples were 
at 4q28.3 and 5p11 and these were at known regions of CNV. 
 
7.4.4 Summary 
The 14q11.2 locus was investigated in the MCDR4 family and 
detailed genotyping analysis conducted. This analysis excluded 
NRL but not RPGRIP1, however, the photoreceptor-specific 
expression of this latter gene does not make it a likely candidate 
due to the associated hearing phenotype of this disorder. NOVA1 
was identified as an interesting candidate but screening of exons 
2 to 5 of this gene revealed no mutations (promoter, exon 1 and 6 
screening needs to be repeated). The longest run of contiguous 
SNPs with shared alleles between MCDR4 affecteds highlighted 
TTC5, TEP1, CCNB1IP1 and TMEM55B as good candidates. 
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8. PROGRESSIVE BIFOCAL 
CHORIORETINAL ATROPHY 
(PBCRA) 
 
8.1 Genetic Analysis 
Progressive bifocal chorioretinal atrophy was identified in a large 
family over 50 years ago and is an interesting disorder as it links 
to an overlapping region on 6q with the MCDR1 locus yet has a 
distinct phenotype. If the same gene is involved in both disorders 
it seems likely that different mutations would be identified. The 
linkage analysis conducted by Kelsell et al. (1995) on the family in 
Figure 8.1 demonstrated significant linkage with seven 6q marker 
loci and due to recombination events in unaffected III:16 between 
D6S249 and D6S268, the PBCRA locus was determined to be 
centromeric to D6S268. A recombination event in patient III:23 
refined the telomeric region to marker D6S301 with data from 
III:24, IV:18, V:8 and V:9 determining the locus to be between 
D6S249 and D6S283. The marker that attained the highest 
maximum LOD score was D6S283, which is within the genomic 
region for GRIK2. Table 8.1 shows the two high-scoring markers 
used to link the disease to the 6q locus. The novel inter-
photoreceptor matrix proteoglycan, IMPG1 was mapped to 6q13-
q15 and Gehrig et al. (1998) showed that no disease mutations in 
this gene were associated with the PBCRA family.  
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Table 8.1 Information for the markers used to link the PBCRA 
disease locus.  
 
 
 
Prior to ending her term at the UCL Institute of Ophthalmology, 
Dr A. Kalhoro collaborated in the processing of DNA from six 
affected members of the original British family in Figure 8.1 (III:1, 
III:14, III:24, III:34, IV:24 and V:9) over the Affymetrix 250K Sty I 
GeneChips. The data analysis was not completed and so the 
analysis has been conducted as part of this project. The aim is to 
refine the 6q disease locus in the family in Figure 8.1 and in doing 
so identify candidate genes or possible disease-causing CNVs. 
 
DNA from a small French family consisting of an affected parent 
and two affected offspring with a PBCRA-like phenotype will also 
be processed over the SNP chips and screened for mutations in 
candidate genes. Previous marker analysis data is not available 
for this family and the genotyping data will be compared to the 
PBCRA family to see if there are consistent disease alleles between 
the two families (indicating a common ancestral haplotype). 
 
8.2 Methods Applied 
8.2.1      Affymetrix 250K Protocol 
The 250K Affymetrix protocol was followed as in Section 3.2.3, 
processing the samples circled in red in Figure 8.1 
 
Chapter 8 
     Genetic Analysis of Inherited Retinal Dystrophies 178 
8.2.2      Candidate Gene Screening 
MCHR2 
Primers were designed by Dr A. Kalhoro and PCRs conducted 
using the BIOTaq protocol (Section 3.1.1). All amplicons were gel-
extracted prior to sequencing. Primers and annealing 
temperatures are shown in Table 8.2. 
 
Table 8.2 Primers and annealing temperatures for MCHR2 coding 
exons. 
 
 
 
FBXL4  
Gradient BIOTaq PCRs were conducted for all primers (see Section 
3.1.1) and PCRs then carried out at the optimal annealing 
temperature for each primer set using the BIOTaq protocol. 
Primers and annealing temperatures are shown in Section 5.3.2, 
Table 5.2. 
 
SIM1 
Gradient BIOTaq PCRs were conducted for all primers sets 
(Section 3.1.1) and PCRs then carried out at the optimal 
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annealing temperature for each primer set. The BIOTaq protocol 
was used and amplification products used directly in sequencing 
reactions unless otherwise stated (primers and annealing 
temperatures listed in Section 5.3.2, Table 5.3). 
 
8.2.3      QPCR 
QPCR experiments using SYBR Green were conducted to 
investigate copy number variations in affected individuals. The 
SYBR Green protocol was followed (Section 3.1.7). Primers for 
GAPDH (Table 8.3) were used in control reactions. The primers 
were tested for specificity in BIOTaq reactions using both the 
BIOTaq PCR cycles and the SYBR Green PCR cycles and a single 
amplicon was produced from each (Figure 8.2), which were 
sequenced for confirmation of the product.  
 
 
 
 
Figure 8.2 Gel image showing a single amplicon produced from 
BIOTaq and SYBR Green cycling schedules with GAPDH primers. 
 
The test primers were used in BIOTaq gradient PCRs to identify 
the optimal annealing temperature and the amplicon was 
sequenced for confirmation of the product (Figure 8.3). The bands 
seen at the bottom of the gel represent the primers. 
 
300bp 
200bp 
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Figure 8.3 Gel image of the gradient BIOTaq PCRs conducted with 
the test primer set. 
 
The PBCRA samples were diluted to a concentration of ~10ng/µl 
but due to the poor quality of the DNA accurate concentrations 
could not always be achieved. The primers are listed in Table 8.3. 
 
Table 8.3 Primers used for PBCRA QPCRs. 
 
 
 
8.3 Results 
8.3.1 Affymetrix Data 
Genotyping Analysis 
At 0.1 confidence the QC for each sample was >82%, whereas at 
0.5 confidence it was >95%. Given the number of NoCalls at 0.1 
confidence, the genotypes were extracted at 0.5 confidence.  
 
As for MCDR1, MCDR3 and MCDR4, this analysis used only 
affected members but whereas MCDR3 and MCDR4 contained 
only affected parent-offspring samples, here affected parent-
offspring samples have been used to determine the disease alleles 
in two cases. Two further samples have been run to increase the 
200bp 
100bp 
Desired amplicon 
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meiotic events between samples and therefore more excluded 
SNPs are expected and alleles that are shared by all the members 
are likely to be more significant.  
 
The PBCRA region was originally linked between D6S249 and 
D6S301 (Table 8.1). When the British family PBCRA AD for 
chromosome 6 was produced, many excludes were generated 
across the chromosome, which appeared to confirm and refine the 
disease region at 6q. Excludes across the entire chromosome were 
consistent in pattern and highlighted a long run of SNPs without 
excludes over 233 SNPs between rs1481454 (99,098,503) and 
rs9499580 (104,049,086), Figure 8.4.  
 
 
 
Figure 8.4 Excel sheet extracts showing the excludes that appear 
to define the disease region. The top image shows the excludes at 
the start of the region (the first SNP of the disease locus 
highlighted by the arrow) and the bottom image the excludes that 
appear to define the end of the disease region (identified with the 
arrow). 
 
 
The majority of SNPs between these excludes are shown in Figures 
8.5 to 8.7. In order to fit the data in more easily, some SNPs (those 
with homozygous calls for all samples) were removed but can be 
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seen in Appendix VI. Within the region between these SNPs was a 
single exclude output (Figure 8.6). Data extraction at 0.1 
confidence provided three of the six samples with a NoCall at this 
SNP and the 0.5 exclude output was generated based on the 
genotypes of one these samples. As the Genotyping Console was 
unable to determine a genotype at 0.1 confidence at this SNP for 
half the samples and, more importantly, the sample for which the 
exclude was reliant on, the reliability of the exclude must be 
questioned. As this SNP lies in the middle of the region of 
consecutive SNPs that appear to segregate with the linked region 
(and therefore disease), it seems more likely that the exclude is 
not valid and the result of a miscall. 
 
The disease region determined by the PBCRA AD genotypes 
suggests the locus begins at a similar point to the MCDR1 locus 
but extends beyond it. The markers D6S468 and D6S283, which 
achieved the highest significant LOD scores in the study linking 
PBCRA to chromosome 6q, lie within the disease region defined by 
the PBCRA AD (Figure 8.8).  
 
Genotype Comparisons Between the Two Families 
With a second suspected PBCRA family identified in France, the 
affected parent and offspring were analysed and the disease 
genotype for this family determined. This was then compared to 
the British PBCRA family to see if there may be a common 
ancestral mutation between the two families. If this were the case 
it would be expected that the two families would share alleles 
across the disease locus. At the newly refined PBCRA locus, 
regions of contiguous SNPs where alleles were shared between the 
two families were seen. These are highlighted in red boxes in 
Figures 8.5 – 8.8. 
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Figure 8.5 Excel extract showing the genotypes for the British 
PBCRA samples compared to the French family (V) AD at the top 
of the disease region. Red boxes highlight runs of SNPs at which 
PBCRA and V AD share alleles. 
SNPs that lie 
within gene 
regions 
SNPs closest to 
markers 
 SNPs at which 
both families 
share alleles 
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Figure 8.6 Excel image showing the British PBCRA sample 
genotypes and generated disease AD compared to the French 
family (V) AD over the middle of the disease region. Red boxes 
highlight shared alleles between PBCRA and V AD genotypes. 
 
 
SNPs that lie 
within gene 
regions 
SNPs closest to 
markers 
 SNPs at which 
both families 
share alleles 
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Figure 8.7 Excel extract showing the British PBCRA sample 
genotypes and generated disease AD compared the French family 
(V) AD at the end of the PBCRA disease region. Red boxes 
highlight shared alleles 
 
 
SNPs that lie 
within gene 
regions 
SNPs closest to 
markers 
 SNPs at which 
both families 
share alleles 
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The dominant genotype (AD) for the French family was compared 
to the British and the genotypes of the two families were 85% 
identical at the new PBCRA locus, with just 36 of the 233 AD 
alleles in the suspected disease region differing between the 
British (labelled PBCRA) AD and French (labelled V) AD. 
Throughout the rest of chromosome 6 many exclude outputs were 
given, indicating differences between the British and French 
genotypes. Of a total 14,129 SNPs on chromosome 6, 5,291 
provided exclude outputs, meaning that the overall identity of the 
families chromosome 6 genotypes were 63% compared to 85% at 
the disease locus. 
 
The largest region of contiguous shared alleles between the two 
families occurred between rs3798492 (100,888,625) and 
rs2105118 (102,113,988), shown in Figure 8.8. This indicates 
there could be a shared haplotype between these two families if 
this turns out to be the precise location of the genetic error 
causing PBCRA. 
 
To provide further evidence of linkage of the French family to this 
region, a search for low frequency alleles that segregate with the 
disease was made. Given that in the general population the 
frequency of one allele is much lower than the other, for it to be 
seen in both families may suggest segregation of the allele with 
the disease. There were many SNPs at which a number of the 
samples had heterozygous calls but for the majority the frequency 
of alleles was around 50:50. Five rare alleles were identified in 
both families, which are in the latter half of the disease region and 
listed in Table 8.4, 
Chapter 8 
     Genetic Analysis of Inherited Retinal Dystrophies 187 
 
 
 
 
 
 
 
 
 
Figure 8.8 The possible PBCRA disease region determined from 
250K genotype comparisons between a British and French family. 
Shared alleles are highlighted in the red boxes. 
 
 
 
 
 
 
SNPs that lie 
within gene 
regions 
SNPs closest to 
markers 
 
SNPs at which 
both families 
share alleles 
Chapter 8 
     Genetic Analysis of Inherited Retinal Dystrophies 188 
Table 8.4 SNPs of low frequency alleles that segregate with the 
disease. 
 
 
 
It appears that SNPs between rs1481454 and rs9499580 
segregate with the disease in the British PBCRA family. The 
French family with a PBCRA-like phenotype shows segments 
within this PBCRA locus where contiguous disease alleles match 
those of the British PBCRA family. Low frequency alleles segregate 
with the disease locus in both families. These combined data are 
consistent with a common origin of mutation in the two families. 
Previous marker scores and low frequency allele segregation 
suggest the latter half of the disease region could be more 
important in the search for candidate genes. Further evidence for 
linkage of the French family to this region and a single haplotype 
existing between both families is shown in Figure 8.8. Here, the 
longest run of contiguous shared alleles between affecteds of both 
families is shown and is suggestive of a common haplotype and 
therefore mutation event within the region. Candidate genes in 
this region include SIM1, ASCC3 and GRIK2. Of these, only GRIK2 
expression in the RPE/choroid is reported on the NEIBank 
database. ASCC3 is not revealed in the database to have 
expression in either the retina or RPE/choroid, but ASCC3-like 1 
is, which suggests a role for ASCC3 is not unlikely. Expression of 
SIM1 is not reported in either database. 
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Copy Number Analysis 
The CNV data were determined to be in bounds for the French 
family samples but none of the CNVs identified were consistent 
amongst the family members. Data for all the British PBCRA 
samples were out of bounds but analysis was conducted despite 
this to give an indication of possible CNV regions that could be 
investigated further. 
 
Numerous common CNVs were identified across the genome, 
many of which overlap with known regions of CNV. These are 
shown in Table 8.5 with those that overlap with genes or known 
CNVs indicated. The genes within regions of CNVs common to all 
family members were investigated for expression in the retina or 
RPE/choroids on NEIBank or general eye expression (Unigene). Of 
the genes listed in these databases just six have published roles 
in the eye described. Of these, just one does not occur in a region 
where CNVs have previously been described in “normal” 
individuals. The only CNV unique to the British PBCRA family is 
on chromosome 14q23.1 and results in a deletion of one copy of 
ARID4A (AT-rich interactive domain 4A (RBP1-like)). This CNV was 
not seen in any of the French family members. Although there are 
regions of CNV seen on chromosome 6 in members of this family, 
none are at the linked disease locus. A CNV at EYS is interesting 
because mutations in this cause RP (Abd El-Aziz et al., 2008) but 
variations at this genomic region have been reported in the DGV 
and are therefore unlikely to be significant. 
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At the start of the 6q disease region between SNPs rs9398847 
(99,026,809) and rs12204275 (99,138,875), five of the six British 
PBCRA family samples were determined to have a copy number 
state of one (none of the French family members had a CNV in 
this region). With no samples being of the recommended quality 
for CNV analysis it was deemed worthwhile to further investigate 
this. Despite the CNV analysis detecting a CN state of 1 across 
many SNPs in five of the six samples, there was no evidence in the 
genotyping data of a loss of alleles in this region. If a deletion were 
present, then it would be expected that runs of homozygous SNPs 
would be evident at the deleted SNPs but there were in fact 
numerous heterozygous calls between rs3125579 and rs12204275 
(Figure 8.9). 
 
 
 
Figure 8.9 Excel sheet extract of British PBCRA genotypes at the 
SNPs where the CNV analysis detected loss of one allele. Blue 
highlights AB calls in the suspected region of deletion. Bold letters 
indicate SNPs where a loss of allele was detected by CNV analysis. 
 
Heterozygous calls in the genotyping data at the region of the 
apparent CNV suggest the deletion is not genuine. If one allele 
were deleted across a number of SNPs then homozygous calls 
would be expected across that region. However, the genotyping 
data were also not as reliable as desired as they were extracted at 
SNPs with 
AB call 
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0.5 confidence and with the inconsistencies between the two 
analyses, QPCRs were conducted to determine whether the 
PBCRA samples did have a region of deletion at 6q16.1.  
 
8.3.2 QPCR 
Given the contradiction between the CNV and genotyping 
analysis, QPCRs were conducted to investigate the apparent 
deletion present prior to the PBCRA disease region in five of the 
six samples, as determined by the Affymetrix CNV analysis. 
GAPDH control QPCRs were conducted on the same plate as the 
test QPCR, which amplified a 150bp fragment between SNPs 
rs9388585 (99,027,155) and rs17762161 (99,028,910), Figure 
8.10.   
 
 
Figure 8.10 Graphic showing the relative position of the QPCR test 
primers in relation to three 250K SNPs. 
 
 
The delta-delta Ct method was used to determine copy number 
states (Section 4.5) with the normalised CN state shown in Figure 
8.11 (1 represents the normal CN state). Error bars show 
standard error of the mean (SEM) taken from an average of three 
reactions for all samples. ANOVA revealed no significant difference 
between the Control and test sample group (p = 0.456). Whilst 
sample III:14 appears to have less DNA than the other samples, t-
test analysis revealed no significant difference compared to the 
Control (p = 0.222). The statistical analysis indicates all samples 
have the same CN state and therefore there is no CNV present in 
the PBCRA samples at this region. 
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Figure 8.11 Graph showing the delta-delta-Ct values for the 
chromosome 6 test region. Error bars show SEM. 
 
 
8.3.3 Candidate Screening 
MCHR2 
This gene appeared to be a good candidate as it is known not to be 
present in the equivalent region of the mouse genome and mice 
lack a macula, suggesting it may have a role within in the human 
macula. In the six PBCRA samples and three French samples 
screened, the coding exons (2 to 6) were analysed for mutations 
but none were found. The variations seen are shown in Table 8.6. 
Attempts to amplify the 5’ UTR exon 1 failed despite using 
different primers sets and reaction conditions. 
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Table 8.6 SNPs identified in MCHR2 in the British and French 
PBCRA samples. 
 
 
 
 
 
Figure 8.12 Sequencing example of MCHR2 exon 3 from a French 
family member showing SNP rs74531963. 
 
 
 
 
Figure 8.13 Sequencing data example showing the MCHR2 SNP 
rs4839764 in a member of the British PBCRA family. 
 
 
FBXL4 and POU3F2 
The genotyping comparisons between the British and French 
families identified a region of similarity in the genomic region for 
FBXL4 and POU3F2. Despite identifying variations within the 
coding exons of FBXL4, none were unique to affected individuals. 
These are shown in Table 8.7. The promoter and exon 1 
sequences failed to amplify, which was also the case for control 
and MCDR1 samples. 
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Attempts were made to screen POU3F2 but failed despite 
numerous primer design attempts, using different reagents and 
reaction conditions. 
 
Table 8.7 SNPs identified in FBXL4 in the British and French 
PBCRA samples. 
 
 
 
 
 
 
 
Figure 8.14 Sequencing data for a French family member carrying 
a variation at rs1011676 in exon 3 of FBXL4. 
 
 
 
 
Figure 8.15 Sequencing data from exon 8 of FBXL4 of a British 
family member showing a SNP. 
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SIM1 
This was identified as a possible candidate in the PBCRA 
genotyping analysis comparisons with the French family AD. 
Mutation screening in all coding exons and the promoter region 
revealed no variations in the PBCRA or French family samples 
screened.  
 
8.4 Discussion 
8.4.1 Genotyping Analysis 
The Affymetrix analysis for PBCRA has focused on affected 
individuals only, five individuals from the original British family 
and three individuals from the French family. By analysing 
parent-offspring pairs this has enabled  not only determination of 
a PBCRA haplotype at the disease region  but also extensive data 
on CNVs across a number of affected individuals. In the large 
British family, the affecteds have been selected from across the 
pedigree thereby comparing distant relatives, which increases the 
chance of refining the disease region. Previously linked to 6q14-
q16.3, the genotype comparisons here used excluded SNPs (those 
at which the affected related members do not share the same 
allele on their disease chromosome) to refine the region to 6q16.1-
q16.3. This is a direct overlap with the MCDR1 locus. The British 
PBCRA AD genotypes were compared to the disease AD genotypes 
generated from a small French family with a phenotype consistent 
with PBCRA. Linkage in this French family has not previously 
been conducted due to its small size (affected parent and two 
affected offspring). Comparisons of the chromosome 6 AD 
genotypes did not exclude linkage of the French family to the 
6q16.1-q16.3 region. The AD genotypes showed the two families 
shared 85% AD alleles at the disease region (compared to 63% 
across the whole chromosome), including low frequency alleles 
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that appear to segregate with the disease (Table 8.4). The region of 
high similarity at the 6q16.1-q16.3 between the British and 
French AD alleles, which is not seen across the remainder of 
chromosome 6, suggests alleles in this region may be segregating 
with the disease in both families, which implies there is a common 
origin of disease. Further evidence of this came from the 
genotyping comparisons revealing the longest run of contiguous 
alleles shared between the two families was between rs3798492 
and rs2105118. This region of shared alleles suggests the disease 
region could be refined to this part of 6q16.2, which contains 
SIM1, ASCC3, the pseudogene RP1-121G13.3, snoU13, GRIK2 and 
the pseudogene RP11-93K7.1. In addition to this evidence, the 
highest scoring marker from the previous linkage analysis 
conducted by Kelsell et al. (1998) was within the genomic region 
for GRIK2 and this is the only gene for whom expression is shown 
in the RPE/choroids database (NEIBank).  
 
Candidates other than GRIK2 have been considered in Section 
5.5.3 and will not be repeated here as the same points are valid 
for this disorder. Though MCHR2 was not highlighted by the 
comparison of the AD genotypes from the two families, screening 
was conducted because it was highlighted previously as an 
interesting candidate and screened in MCDR1 samples. The 
British PBCRA family showed no mutations in the coding exons of 
this gene. The French family samples revealed a heterozygous 
change in exon 3 but this is not considered to be important to the 
disease state as it represents a synonymous coding change. SIM1 
was also screened in the two families but identified no mutations 
or variations. 
 
GRIK2 encodes glutamate receptor, ionotropic, kainate 2, which is 
an important neurotransmitter receptor in the central nervous 
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system. Mutations in this gene have been shown to cause 
autosomal recessive mental retardation (Motazacker et al., 2007) 
and are associated with age of onset of Huntington disease 
(Rubinsztein et al., 1997). GRIK2 was identified in amacrine cells 
of the adult retina by Brandstätter et al. (1994) and Vardi et al. 
(1998) showed GRIK2 receptors concentrate on dendrites of 
bipolar cells in monkey and rat retina. Grünert et al. (2003) 
showed GRIK2 is predominantly associated with diffuse bipolar 
cells and rod bipolar cells in primate retina. Based on these 
findings, GRIK2 is likely to be important in the retina despite 
other mutations in GRIK2 being associated with disorders that 
have more wide ranging effects on the central nervous system.  
 
8.4.2 Copy Number Analysis 
The CNV analysis revealed many shared sites of CNV in the 
British family but none in the French family. Unfortunately the 
data quality for the CNV analysis was not ideal and so any 
identified CNVs would need further investigations to ensure they 
were genuine. It was deemed worthwhile to use QPCR to test for a 
possible CNV at the 6q16 disease region. The QPCR data and 
subsequent statistical analysis revealed no significant difference 
between the test samples and the control, indicating all had the 
same copy number and that it was normal. The genotyping data 
also suggested there was no CNV due to the presence of 
heterozygous calls across the region at which there was an 
apparent loss. If an allele were lost it would be evident in the 
genotyping data by the presence of consecutive homozygous calls.  
 
Of the CNV analysis on the other chromosomes, just one site 
revealed a region of interest which, if genuine, would result in a 
loss of ARID4A in all British samples tested. This CNV was not 
indicated in the French family. ARID4A encodes AT-rich 
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interactive domain 4A on 14q23.1. This gene is also named 
retinoblastoma binding protein 1 (RBP1) and regulates cell 
proliferation by binding and inhibiting the activity of growth 
promoting protein, including the transcription factor E2F. 
However, though it is interesting that this CNV was consistent in 
all members of the British family analysed, this CNV is not in the 
linked disease region at 6q and nor was it seen in the French 
family. It is therefore unlikely to be significant in the disease state. 
 
8.4.3 Summary 
Genotyping analysis of members of a British PBCRA family and a 
French family with suspected PBCRA appears to have refined the 
disease region to between 6q16.1 and 6q16.2. The two families 
have a shared region of contiguous SNPs with common alleles that 
appear to segregate with the disease. Mutations in SIM1 or the 
coding exons of MCHR2 and FBXL4 are not the cause of PBCRA. 
The primary candidate gene appears to be GRIK2. 
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9. SPLIT-HAND/SPLIT-FOOT 
MALFORMATION WITH NORTH 
CAROLINA MACULAR DYSTROPHY 
(SHFM & NCMD) 
 
9.1 Genetic Analysis 
This is a rare and unusual condition in which there is a macular 
phenotype that is consistent in penetrance but varies in 
appearance with additional split-hand/split-foot malformations 
that show varying penetrance. Loci for SHFM and images of the 
phenotype are shown in Section 2.5.5. In the two families being 
studied in this project (Figure 9.1), the disorder has not been 
linked to a specific locus. Analysis in this project has focused on 
regions of copy number variation identified by Dr A. Kalhoro 
during her own project. In the French family, a region of copy 
number decrease at chromosome 5p15.33 followed by an area of 
copy number increase at 5p15.32 was identified. The decrease 
was seen in five of six affected individuals analysed and in none of 
the three unaffected individuals whereas the increase in SNP copy 
number state was seen in all affected family members but not in 
the unaffected individuals. It is interesting to note that this 
overlaps with the MCDR3 disease locus (Section 6). 
 
The English family showed no copy number variations in this 
region, which was surprising as it was expected that the two 
families would have a similar genetic basis. Dr A. Kalhoro 
identified a region of copy number increase in each of the three 
affected individuals was present at 6q27 that was not seen in the 
unaffected family member. A copy number variation in this region 
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of the genome is interesting as the homologue of the mouse 
Brachyury T gene is located in this area, mutations in which 
result in abnormal feet and tail in mice (Ruvinsky et al., 2002).  
 
a)  
b)  
  
Figure 9.1 SHFM and NCMD pedigrees: a) a three-generation 
English family and b) a five-generation French family. Circled in 
red are samples run on the Affymetrix 250K SNP Chips. 
 
 
9.2 Methods Applied 
9.2.1 Candidate Screening 
The English family members were screened for variations in the 
novel ncRNA AC026711.1 using the BIOTaq protocol and an 
annealing temperature of 60oC. The primers 5DelRNA (listed in 
Table 9.1) were used and the PCR product used directly in a 
sequencing reaction as the DNA template. 
 
I 
II 
III 
I 
II 
III 
IV 
V 
V 
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9.2.2 QPCR 
QPCR experiments using SYBR Green were conducted to 
investigate copy number variations in affected individuals. The 
SYBR Green protocol was followed (Section 3.1.7). Primers for 
GAPDH were tested as in Section 8.2.3. The test primers are listed 
in Table 9.1. The 5DelRNA, 5DelE and 5DelF primers were tested 
for specificity with SYBR Green and all test sets produced a single 
amplicon. The QPCR plate contained three repeats for each 
sample and GAPDH control QPCRs were conducted on the same 
plate as one of the three test QPCRs. Three separate test QPCR 
regions were amplified within the suspected disease region. The 
5DelF primers amplified 162bp overlapping the SNP rs1346474. 
5DelE primers amplified 151bp overlapping the SNP rs261189. 
Finally, the primers 5DelRNA amplified a 179bp region containing 
the ncRNA AC026711.1 (4,302,889 – 4,302,974). 
 
Table 9.1 Primers for QPCRs. 
 
 
 
9.3 Results 
9.3.1 Affymetrix Data 
Genotyping Analysis 
For this analysis all members for whom DNA was available were 
processed over 250K Sty I Affymetrix SNP chips, obtaining 
genotype data for both affected and unaffected family members. 
The usefulness of this in identifying Mendel errors is apparent in 
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the analysis. When the genotyping data for the French family 
samples were aligned and Mendel checks carried out, a run of 
errors was identified in more than one sample over the same 
region on chromosome 5, suggesting loss of one allele over a 
number of SNPs. For example, patient III:1 is the affected parent 
of IV:1 and the unaffected parent is III:2 (Figure 9.1b). In Figure 
9.2, there is a run of consecutive SNPs from rs7716544 
(4,296,367) to rs17677148 (4,399,737) at which IV:1 is apparently 
homozygous for alleles which correspond only to the genotype of 
the unaffected parent, III:2. Over this range IV:1 should be 
heterozygous (AB) as III:1 is apparently homozygous for the 
opposite alleles to those of III:2. Similarly, III:1 appears to only 
have inherited alleles from his unaffected parent at the same 
region of SNPs, Figure 9.3.  
 
 
 
 
 
 
 
Figure 9.2 Excel sheet extract that shows the region of SNPs in 
which a run of Mendel errors was identified in IV:1 when compared 
to the affected parent (III:1) and unaffected parent (III:2). 
 
SNPs that lie 
within gene 
regions 
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Individuals III:3 and V:1 have only a single error, each at one end 
of the apparent deletion region but over the other SNPs in the 
region only homozygous calls are seen (III:3 shown in Figure 9.4). 
For III:1 and III:3 the first error was detected at rs1346474 
(4,220,728) but homozygous calls were given at many SNPs prior 
to this, suggesting the deletion may begin prior to this SNP. 
 
 
 
 
Though errors were detected between SNPs rs1346474 to 
rs17677148, heterozygous calls in affected samples were not seen 
over a wider area than this, whereas for the unaffected samples 
heterozygous calls were seen throughout the region. The 
heterozygous calls seen in affecteds closest to the telomeric end of 
the region of errors were seen at rs11134030 (4,065,252) and after 
Figure 9.3 Excel sheet extract that shows the region of SNPs in 
which a run of Mendel errors was identified in III:1 when 
compared to the affected parent (II:2) and a dummy unaffected 
parent. 
 
Figure 9.4 Excel image showing a single Mendel error in III:3. 
 
SNPs that lie 
within gene 
regions 
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the end of the error region at rs11744458 (4,664,870), shown in 
Figure 9.5. This suggests the deletion may extend beyond where 
the error calls identify loss of alleles. Annotations in this region 
contain no known characterised genes but upstream lies IRX1, 
C5orf38 and IRX2 and downstream is ADAMTS16. The deletion 
also overlaps the region of the MCDR3 marker D5S2088, therefore 
it is possible the two disease states may be caused by different 
changes in the same gene. Between the SNPs rs11134030 and 
rs11744458 are the annotations: AC025187.1, CTD-2008N3.1, 
RP11-445O3.1, AC026711.1, AC106799.1, RP11-445O3.2 and 
CTD-2318H23.1. None of these have been characterised. 
AC025187.1 and AC106799.1 are annotated as known protein 
coding genes. CTD-2008N3.1, RP11-445O3.1, RP11-445O3.2 and 
CTD-2318H23.1 are processed transcripts and AC026711.1 is a 
novel ncRNA. 
 
 
 
 
 
 
 
Figure 9.5 Excel image showing the genotype calls for subjects 
from the pedigree in Figure 9.1b. The region highlighted in red 
covers the region of errors highlighted by the Mendel checks. The 
green boxes highlight the first heterozygous calls seen in affected 
samples. 
SNPs that lie 
within gene 
regions 
SNPs with 
Mendel error 
First SNP 
with het call 
Chapter 9 
     Genetic Analysis of Inherited Retinal Dystrophies 206 
Looking at the English family SNPs in this region, the same errors 
in the pattern of inheritance were not seen. At this 5p region, the 
English family genotypes showed numerous heterozygous calls 
from rs7716544 (4,296,367) onwards. However, homozygous calls 
are seen before this point, therefore it is possible that a 
microdeletion is present in the same region where it was identified 
in the French family. From Figure 9.6 it is clear however that the 
genotypes of the unaffected offspring are very similar to the 
affecteds. The previous CNV analysis by Dr A. Kalhoro did not 
identify a deletion in this family at the 5p region and Figure 9.6 
aligns the English family genotypes across the same SNPs as in 
Figures 9.2 - 9.4. The genotyping data appears to confirm that 
there is no deletion at this region in the English family. 
 
 
 
Figure 9.6 Excel sheet showing the 5p genomic region as seen in 
Figures 9.2 - 9.4 but here the genotypes of the English family are 
shown and reveal no Mendel errors. 
 
The Mendel errors seen in the French affected members are 
summarised in Table 9.2. The heterozygous calls found in the 
same region are also summarised as an indication of how large 
the actual deletion may be. 
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Table 9.2 Summary of the Mendel errors in the affected French 
family members. Heterozygous calls at the same region indicate 
how large the actual deletion may be. 
 
 
 
Copy Number Analysis 
The quality of the sample data was relatively poor for both families 
but despite this the analysis appeared to identify CNVs. In 
previous analysis, Dr A. Kalhoro identified common regions of 
CNV that required further investigation. A deletion was 
highlighted at 5p15.33 in all but one affected individual of the 
French family that was not seen in any of the unaffecteds or 
members of the English family. The deletion appeared to run from 
rs655652 (4,137,004) to rs261165 (4,340,479), which corresponds 
with the Mendel errors in the genotyping data (Figure 9.7). 
 
 
 
 
Figure 9.7 Ensembl image of the original region of deletion 
identified in the French family by Dr A. Kalhoro with the analysis 
highlighted by the new CNV analysis highlighted by the red box. 
 
 
 
Region of 
deletion 
identified 
in repeat 
analysis 
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The repeat CNV analysis conducted with the new Genotyping 
Console in this project identified a CN state of 1 between 
rs11134035 (4,175,312, which suggests the deletion begins 
further upstream near the first heterozygous call in Figure 9.5) 
and rs1346474 (4,220,728) in three affected members of the 
French family (highlighted by the red box in Figure 9.7). A 
duplication was then identified in five affected members of the 
French family between rs17677148 (4,399,737) and rs1428984 
(4,626,460), shown in Figure 9.8 in the red box.  
 
 
 
 
Figure 9.8 Ensembl image showing the overlap of the duplication 
region identified from Affymetrix 250K CNV analysis by Dr A. 
Kalhoro in the French family with the new analysis highlighted in 
the red box. 
 
 
The DNA from III:3 was further analysed on a SNP 6.0 chip, which 
contains one million SNPs across the genome and is ideal for 
identifying CNVs. A CN state of 1 was given between the SNPs 
rs4479812 (4,216,057) and rs9942406 (4,409,489) and a CN state 
of 4 (triplication of one allele or double duplication) given between 
CNV sites CN_112820 (closest SNP rs9942406) to CN_1137043 
(closest SNP rs293127, 4,622,584). These regions are shown in 
Figure 9.9, taken from the Chromosome Analysis Suite (CAS). The 
CAS uses the human genome build 36 as reference so the 
physical positions in Figure 9.9 are different from those used 
Region of 
deletion 
identified 
in repeat 
analysis 
Chapter 9 
     Genetic Analysis of Inherited Retinal Dystrophies 209 
elsewhere in this project, which are from the most recent human 
genome build, 37. In the white box of Figure 9.9, the red and blue 
bars at the top represent the region where a run of copy number 
loss (CN state of 1, red) was identified and appears to be 
immediately followed by a run of duplication (CN state of 4, blue). 
The log2 Ratio shows the trace of the raw data whilst the orange 
line above this depicts the CAS interpretation of the raw data. The 
region at which there are consecutive CN state calls of one 
extends over 167 markers whilst a CN state of 4 is given over 156 
consecutive markers. The data from a control sample are also 
shown in Figure 9.9. This confirms the analysis of the 250K 
genotyping and CNV analysis. 
 
The SNP 6.0 analysis also detected a loss of one allele at 1p33, 
resulting in a predicted deletion of an intron of AGBL4. A CN state 
of 4 was also detected at 17q11.2 that would result in a 
duplication of CRLF3. As only one family member had these 
regions highlighted, it is unlikely that these CNVs are significant. 
Neither of these genes are listed as being expressed in retina or 
RPE/choroid, and neither are at known SHFM or macular 
dystrophy loci. 
 
The data returned from the SNP 6.0 array analysis of one sample 
confirmed the 250K data and indicated the deletion region to be 
~200kb in size. A duplicated region with a gain of 4 directly 
following the deletion was detected, which also appeared to be 
~200kb in size. This implies a duplication on both chromosomes 
or a triplication on one. There are a few annotations within both 
the deletion and the duplication regions and all are 
uncharacterised. 
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The deletion region contains the majority of exons of the known 
processed transcript RP11-445O3.1, a novel non-coding RNA 
AC026711.1 and the partial sequence of the known processed 
transcript RP11-445O3.2 (Figure 9.5). The duplication region 
contains only the partial sequence of this latter transcript (Figure 
9.8). It is unclear whether the deletion or duplication is more 
likely to be involved with the disease state, although hemizygous 
loss of gene function would generally be more detrimental. 
However, gene dosage with either less or more than normal copies 
of genes is important in disease (Emanuel and Shaikh, 2001). 
 
When these CNVs were first identified they appeared to be novel 
but subsequently other CNVs have been detected in normal 
populations. In the Ensembl genome build 37 there is an 
annotated region between 4,232,530 and 4,288,545 (which is 
before the ncRNA AC026711.1) and another between 4,648,027 to 
4,661,512 (at CTD-2318H23.1) identified in the study by Itsara et 
al. (2009). The Chromosome Analysis Software used to interpret 
the SNP 6.0 data showed the deletion and duplication to overlap 
with a known CNV, evident in Figure 9.9 as a blue band at the 
bottom of the image. This represents the position of the CNV on 
the previous human genome build (36). The CAS links to the 
database for genomic variants (DGV) and highlights them in the 
analysis window. However, not all current known CNVs are 
presented in Figure 9.9 as the comparisons were made to the 
human genome build 36 database. The CNVs in the current DGV 
(build 37) that have been found within the 5p region are 
highlighted in this family and shown in Table 9.3. The French 
family data and known areas of CNV are summarised in Figure 
9.10. 
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Table 9.3 Summary of the CNV regions identified in the French 
SHFM and NCMD samples in the various analysis types and 
compared to known CNVs. 
 
 
 
 
 
 
 
 
Figure 9.10 Image showing the relative position of the CNVs 
identified in the NCMD and SHFM analysis and the relative 
positions of the known CNVs described in Table 9.3. 
 
 
Chapter 9 
     Genetic Analysis of Inherited Retinal Dystrophies 213 
Previous analysis by Dr A. Kalhoro revealed a duplication in 
affected members of the English family at 6q27. However, 
reviewing the CNV data has revealed the 6q27 CNV to be a known 
region of CNV and therefore is unlikely to be significant to the 
disease state. The 250K CNV analysis for the English family 
revealed numerous sites across the entire genome where the 
affected samples had common CNVs. These are shown in Table 
9.4. Known regions of CNV (when compared to the DGV) have 
been excluded from this Table. None of the regions identified were 
in known SHFM loci and though there are numerous CNV regions 
containing genes, none stand out as primary candidates. 
 
Table 9.4 CNVs common to all English family affected members 
and not present on the DGV. 
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9.3.2 QPCR 
QPCRs were used to confirm the presence of a deletion in affected 
members of the French family, as determined by the Affymetrix 
genotyping and CNV analyses and to show the QPCR technique is 
able to detect such CNVs (previous PBCRA analysis contrasted to 
the Affymetrix CNV analysis to suggest no CNV was present). As 
for the previous PBCRA analysis the delta-delta Ct method was 
used to determine the CN state of each sample within the 5p 
genomic region. The CN state of sample genomes at the 5DelE, 
5DelF and 5DelRNA regions are shown in Figures 9.11 – 9.13, 
respectively. 1 represents a normal CN state therefore a loss of 
one allele would provide a 0.5 output. Error bars represent the 
standard error of the mean (SEM). Comparison of the Control and 
unaffected sample III:2 for 5DelE revealed no significant difference 
(p = 0.884). The t-test comparisons of the Control with each 
affected sample are shown in Figure 9.11. 
 
 
 
Figure 9.11 The CN state values over the 5DelE region calculated 
using the delta-delta-Ct method. III:2 is an unaffected member. 
Error bars represent SEM. 
 
For the 5DelF region, ANOVA between the Control and unaffected 
III:2 was also not significant (p = 0.258). T-test comparisons with 
each affected sample are shown in Figure 9.12.  
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Figure 9.12 The CN state values over the 5DelF region calculated 
using the delta-delta-Ct method. III:2 is an unaffected member. 
Error bars represent SEM. 
 
 
At the 5DelRNA region, ANOVA between the Control and 
unaffected samples II:5 and II:7 was slightly significant (p = 0.01), 
whereas the comparison with the affected samples was strongly 
significant (p = 0.000004). T-test comparisons with each affected 
sample are shown in Figure 9.13.  
 
 
 
Figure 9.13 The CN state values over the 5DelRNA region 
calculated using the delta-delta-Ct method. III:2 and II:7 are 
unaffected members. Error bars represent SEM. 
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It is clear from the QPCR data that the affected samples shown 
contain a loss of DNA at the three regions tested, which each 
occur within the region detected in the genotyping and copy 
number analysis. Not only do the affected samples consistently 
show significantly less DNA than the control sample, but the 
unaffected samples consistently show no or minimal significant 
difference in comparison. The exception is for IV:1 at the 5DelE 
region. Though the genotyping and CNV data suggest a deletion at 
this region, the QPCR data is inconclusive. Whereas the other 
samples clearly show a significant reduction in the amount of 
DNA compared to the control and unaffected samples, IV:1 does 
not. This is likely to be due to an error in providing the same 
concentration of DNA for all samples. For samples of poor DNA 
quality, obtaining an accurate concentration, particularly when so 
little is used, will likely achieve errors. The standard error bars are 
small suggesting that within the experiment the data were 
consistent but ideally the analysis would be repeated to check the 
results and over a greater 5p region to find the limits of the CNV. 
Overall, Figures 9.11 – 9.13 confirm the French family affecteds 
carry a genome deletion at 5p15.33 not seen in the unaffected 
members, which includes loss of one copy of a novel ncRNA, 
AC026711.1. 
 
Genomic DNA from one affected member of the English family 
(II:2) was used analyse CNV at the 5DelRNA region but a normal 
CN state was achieved. 
 
Running a BLAST search with the predicted mature miRNA 
sequence of AC026711.1 (expanded in Figure 9.14) so as to 
identify genes that show complementarity within 3’ UTRs, may 
reveal possible gene targets. This is not a precise method of 
predicting ncRNA targets as other factors are important to 
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consider in target prediction, such as thermostability and 
accessibility of the target binding site (Hammell, 2010). It does 
however, provide some idea of possible targets. 
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A BLAST search with the mature miRNA sequence revealed a 
number of genes with complementarity in 3’ UTRs, which are 
shown in Table 9.5. 
 
Table 9.5 Genes for which the predicted mature sequence of 
AC026711.1 showed complementarity to the 3’ UTR sequences. 
 
 
 
 
9.4 Discussion 
9.4.1 Genotyping Analysis 
Analysis of two families with a Sorsby syndrome-like phenotype 
had previously been initiated by Dr A. Kalhoro and has been 
extended here. The analysis has highlighted regions of apparent 
error in Mendelian inheritance in a French family, identified as 
runs of homozygous calls in offspring over SNPs that should have 
been heterozygous based on the parent genotypes. In samples 
where parent data were not informative in Mendel checks, runs of 
homozygous calls were seen across the same group of SNPs, 
suggesting that a region of hemizygosity in the samples was also 
possible. Unaffected samples revealed heterozygous calls 
throughout the region, indicating no loss of allele. The errors 
identified in the Mendel check ran between rs1346474 (4,220,728) 
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and rs17677148 (4,399,737) but homozygous calls extended 
beyond these SNPs, suggesting the deletion region may extend 
beyond these points. The data were consistent with Dr A. 
Kalhoro’s previous CNV analysis and the region lies within the 
MCDR3 locus. This analysis has highlighted the usefulness of 
analysing all members of a pedigree, both affected and unaffected. 
Without a disease locus, further genotyping analysis would reveal 
little informative analysis. The Mendel errors determined in the 
French family were not present in the British family. 
 
9.4.2 Copy Number Analysis 
SNPs with a CN state of 1 were identified between rs11134035 
(4,175,312) and rs1346474 (4,220,728) in three of the affected 
samples from the French family but not in any of the unaffecteds 
or any of the English family members. A run of SNPs with a CN 
state of 3 were also detected from rs17677148 (4,399,737) to 
rs1428984 (4,626,460) in five of the affected samples. These 
results match the genotyping analysis but do miss a section of the 
deletion detected through the former analysis. The CNV analysis 
also failed to detect a deletion and duplication in all the affected 
samples, which may be explained by the poor sample quality. The 
deletion was shown by QPCR to be present in affected samples. 
Therefore it seems most likely that the reduced quality of the data 
for the Affymetrix CNV analysis was the reason for failing to detect 
a CNV. It would appear that there is a deletion in all of the French 
affected members that segregates with the disease state.  
 
A single sample (III:3) was additionally analysed over a SNP 6.0 
chip, an array containing one million SNPs and ideal for detecting 
CNVs. This analysis again identified a run of SNPs (167 
consecutive) that revealed a CN state of 1 between rs4479812 
(4,216,057) and rs9942406 (4,409,489). This was interesting 
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because the deletion had previously been inferred in this patient 
from the genotyping analysis in which just one SNP revealed a 
Mendel error with the remaining calls homozygous. The SNP 6.0 
data was able to confirm the suspicion that this individual did 
also have a deletion across 5p15.33. The SNP 6.0 analysis also 
revealed a run of SNPs (156 consecutive) with a CN state of 4 
directly following the deletion region and the gain of alleles 
extended to rs293127 (4,622,584). A CN state of 4 suggested there 
was either a triplication of one allele or a duplication of both 
alleles across this region. In the 250K CNV analysis however, 
samples were revealed to have a CN state of 3. As the data quality 
from the 250K arrays were somewhat unreliable, it is suspected 
that the CN state of 4 given by the SNP 6.0 array is the more 
accurate CN state call. This implies that the other four samples 
that gave a CN state of 3 from the 250K analysis may more 
accurately have a CN state of 4. Overall, the genotyping, CNV and 
QPCR reveal a deletion followed by a duplication of similar lengths 
on chromosome 5p15.33 that segregate with the disease state in 
the French family. 
 
The SNP 6.0 analysis also revealed the single affected analysed  
had a deletion within an intron of AGBL4 on 1p33 and a partial 
triplication of CRLF3 on 17q11.2. AGBL4 encodes ATP/GTP 
binding protein-like 4 and CRLF3 cytokine receptor-like factor 3. 
Neither are listed on the NEIBank database of retina and 
RPE/choroid genes and do not seem likely candidates for the 
disorder. Given that just one sample was anlaysed on the SNP 6.0 
array and that these CNVs were not detected in other members of 
the family in the 250K analysis, it seems more likely that these 
variations are unique to this individual. 
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9.4.3 Candidate Genes 
Within the deletion and duplication regions are few annotations, 
all of which are uncharacterised. Predicted exons for the 
processed transcript RP11-445O3.1 and the novel ncRNA 
AC026711.1 are annotated in the region of deletion. Exons of 
RP11-445O3.1 extend into the duplication region although 
Ensembl does not describe a protein product for this annotation. 
The duplication also contains predicted exons of the processed 
transcript RP11-445O3.2 and the protein-coding gene 
AC106799.1. Here the ncRNA has been investigated due to the 
novel influence it may have.  
 
In contrast to siRNAs, miRNAs tend to be distinct from annotated 
genes and have a distinct expression in cell types. They are 
processed from longer ncRNA structures that bind to partially 
complementary sequences on target mRNAs in the 3’ untranslated 
regions (UTRs) and regulate expression by mRNA degradation 
and/or translational repression (Bartel, 2004). The micro RNA 
database (miRBase) has currently identified 1,048 human miRNA 
genes in the human genome build 37. In this project, Affymetrix 
and QPCR analysis have confirmed loss of one copy of the novel 
ncRNA AC026711.1 in affected members of the French family. 
This ncRNA was predicted from Rfam (ncRNA families) and 
miRBase databases. A sequence search in Rfam  (Gardner et al., 
2009) revealed sequence homology with the mir-548 family of 
miRNAs (Figure 9.14). A group of hsa-mir-548 sequences were 
identified by Piriyapongsa et al. (2007), who provided evidence 
showing these miRNAs are derived from transposable elements 
(TEs). They found seven closely related hsa-mir-548 sequences 
that co-localised with dispersed members of a single family of TEs 
known as Made1. These sequences are included in Figure 9.14 
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and the similarity of AC026711.1 with these sequences is 
apparent.  
 
Though miRNAs can bind the 5’ end or cleave within mRNA, the 
most common mechanism for preventing translation is by binding 
to the 3’ UTR. A search for complementary sequences in genes 
using the predicted mature miRNA sequence from Figure 9.14 was 
run and produced many hits within the human genome, with 55 
of them associated with characterised genes. Of these just six 
showed complementarity to the predicted AC026711.1 mature 
miRNA at the 3’ UTR: LRRC55, MTMR6, KATNAL1, TTC12, SMU1 
and CLEC7A (Table 9.5). Of these only two appear to have 
interesting roles: KATNAL1, expression of which is needed for 
dendrite severing in Drosophila and katanin p60 has recently been 
shown to be required for skeletal re-organisation. The other 
interesting gene is SMU1, which suppresses HSPG expression 
(heparan sulphate proteoglycan core protein). The protein product 
of HSPG appears to have a role in the retina (Walz et al., 1997).   
 
KATNAL1 encodes katanin p60 subunit A-like 1, which has been 
shown to be required for dendrite severing in Drosophila (Lee et 
al., 2009). Excess katanin p60 (KATNA1) results in short 
microtubules (Yu et al., 2008) and recently this microtubule-
severing protein has been shown to be needed for skeletal 
reorganisation in mice (Iwaya et al., 2010). As KATNAL1 has 
sequence similarities to KATNA1 it is possible that the protein 
product also has similar functions. However, no expression in 
either the retina or RPE/choroid is listed in NEIBank databases.  
 
TTC12 is a tetratricopeptide repeat protein, which again is not 
listed in retina or RPE/choroid databases but related members 
are. TTC12 cDNA is listed in Unigene as detected in eye tissue so 
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there may be an as yet unidentified role for the protein in the eye. 
The related member TTC5 has been identified in this project as a 
candidate for MCDR4. 
 
SMU1 expression is listed in both retina and RPE/choroid 
databases and this encodes suppressor of mec-8 and unc-52 
homolog (Caenorhabditis elegans). Interestingly, unc-119 homolog 
(C. elegans) mutations have been found to cause autosomal 
dominant CORD (Kobayashi et al., 2000; Section 2.3). The protein 
product of unc-52 is also known as perlecan, and the human 
ortholog is the basement membrane-specific heparan sulphate 
proteoglycan core protein (HSPG). This is closely related to the 
Drosophila eyes shut gene (eys, Husain et al., 2006) and 
mutations in the human EYS gene cause autosomal recessive RP 
(Abd El-Aziz et al., 2008). Expression of HSPG was shown by 
Regatieri et al. (2010) to parallel areas of choroidal 
neovascularisation in rat retina but in diabetic rats HSPG 
expression in the retina was decreased when compared to 
expression in the retina of normal rats (Bollineni et al., 1997). If 
SMU1 suppresses HSPG and AC026711.1 suppresses SMU1, then 
with one less copy of the ncRNA there would be less suppression 
of SMU1 and therefore more available to suppress to HSPG, 
resulting in a decrease of HSPG. If a decrease in HSPG is 
important in the phenotype of the retina in diabetic mice, then it 
may have an effect on the human retina as well.  
 
9.4.4 Overlap with Known CNVs 
Within the region of CNV identified in the affected members of the 
French family were a number of known CNVs (Table 9.3 and 
Figure 9.10).  Of these, the biggest overlap came from the CNVs 
identified by Wong et al. (2007), which overlap with most of the 
region of duplication seen in the affected members of the French 
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family. The CNVs detected at this region by Wong et al. (2007) 
consisted of 11 gains and 12 losses from 95 control samples, so 
~22% of control samples had a CNV. However, the region does not 
cover the region of deletion seen in all affecteds of the French 
family, suggesting that though the region of duplication may not 
be an uncommon CNV, the deletion may be unique. Itsara et al. 
(2009) published data identifying large CNV hotspots prone to 
recurrent mutation. They identified a CNV that sits within the 
region of deletion of the French family but prior to the ncRNA 
AC026711.1. From the publication data it appeared that the CNV 
identified at this site in the cohort was a duplication rather than a 
deletion. Though CNVs have been identified in the 5p15.33 region, 
the combination of a deletion followed by a duplication is an 
unusual occurrence so to find it consistently in every affected 
member of the French family suggests it may be significant. 
 
The deletion and duplication appear to segregate with the disease 
in the French family and seem to be approximately the same size, 
which suggests that they may have arisen from a single event. In 
affected individuals, a region with a CN state of 1 was followed by 
a region with a CN state of at least 3 but possibly 4. This is a rare 
occurrence, although, variation at the site of duplication has been 
seen in the control population (Conrad et al, 2009 and Bentley et 
a., 2008). If this site may be duplicated irrespective of disease 
state then this may explain the CN state of 4 identified from the 
SNP 6.0 array data of subject III:3. This suggests an affected 
member may have a CN state of 3 or 4 depending on whether the 
individual also carries a normal CNV.  
 
Given the similarities in the size of the deletion and duplication 
and that the deletion only seems to occur in the affected 
members, a duplication on the strand carrying the deletion may 
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be related to the deletion event, which may in turn be associated 
with the disease state. Though hemizygosity is thought to be more 
likely associated with a disease state, it is possible that the 
duplication is important. For example, though in a control 
population a small number of individuals were found to have a 
duplication, it may be that a single duplication is not enough to 
cause a physiological change but any levels above that do have an 
effect. Gene dosage is identified as an important factor in disease 
states and it could be that whist a CN state of 3 is not important, 
a CN state of 4 at this region is. For example, Emanueal and 
Shaikh (2001) have shown the importance of segmental aneusomy 
in disease, i.e. disorders that result from inappropriate gene 
dosage. 
 
9.4.5 English Family Affymetrix Data 
As this family is so small, linkage analysis has not been 
conducted and therefore the disease locus is not known. This 
means that unless the genotyping data produced regions of 
Mendel error, as occurred in the French family, the genotyping 
data would not be very informative.  
 
Analysis at the 5p15.33 region did not reveal the same Mendel 
errors or runs of homozygous calls that were evident in the French 
family (Figure 9.6). The calls of the unaffected offspring analysed 
were very similar to those of the affecteds and hetereozygous calls 
were given for all samples analysed, indicating a region of deletion 
in these samples was unlikely. Without genotyping data for more 
family members, linkage analysis across the genome using the 
genotyping data is not possible. Attempts to analyse the 
chromosomes from the genotyping data would be uninformative 
due to the lack of meioses between samples.  
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Through the CNV analysis many sites of variation at which all 
affected samples exhibited common CNVs were identified (Table 
9.4). The previous CNV at 6q27 identified by Dr A. Kalhoro was 
removed as a region of interest in this analysis due to the overlap 
with numerous known sites of CNV. Of the CNVs not listed in the 
DGV and common to the affected English family members many 
contained genes but just two currently appear to be of interest, 
CXCR4 and SIRT1. A gain on 2q22.1 of CXCR4 is interesting 
because this gene has been shown to be important in ocular 
neovascularisation (Lima e Silva et al., 2007) and to mediate 
photoreceptor tip cell morphology and vascular patterning in 
neonatal retina (Strasser et a., 2010). However, no roles have been 
described that would relate to the SHFM phenotype.  
 
SIRT1 is involved in many pathways but it is particularly known 
for its role in repairing double-stranded DNA breaks. It is 
expressed throughout the retina and appears to be important in 
protecting cells from apoptosis though it is lack of this gene that 
causes problems (Ozawa et al., 2010). A gain of this gene was 
identified at 10q21.3 in the English family but what affect an 
extra copy may have in the retina or in development of limbs is 
unknown.  
 
9.4.6 Summary 
The affected members of the French family appear to have a 
region of deletion at 5p15.33 followed directly by a region of 
duplication of similar length. This lies within the MCDR3 locus 
and appears to segregate with disease as it was not seen in 
unaffected members of the family. There are no characterised 
genes within this region and it is suggested that loss of one copy 
of a novel predicted ncRNA could be influencing the disease state. 
The affected members of the English family did not show a CNV at 
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5p15.33 but did reveal numerous other regions of CNV at other 
areas of the genome. 
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10. BULL’S-EYE MACULAR 
DYSTROPHY (MCDR2) 
 
10.1 Genetic Analysis 
In the study by Michaelides et al. (2003b), the disease was linked 
to 4p15-p16.3, and PROM1 identified as a possible candidate 
gene. This gene encodes human prominin (mouse)-like-1, a 
member of the prominin family of 5-transmembrane domain 
proteins and is expressed in retinoblastoma cell lines and adult 
retina (Jászai et al., 2007). The product of the mouse orthologue is 
concentrated in membrane evaginations at the base of the outer 
segments of rod photoreceptors. Mutations in this gene have 
already been found to cause retinal disease, such as the 
homozygous mutation in exon 15 (c.1,726C>T) identified in an 
Indian pedigree with an autosomal recessive retinal dystrophy 
(Zhang et al., 2007). This mutation results in formation of a 
truncated protein that was shown by functional studies in CHO 
cells not to reach the cell surface. A deletion in PROM1 exon 16 
(c.1,841delG) that causes a frameshift mutation at codon 614 and 
results in predicted premature termination of translation has also 
been shown to cause retinal degeneration (Maw et al., 2000). 
STGD4 has been linked to this locus (Kniazeva et al., 1999) and 
more recently Permanyer et al. (2010) have identified the mutation 
c.869delG in exon 8 as another cause of autosomal recessive RP. 
MCDR2 sufferers have been reported to show a substitution in 
exon 10 of PROM1 (c.1,117C>T), which results in an amino acid 
change of arginine to cysteine (Arg373Cys, Figure 10.1; 
Michaelides et al., 2003a). Yang et al. (2008) developed a mouse 
model expressing this mutation in a human PROM1 gene and 
demonstrated that the mutated protein disrupts photoreceptor 
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morphogenesis in a transgenic mouse model. The mutation 
caused effects predominantly in cones with sub-retinal deposits 
and photoreceptor atrophy characteristic of Stargardt disease 
evident. In their report, Yang et al. also stated that the screening 
of STGD4 and cone-rod dystrophy sufferers revealed this same 
PROM1 missense mutation. The families did, however, have 
distinct disease haplotypes, indicating the mutations arose 
independently. Michaelides et al. (2010) re-assessed the STGD4, 
MCDR2 and RP families with the Arg373Cys mutation in addition 
to reporting two new British MCDR2 families in which the 
Arg373Cys mutation was identified in this project. Previous 
MCDR2 families have been linked with the marker D4S1601 with 
two different alleles identified. New families in this project will be 
screened to discover if they carry one of these alleles at this 
marker. If the same allele is identified that will indicate the 
families share the same ancestral mutation. 
 
Another variation identified in PROM1 that leads to a retinal 
dystrophy is the insertion c.1,349insT in exon 12. This mutation 
was identified in a CORD family and leads to a frameshift 
mutation at codon 452 and a premature stop codon at 464 (Pras 
et al., 2009). Mutations in RIMS1 have also been shown to cause 
CORD (Johnson et al., 2003, Section 2.3). RIMS1 encodes 
regulatory synaptic membrane exocytosis 1, which is expressed in 
the photoreceptors and thought to be important in synaptic 
transmission (Wang et al., 1997). It is possible that mutations in 
this gene may also arise in some members of the panels being 
analysed in this project. 
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10.2 Methods Applied 
10.2.1 Screening 
RIMS1 
Exon 14 of this gene was screened using the BioTaq PCR method 
(Section 3.1.1) in two suspected MCDR2 patients. These subjects 
did not have the PROM1 exon 10 mutation and given their 
phenotype, it was considered a possibility that a mutation in 
RIMS1 could be responsible for their disease state. 
 
 
Table 10.1 Primers used for amplifying exon 14 of RIMS1. 
 
 
 
 
PROM1 
Coding exons of PROM1 were screened using the BIOTaq PCR 
method (Section 3.1.1). Primers were designed by Dr Richard Yang 
though some exons required new primers to be designed (Table 
10.3). 
 
10.2.2 Genotyping 
For the genotyping of D4S1601, see Section 3.1.9. The primers 
used are listed in Table 10.2 and the reactions were carried out 
using a 56oC annealing temperature. 
 
 
Table 10.2 Primers used for amplifying D4S1601. 
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Table 10.3 Primers and annealing temperatures of the PROM1 
exons. 
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10.3 Results 
10.3.1 MCDR2 Panel 
PROM1 
This panel consisted of twenty-one subjects diagnosed with BEM 
and suspected MCDR2 with an additional unaffected parent of 
three of these samples analysed. Only half the samples had all 27 
exons screened for variations, this is because the original panel 
consisted of only 11 samples and for the duration of the project 
samples would arrive for screening one at a time and so these 
were screened for the exon 10 mutation only.  
 
Of the samples screened, three new MCDR2 families with a 
c.1,117C>T mutation encoding an Arg373Cys substitution were 
identified (Figure 10.2); two of these families have been reported in 
Michaelides et al. (2010). 
 
 
 
In the full PROM1 screen, a handful of variations in nucleotide 
sequence were identified (Table 10.4). Five samples had the low 
frequency allele at rs3815344, which lies in intron 21; two 
families revealed a low frequency allele at rs2286455 in exon 8 
and all affecteds had A and G nucleotides at rs6449209 upstream 
of exon 23 (Figure 10.3a). For one family A/A was seen at 
rs6449209 in addition to an inserted G prior to the SNP (Figure 
10.3b). This insertion is not described in the NCBI SNP database. 
Figure 10.2 Image 
showing heterozygosity 
in exon 10 at position 
1,117 for a C>T 
mutation in the third 
new MCDR2 family 
identified. 
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All samples had the 42bp rs33950047 insertion within intron 20. 
One sample had a variation in exon 19 not seen in her two 
affected siblings, this variation was not annotated in Ensembl and 
does not alter the amino acid sequence. 
 
Table 10.4 Nucleotide variations in samples screened for 
mutations in PROM1. 
 
 
 
 
a)  
b)  
 
 
 
 
 
Figure 10.3 a) Nucleotide trace from one subject with the normal 
PROM1 sequence included above the trace and the consensus 
sequence highlighting the variation on the top line. The A/G 
variation upstream of exon 23 is designated as rs6449209 and 
was seen in all subjects except one family: b) shows the nucleotide 
trace from one of three siblings that showed an insertion of G prior 
to this SNP. 
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PROM1 Haplotypes 
In order to refine the haplotype of the PROM1 genomic region, the 
marker D4S1601, identified as being linked to PROM1, was 
screened in affected families. The new British families were found 
to have the allele with 135 repeats, whilst the previous British 
family had a distinct allele with 129 repeats. This suggests the 
three new families have a common ancestral haplotype, whereas 
the previously identified family does not. These results have been 
presented in Michaelides et al. (2010). 
 
RIMS1  
Two of the MCDR2 subjects that lacked a PROM1 mutation were 
screened for mutations in exon 14 of RIMS1 (Johnson et al., 2003) 
but no changes were found. 
 
10.3.2 BEM Panel 
Fourteen individuals diagnosed with bull’s-eye maculopathy 
(BEM) were screened for mutations in exon 10 of the PROM1 gene 
but none were found.  
 
10.4 Discussion 
MCDR2 is an autosomal dominant form of bull’s-eye maculopathy 
characterised by annular RPE atrophy with central sparing of the 
fovea. ABCA4 sequence variants have been described as causing 
BEM (Michaelides et al., 2007) but MCDR2 was linked to 4p15-
p16.3 (Michaelides et al., 2003b) and the mutation Arg373Cys in 
PROM1 identified (Michaelides et al., 2003a). This mutation has 
been linked to three other forms of retinal dystrophy; RP 
(Michaelides et al., 2010), STGD4 and CORD (Yang et al., 2008). A 
panel of BEM families with suspected MCDR2 were screened for 
mutations in all PROM1 coding exons. Other members of the panel 
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were screened only for mutations in exon 10 (the c.1,117 C>T 
mutation that leads to Arg373Cys). Though nucleotide variations 
were identified in the screening process, they generally occurred 
at known SNP sites (Table 10.4). The exception was a homozygous 
change in exon 19 not annotated in Ensembl, seen in one 
individual. The two siblings of this individual did not carry the 
allele and were homozygous for the common nucleotide. The 
nucleotide change would not alter the amino acid sequence so it is 
not thought to be associated with the disease. Despite no new 
mutations being found, three new families with the c.1,117C>T 
mutation were identified (only two families, D and E, were 
described in Michealides et al., 2010). All three new families with 
the Arg373Cys mutation had the 135 haplotype for the marker 
D4S1601, which is linked to PROM1. This marker haplotype was 
also seen in the RP family with BEM reported by Michaelides et al 
(2010) but the original British MCDR2 family had a 129 
haplotype.  
 
PROM1 is a membrane-associated protein normally found at the 
base of outer segment disk membranes in the photoreceptors 
where new disks are formed (Figure 10.4). Yang et al. (2008) 
generated transgenic mice with the Arg373Cys mutation in 
human PROM1 under the control of the rhodopsin promoter to 
achieve exclusive expression in the rod photoreceptors. They 
found that rather than PROM1 being at the outer segments, 
endogenous protein gathered in the photoreceptors. Combined 
with evidence of overgrown and disorientated disk membranes 
they suggested PROM1 may be responsible for new disk 
formation. Yang et al. (2008) data also indicated an interaction of 
PROM1 with PCDH21, which suggests that mutations in this gene 
may also cause macular dystrophy. Mutations in PCDH21 have 
been associated with autosomal recessive RP (Bolz et al., 2005). 
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Whilst the Arg373Cys mutation occurs in different retinal 
diseases, a consistent feature of the phenotypes seen is BEM. Of 
the two panels screened in this project, only three new families 
identified as MCDR2 carried this mutation, therefore there are 
clearly more causes of MCDR2 and BEM to be identified. 
Screening of RIMS1 exon 14 (a mutation in which causes CORD, 
Johnson et al., 2003) revealed no variations in the MCDR2 
subjects screened. 
 
 
 
Figure 10.4 Taken from Kleinman and Ambati (2008) showing that 
PROM1 normally localises at nascent disk membranes but with 
the Arg373Cys mutation it remains in the myoid region. 
 
 
In summary, of one panel of MCDR2 and one of BEM subjects, 
three new families with the Arg373Cys mutation in PROM1 were 
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identified. No new mutations in PROM1 were detected in the 
MCDR2 panel screened. It is evident that mutations in other 
genes yet to be identified exist that cause BEM, an interesting 
candidate appears to be PCDH21. 
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11. BORNHOLM EYE DISEASE 
 
11.1 Genetic Analysis 
Bornholm Eye Disease (BED) is a rare non-progressive, X-linked 
disorder in which patients exhibit the key features of myopia, cone 
dysfunction and dichromacy. Families have been identified with 
both protanopic and deuteranopic dichromacy with the other 
features of the disorder common to all. The BED locus has been 
linked to Xq28 (Schwartz et al., 1990 and Young et al., 2004), the 
region at which the L and M opsin gene array lies, variations in 
which lead to dichromacy. 
 
The L and M cone photopigments are encoded by genes in a head-
to-tail tandem array on the X chromosome with only the first two 
genes in the array being expressed (Section 1.2.4). The genes and 
expressed opsins are highly similar with spectral differences 
between the visual pigments reliant on just seven amino acid 
residues (116, 180, 230, 233, 277, 285 and 309, Asenjo et al., 
1994; Section 1.2.4). Hybrid genes consisting of exons from both L 
and M genes therefore encode pigments with different spectral 
peaks to the normal L and M genes. The residues in exon 5 (277, 
285 and 309) determine whether the pigment functions 
predominantly as an L or M opsin.  
 
Mutations in either of the L or M genes, either by amino acid 
change or gene deletion/replacement, are associated with 
dichromacy (Section 1.2.4). The most frequently reported 
mutation in these opsin genes is the substitution of an arginine 
for a cysteine at position 203 (Cys203Arg), which renders the 
pigment non-functional (Kazmi et al., 1997). Both Young et al. 
(2004) and Michaelides et al. (2005) identified this mutation in 
Chapter 11 
     Genetic Analysis of Inherited Retinal Dystrophies 240 
families exhibiting BED but though the phenotype was consistent 
across families, this mutation was not. This finding suggested that 
different mutations in the L or M genes could be responsible for 
BED in other families. Nathans et al. (1989) previously observed 
that the combination of amino acids leucine, isoleucine, alanine, 
valine, alanine (LIAVA) at 153, 171, 174, 178 and 180, 
respectively, may be a cause of blue cone monochromacy (BCM). 
BCM results when individuals express a functional S opsin only 
and affected members of one family reported by Nathans et al. 
(1989) had a single X-linked visual pigment gene with the LIAVA 
exon 3 combination and this co-segregated with absence of 
function of the corresponding cones. In 2004, Neitz et al. reported 
on a dichromatic individual with cone dysfunction with this 
combination of amino acids encoded by their M gene. The LIAVA 
amino acid combination in exon 3 was not observed in more than 
300 L and M pigment gene sequences from individuals with 
normal colour vision, as reported by Neitz et al. (2004). Other 
publications of exon 3 amino acid combinations in dichromats 
also show no evidence of the LIAVA combination (Sharpe et al., 
1998; Ueyama et al., 2004). It was suggested that this 
combination of amino acids at these polymorphic sites was 
inactivating the opsin, causing both the dichromacy and cone 
dysfunction. Carroll et al. (2004) published adaptive optics 
evidence on this individual that revealed there was in fact a loss of 
cones from the retina. In this subject the LIAVA appeared to result 
in a non-functional M opsin and patchy loss of cones was seen 
throughout the cone mosaic. 
 
Based on these reports it was hypothesised that the BED subjects 
may have the combination of LIAVA encoded by either the first or 
second gene in their opsin arrays, leading to loss of the 
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corresponding cone class and resulting in both dichromacy and 
cone dysfunction.  
 
11.2 Methods Applied 
11.2.1 L/M Exon 3 Screening 
BIOTaq PCRs were conducted to amplify exon 3 of the L and M 
opsin genes using the primers in Table 11.1 and a 60oC annealing 
temperature. Amplicons were gel-extracted and ligated into 
pGEM-T vectors before being transformed into competent JM109 
cells, following which around 50 colonies were selected and the 
plasmids extracted and inserts sequenced (for cloning protocol, 
see Section 3.3). 
 
11.2.2 L/M Exons 3-5 Screening 
The BIOXACT Long range with HiSpec protocol was used (Section 
3.1.4) to amplify across exons 3 and 5, a distance of 3,809 
nucleotides. Reactions were conducted with a 62oC annealing 
temperature using the exon 3F and 5R primers listed in Table 
11.1. The amplicons were then cloned, extracted and sequenced 
as in Section 11.2.1 but with 30 colonies selected. 
 
11.2.3 Amplifying First and Downstream Genes of the 
L/M Array 
Primers specific to the promoter region of the upstream L gene 
and downstream sequence following exon 6 were used to amplify 
the first gene in the array (Section 3.1.6, primers listed in Table 
11.1, taken from the publication by Oda et al., 2003). For the 
amplification of the downstream genes, the forward primer was 
designed to be specific to the downstream promoter (Table 11.1) 
and both reactions used the same reverse primer. When visualised 
on a 0.5% gel, the bands were often feint but visible nonetheless. 
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These PCR reactions were then used as the DNA template for 
subsequent BIOTaq reactions for the amplification of exons 2, 3, 4 
and 5 using the primers listed in Table 11.1 (annealing 
temperatures 60oC). The amplified exons were then sequenced 
using the BigDye protocol (Section 3.1.1). 
 
Table 11.1 Primers used for the various amplifications of the L/M 
gene arrays. 
 
 
 
 
11.2.4 Ratio of L to M Genes 
The method published in Ueyama et al. (2004) was initially 
attempted to determine the ratio of L to M genes (Section 3.1.10), 
which involved amplifying the promoters of the L and M genes 
Chapter 11 
     Genetic Analysis of Inherited Retinal Dystrophies 243 
using the same set of primers and the GoTaq PCR protocol (Table 
11.1). These amplicons were then digested with Bsr F1 and the 
digested products run on a low-melt agarose gel and stained with 
SYBR Green I (Figure 11.1).  
 
 
 
   
 
Figure 11.1 Gel images showing: top; the PCR products of the 
promoter amplifications and bottom; staining of Bsr F1 digested L 
and M promoters with ethidium bromide (left) and SYBR Green 
(right). 
 
 
11.2.5 TaqMan L and M QPCRs 
This method was taken from Neitz and Neitz (2000) and is 
outlined in Section 3.1.8. The same set of primers were used to 
amplify exon 5 of the L and M genes with the addition of probes 
specific for either the L or M exon 5 sequence (Table 11.1). The  
delta-delta-Ct method was used to determine the ratio of L exon 5 
to M exon 5 in a sample of genomic DNA. Experiments were 
repeated on three separate occasions. 
200bp 
200bp 
100bp 
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11.3 Results 
11.3.1 Outline of Analysis 
Exon 3 Screening 
Initially, 12 subjects from four BED families (one of which was 
deuteranopic) and an unrelated BED protanope (Subject Y) were 
screened for variations in exon 3 of their L and M opsin genes. In 
order to separate the L and M sequences, the amplicons were 
cloned and around 50 colonies selected for screening. 50 colonies 
were selected to ensure that all forms of L and M sequences were 
identified and to determine that any variations in coding sequence 
seen were genuine and found in more than one colony. In all but 
three samples (from the same protanopic family), this screening 
identified a combination of nucleotide changes that would result 
in a specific amino acid combination not seen in normal 
trichromats of: LIAVA at amino acid sites 153, 171, 174, 178 and 
180, respectively. Figure 11.2 shows the nucleotide trace for one 
of the affected males from the deuteranopic family and the amino 
acid changes that would be encoded. The common sequence at 
these amino acid sites is leucine, valine, alanine, isoleucine and 
serine (LVAIS). All samples had the combination methionine, 
valine, valine, valine, alanine (MVVVA) at these sites in their M 
exon 3 (the common sequence is MVAIA) but this variant is 
occasionally seen in the normal population.  
 
For the protanopic family that did not show this combination of 
amino acids, exon 4 was screened and the mutation that results 
in the Cys203Arg amino acid substitution identified, as found 
previously in this family by Michealides et al. (2005). No other 
variations were found in this family. 
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Figure 11.2 The top image shows the alignment of the nucleotide 
trace from a deuteranopic BED male with the L opsin exon 3 
sequence. These nucleotide changes result in amino acid 
substitutions at sites 171, 178 and 180 shown in the bottom 
image (the normal sequence at the sites highlighted in purple is: 
LVAIS). 
 
Exon 3 to 5 Screening 
In order to determine whether the LIAVA combination encoded by 
exon 3 was linked to an L or M exon 5, exons 3 to 5 were 
amplified in a single amplicon, cloned and screened (Section 
11.4.2). In order to ensure no sequences were missed, up to 30 
clones were isolated and used for screening. Given the similarities 
between the L and M exon and intron sequences, formation of 
chimeric sequences from the exon 3 to 5 amplifications was 
possible (Figure 11.3). Such PCR artifacts would result in false 
hybrids. Chimeric amplicons can be formed when synthesis of a 
nascent strand begins on one template but becomes interrupted. 
If this strand shows homology to another template it can bind to 
this and amplification continue from this strand. The potential for 
this in the PCRs conducted in this section is high given the 
sequence homology between the L and M genes. Sequences found 
in a number of clones were predicted to be genuine and in 
general, this has been subsequently confirmed. Predictions of the 
ratio of L to M were also made from the cloning data. 
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Long Range PCRs 
In order to validate the cloning data and accurately determine 
gene structure of the L and M arrays in the subjects, the method 
published by Oda et al. (2003) was used. The protocol for these 
long-range PCRs is described in Section 3.1.6. Essentially, 
primers specific to the promoter region of the upstream L gene 
and the region following exon 6 were used to amplify the first gene 
in the array (primers listed in Table 11.1 taken from the 
publication by Oda et al., 2003). The position of the primer for the 
first gene amplification is shown in Figure 11.5. For the 
amplification of the downstream genes, the forward primer was 
designed to be specific to the downstream promoter (Table 11.1) 
and used the same reverse primer as for the first gene 
amplification. When visualised on a 0.5% gel, the bands were 
often feint but visible. These PCR products were then used as the 
DNA template for subsequent BIOTaq reactions for the 
amplification of exons 2, 3, 4 and 5 (annotated in Figure 11.4).  
 
L to M Ratio 
Attempts were made to determine the ratio of L to M genes. 
Initially, the method published by Ueyama et al. (2004) was used. 
The gels were stained with ethidium bromide to ensure the 
digestion of the PCR products was successful (Figure 11.1). 
Unfortunately, the fluorescence with SYBR green failed, so the 
relative amounts of product could not be determined.  
 
As this method was unsuccessful in determining the ratio of L to 
M genes, the TaqMan QPCR method described by Neitz and Neitz 
(2000) was used. This method involved amplifying the L and M 
exon 5 sequences in the same reaction with the same set of 
primers (Figure 11.5).  
Chapter 11 
     Genetic Analysis of Inherited Retinal Dystrophies 248 
 F
ig
u
re
 1
1
.4
 I
m
a
ge
 f
ro
m
 G
en
ei
ou
s 
(D
ru
m
m
on
d
 e
t 
a
l.
, 
2
0
1
0
) 
sh
ow
in
g 
th
e 
re
la
ti
ve
 p
os
it
io
n
s 
of
 L
 o
p
si
n
 g
en
e 
ex
on
s 
a
n
d
 t
h
e 
p
ri
m
er
s 
li
st
ed
 i
n
 T
a
b
le
 1
1
.1
. 
T
h
e 
G
re
y 
a
n
n
ot
a
ti
on
s 
in
d
ic
a
te
 t
h
e 
a
m
p
li
co
n
s 
a
m
p
li
fi
ed
 f
ro
m
 t
h
e 
m
a
in
 f
ir
st
 
ge
n
e 
a
m
p
li
fi
ca
ti
on
 (
in
 r
ed
).
 P
u
rp
le
 a
n
n
ot
a
ti
on
s 
in
d
ic
a
te
 d
if
fe
re
n
ce
s 
b
et
w
ee
n
 L
 a
n
d
 M
 o
p
si
n
 s
eq
u
en
ce
s.
 
Chapter 11 
     Genetic Analysis of Inherited Retinal Dystrophies 249 
 
 
Figure 11.5 Image showing the L gene exon 5 sequence with the 
region amplified by the TaqMan primers highlighted in grey. The 
probe positions are also annotated. 
 
Each reaction included one probe (labelled with 6FAM) that would 
specifically bind to the L exon 5 sequence and a second probe 
(labelled with JOE) that would specifically bind to the M exon 5 
sequence. The probes anneal to the single strands of their specific 
exon 5 sequences and as Taq polymerase extends the primer and 
creates the new strand it encounters the probe and begins to 
degrade it. This releases the fluorophore from the 5’ end of the 
probe, levels of which are detected following each amplification 
cycle. Prior to degradation, the fluorophore is prevented from 
fluorescing by a quencher on the 3’ end of the probe (TAMARA). 
The fluorescence detected is therefore directly proportional to the 
fluorophore released and the amount of DNA template in the PCR. 
The raw data obtained from these QPCRs were analysed using the 
delta-delta-Ct method to determine to ratio of L to M genes 
(Section 4.5). The L gene amplification was used as the reference 
gene and a sample from the Deuteranopic Family used as the 
“control” DNA sample. The QPCR data were combined with the 
results from the long range PCRs to predict the array structures, 
as shown in Table 11.13. 
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Long range PCR results were consistent in replicate experiments 
with only Offspring 2 of Protanopic Family 1 failing to have first 
gene and downstream gene sequences separately amplified and 
sequenced. This occurred in replicate experiments so seems 
unlikely to be due to experimental error. It may be that the 
promoter regions to which the primers for the first and 
downstream genes specifically bind are altered in this subject, 
resulting in primer binding being non-specific to the opsin arrays. 
 
11.3.2 Deuteranopes 
Family 1 
Family 1 consisted of a mother and two affected male offspring. 
The results of the exon 3 to 5 cloning are shown in Table 11.2. All 
three samples produced a number of hybrid sequences, with some 
of these represented by only a few clones. For example, the L, 
L3M4, M4L5 and M sequences were found in each sample, with L, 
L3M4 and M found at the highest frequencies. This suggests that 
these were amplified directly from corresponding genes whereas 
the others may be hybrid artifacts. A summation of L and M exon 
5 sequences across the clones gives an indication of the ratio of 
these L and M exons within each opsin gene array, but does not 
give any indication of gene order within each array. Long-range 
PCRs were conducted for this purpose and the results are shown 
in Table 11.3.  
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Table 11.2 Sequences extracted from clones containing amplicons 
of exons 3 to 5 of the L and M genes from genomic DNA of a 
Deuteranopic Family 1. 
 
 
 
 
Table 11.3 Data from the long range PCRs conducted with DNA 
from the Deuteranopic Family 1 are shown. The identities (L or M) 
of each exon screened are given and the combined genotypes of 
the first and downstream genes are shown. Each experiment was 
repeated. 
 
 
 
 
The long-range PCRs produced fewer sequence variations, 
confirming the suspicion that many of the sequenced hybrids were 
PCR artifacts. First gene amplifications for the mother identified 
two L genes, one with a normal sequence and one with the LIAVA 
combination. This is consistent with one L gene on each X 
chromosome. The downstream gene amplifications revealed an 
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L3M4 sequence that also contained the LIAVA sequence and M 
sequence with the uncommon MVVVA combination. Both 
offspring were identified as having an L (LIAVA) gene followed by 
L3M4 (LIAVA) and M (MVVVA) sequences, although the order of 
the downstream sequences was not determined. These sequences 
represent 21 of 26 and 23 of 28 sequences from the exon 3 – 5 
amplicons for Offspring 1 and 2 respectively, indicating that the 
other four hybrids are PCR artifacts. To determine the relative 
numbers of genes within the opsin arrays, QPCRs were 
conducted. The carrier mother’s L to M QPCR ratio was generated 
as 2:4, which equates to a single L and two M genes on each 
chromosome. Male Offspring 1 gave a ratio of 1L:4M whilst male 
Offspring 2 had a ratio of around 1L:2M. The data from this 
deuteranopic family are combined in Figure 11.6. ANOVA 
comparison of the Mother’s L and Offspring 2 M revealed no 
significant difference (p = 0.1), which was also found for Offspring 
1 and 2 L comparisons (p = 0.233) and the Mother’s M and 
Offspring 1 M (p = 0.487). This indicates the ratios are correct. 
 
 
 
 
Figure 11.6 
Comparisons of 
the exon 5 L 
and M ratios of 
the 
Deuteranopic 
Family. Error 
bars represent 
SEM.  
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The data for this family were consistent and revealed the mother 
to have one array consisting of an L (LIAVA) gene followed by 
L3M4 (LIAVA) and a single M (MVVVA) gene. This array was 
inherited by both offspring. The second of the mother’s arrays is 
normal and contains L (LVAIS) followed by two M genes (MVVVA). 
In Offspring 1 it appears that a recombination occurred between 
the Mother’s two arrays, giving the structure: L (LIAVA), L3M4 
(LIAVA), M (MVVVA), M (MVVVA), M (MVVVA) and M (MVVVA). 
This is consistent with QPCR data that provided a ratio of 1L:4M 
exon 5 sequences (Figure 11.6). 
 
The Original BED Family 
A single sample from the original Danish BED family (Haim et al., 
1988) was analysed. The exon 3 to 5 cloning process identified the 
sequences shown in Table 11.4. 
 
Table 11.4 Sequences extracted from clones containing 
amplifications of exons 3 to 5 of the L and M genes from BED 
genomic DNA. 
 
 
 
 
L, M3L4 and M gene sequences were identified. The sequence of 
the L exon 3 encoded V (valine) rather than I (isoleucine) at site 
171 to give the LVAVA combination. Like LIAVA, this is a rare 
sequence amongst both trichromats and dichromats. The L and M 
exon 5 frequencies in the clones gave a predicted 1:1 ratio of the L 
and M exon 5 sequences within the array. This ratio suggests 
therefore that the array contains two M genes. As the subject is 
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deuteranopic (lacking a functional M opsin), this leads to an array 
prediction of L (LVAVA), then M3L4, followed by two M sequences.  
 
The long-range PCR data shown in Table 11.5 confirmed the 
cloning data and identified an upstream L gene with a nucleotide 
sequence that would lead to an LVAVA amino acid combination at 
residues 153, 171, 174, 178 and 180, respectively. The L 
sequence would then be followed by downstream M3L4 and M 
sequences. The ratio of these genes was analysed by QPCR and a 
ratio of 1L:1M (p = 0.566) exon 5 sequence detected, shown in 
Figure 11.7. This ratio is consistent with the long range PCR, 
which showed the presence of two L exon 5 sequences and two M 
exon 5 sequences. The QPCR results were compared to those from 
the Mother of Deuteranopic Family 1 (DFM1), where a ratio of two 
L and four M exon 5 sequences was determined. Though the 
difference in levels fails to reach insignificance when compared to 
DFM1 (p = 0.016), the ratio is 1:1 and combined with the long-
range PCR data it appears that there are two L and two M genes in 
this sample. Combined, the long-range PCR and QPCR data 
confirm the original array structure predictions made from the 
cloning data. The long-range PCR data show the L (LVAVA) gene is 
the first gene in the array. It is suggested that this would lead to 
the production of a non-functional opsin and based on the 
deuteranopic phenotype, this means the next gene in the array 
would have to encode a functional L opsin. This leads to the 
prediction that the array structure for this subject is: L (LVAVA) 
followed by M3L4 then two M genes.  
 
Table 11.5 Data from the long range PCRs for the original BED 
subject with the combined genotype of first and downstream 
genes provided. Each experiment was repeated.   
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Figure 11.7 Comparisons of the exon 5 L and M ratios of the 
Original BED family member compared to the Deuteranopic 
Family Mother (DFM1). Error bars represent SEM.  
 
 
Deuteranopic Subject X 
A single male subject for whom data has not been previously 
reported was analysed. The cloning results are shown in Table 
11.6 and reveal a number of different clones.  
 
Table 11.6 Sequences extracted from clones containing 
amplifications of exons 3 to 5 of the L and M genes from Subject X 
genomic DNA. 
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As for the deuteranopic family, it was suspected that some of the 
sequences of the clones were PCR artifacts. As the clones of the 
highest frequencies in Deuteranopic Family 1 were confirmed to 
be the genuine clones, that would suggest the real sequences from 
Subject X are L (LVAVA), M4L5 and M. As neither long-range nor 
QPCR were conducted on this sample, the cloning data alone have 
been used to predict the array structure. Given the deuteranopic 
phenotype this subject would lack a functional M opsin, therefore 
a normal M gene sequence would not be in position one or two of 
the array. An array of L (LVAVA), M4L5, M (MVAIA) and M 
(MVAVA) would be consistent with the deuteranopia of Subject X. 
The LVAVA combination in the first L gene would be predicted to 
be non-functional and lead to cone dysfunction and the M4L5 
hybrid gene would produce a functional L pigment. This array 
prediction is not entirely consistent with the 2L:1M ratio of exon 5 
sequences determined by cloning. It should be noted however that 
the actual ratio is 1.72 L to 1 M. 
 
11.3.3 Protanopes 
Protanopic Family 1 
The cloning data for this family are shown in Table 11.7. 
Comparison of the clones found in all three subjects suggest that 
the mother has an array consisting of an L gene (LIAVA) followed 
by at least one M (MVVVA) gene, which is inherited by both 
offspring. The mother would have a second array but from the 
cloning data it is difficult to predict its structure.  
 
The ratios determined from the clone frequencies suggest the 
mother has an equal number of L and M opsin genes whilst both 
offspring have one L to two M opsin genes. To give an overall ratio 
of 1L to 1M, the mother’s second array would need to be either a 
single L gene or two L genes with one M gene. As the LIAVA 
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combination is rare it would seem unlikely that the mother would 
have an L gene with this combination on each chromosome. As no 
other L gene sequence was identified this would suggest that 
either M3L4 or M4L5 are present in the first gene position on the 
mothers second array, which may or may not be followed by a 
second hybrid and M sequence, if the ratio determined from the 
clones is correct. 
 
As with other subjects, it seemed that the cloning data and 
predicted ratio from this family should be treated with caution 
and further analysis conducted to obtain more reliable data for 
predicting the array structures. The long-range PCR results, 
summarised in Table 11.8, show that the predictions made from 
the cloning data appear to be largely correct. Although 
amplifications of Offspring 2 did not separate the L and M 
sequences on two separate occasions, data from Offspring 1 
combined with the previous cloning data suggest that the array 
consists of an L (LIAVA) followed by at least one downstream M 
(MVVVA) gene. The mother appears to have one array of this same 
structure with a second consisting of M3L4 (MVVIS) followed by at 
least one M (MVVVA) gene. 
 
Table 11.7 Sequences extracted from clones containing 
amplifications of exons 3 to 5 of the L and M genes from 
Protanopic Family I genomic DNA. 
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Table 11.8 Data from the long range PCRs conducted with DNA 
from the Protanopic Family I. Identities of the sequences for each 
exon screened are given and the combined genotype of first and 
downstream genes provided. Each experiment was repeated.  
  
 
 
QPCR data for the mother of this family consistently gave a ratio 
of 2:4 (Figure 11.8), which would mean the presence of two L exon 
5 and four exon 5 M sequences. Analysis of the offspring data 
gave an L to M exon 5 ratio of 1:2 for both. ANOVA comparison of 
the mother’s L and both offspring M samples revealed no 
significant difference in the copy number (p = 0.718), indicating 
the same levels of each were present. Similarly, no significant 
differences were seen between Offspring 1 and 2 L samples (p = 
0.268) and M samples (p = 0.614). 
 
 
 
Figure 11.8 Comparison of the exon 5 L and M ratios of 
Protanopic Family 1. Error bars represent SEM. 
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Combined, it would appear that the mother has one array 
consisting of M3L4 (MVVIS) followed by two M (MVVVA) genes. 
The hybrid pigment from the first gene would function as an L 
opsin. The second array has an L (LIAVA) gene followed by two M 
(MVVVA) genes and it is this array that is inherited by both 
offspring. This array would also appear to encode an L and M 
pigment but the LIAVA combination in the L opsin would render it 
non-functional, leaving only a functional M pigment and giving a 
protanopic phenotype. 
 
Protanopic Family 2 
Long-range PCRs and QPCRs were not carried out on this family. 
Data from cloning of exons 3 to 5 from the two siblings are shown 
in Table 11.9.  
 
Table 11.9 Sequences extracted from clones containing 
amplifications of exons 3 to 5 of the L and M genes from 
Protanopic Family 2 genomic DNA. 
 
 
 
The results indicate that the siblings have a hybrid L4M5 
upstream sequence with the LIAVA combination in exon 3 and two 
downstream M genes with the exon 3 MVVVA combination in both 
siblings. The data also show the presence of M3L4M5 hybrid 
clones in both, though the low numbers indicate that they are 
most likely PCR artifacts. With or without these hybrids, the 
structure of the array would explain the protanopia in these 
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males. The LIAVA combination in the hybrid L4M5 is predicted to 
lead to production of a non-functional protein and cause the cone 
dysfunction in this family. 
 
Minnesota Family 
One sample from the Minnesota Family reported on by Young et 
al. (2004) was analysed. The cloning of exons 3 to 5 identified an 
M gene and three types of hybrids (all encoding an M pigment, 
Table 11.10). The M sequence would appear to be genuine and it 
would be expected that just one of the other hybrids would also be 
a genuine sequence as an array consisting of more than one 
switch between L and M is uncommon. Given the equal frequency 
of the single switch clones, the array structure could not be 
predicted from the cloning data but seems likely that either the 
L3M4 or L4M5 is followed by at least one M gene sequence. 
 
Table 11.10 Sequences extracted from clones containing 
amplifications of exons 3 to 5 of the L and M genes from the 
Minnesota subject genomic DNA. 
 
 
 
The long-range PCR screening results for this subject are shown 
in Table 11.11 and identified an upstream L gene sequence with 
the exon 3 combination LVAVA. This sequence was not found 
amongst the sequenced clones but was consistently present in the 
upstream long-range PCRs. The downstream sequences also 
contrast with the cloning data by revealing M and M3L4 genes 
(with two different M exon 3 sequences, one MVVVA and one 
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MVAIA). As with Protanopic Family 1, the presence of an L gene in 
the array would not normally be expected in protanopic 
individuals but as it contains the exon 3 LVAVA combination, it 
would be predicted to be a non-functional opsin. An intact M gene 
would therefore be expected to be directly downstream of the L 
gene in this array since, if M3L4 was in this second position and 
therefore expressed, a functional L pigment would be produced 
and the phenotype would not be protanopia. 
 
Table 11.11 Data from the long range PCRs conducted with DNA 
from the Minnesota subject. Identities of the sequences for each 
exon screened are given and the combined genotype of first and 
downstream genes provided. Each experiment was repeated. 
 
 
 
 
QPCR analysis determined a ratio of 1:1 L and M exon 5 
sequences (p = 0.779, Figure 11.9). Comparison with data from 
the Mother of the Deuteranopic Family 1  (labelled DFM1), who 
has two L exon 5 and four M exon 5 sequences, suggests there are 
two L and two M exon 5 sequences in the array as there is no 
significant difference between the MN L, M and DFM1 L samples 
(p = 0.198). This ratio of 2L:2M exon 5 sequences is consistent 
with the long-range PCR data. 
 
Overall, the data for this subject suggest his array consists of an L 
(LVAVA) gene followed by an M, M3L4 and another M gene. 
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Figure 11.9 Comparison of the MN exon 5 L and M ratio compared 
to DFM1. Error bars represent SEM. 
 
Protanopic Family 3 
This protanopic family has not previously been investigated and 
screening analysis did not reveal the LIAVA or LVAVA 
combinations encoded by exon 3 seen in the other families. 
Screening for the Cys203Arg substitution revealed no mutation 
but screening of exon 2 revealed a new mutation of c.121G>A that 
would result in a Glu41Lys (glutamate to lysine) substitution. This 
mutation was present in both the carrier mother and affected 
male offspring (Figure 11.10).  
 
 
Figure 11.10 Image showing the nucleotide trace of the affected 
male from Protanopic Family 3 with a novel mutation in exon 2 
that results in the amino acid substitution Glu41Lys. 
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The DNA from this family were used in long-range PCRs and the 
sequences identified are shown in Table 11.12.  
 
 
Table 11.12 Data from the long range PCRs conducted with DNA 
from the Protanopic Family 3 subject. Identities of the sequences 
for each exon screened are given and the combined genotype of 
first and downstream genes provided. Each experiment was 
repeated. 
 
 
 
 
From Table 11.12 it appears that the male offspring has only a 
single gene in his opsin array and that it is a complex hybrid: 
L2M3L4M5, which would encode an M opsin and would be 
consistent with protanopia. The first gene screening of the 
mothers array also revealed this hybrid with an additional normal 
L gene sequence followed by normal downstream M sequences. 
 
QPCR analysis of the L to M ratio of the Mother only successfully 
amplified an L exon 5 in one of the three experiments in which 
this was attempted, despite the long range PCRs consistently 
detecting an L gene sequence. This may be due to poor DNA 
quality and inefficient binding of the primers. The M opsin 
amplifications were successful and these were combined with the 
long range PCR data to determine the array structures for the 
Mother. The Offspring had no L sequence amplified, which was 
expected from the screening results (Table 11.12). Comparison of 
the mother’s M exon 5 sequences to the DFM1 from revealed no 
significant difference (p = 0.109) but the QPCR data shown in 
Figure 11.11 suggests the mother has three copies of M exon 5 
compared to one in the Offspring. 
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Figure 11.11 Comparison of the Mother and Offspring from 
Protanopic Family 3 to DFM1. Error bars represent SEM. 
 
 
Combined, the long-range and QPCR data show that the male 
offspring of this family has a single gene in his opsin array. This 
gene is an L2M3L4M5 hybrid that contains a novel mutation in 
exon 2 that would result in a Glu41Lys amino acid substitution. 
To account for the cone dysfunction, the loss of functional cones 
would be predicted to be progressive as only a single opsin gene is 
present in the array and the subject does not present as a blue 
cone monochromat. The pigment would be expressed as a 
functional M, explaining the protanopic phenotype with 
progressive loss of cones expressing the mutated pigment causing 
the cone dystrophy. The mother has this array plus a second 
array containing a normal L gene followed by two normal M genes 
(based on the QPCR data). 
 
All data are summarised in Table 11.13. 
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11.4 Discussion 
11.4.1 L/M Mutations and Array Structure 
One deuteranopic and four protanopic families with BED were 
analysed in addition to unrelated deuteranopic and protanopic 
subjects, including one sample from the original Danish BED and 
Minnesota families reported on by Young et al. (2004). All subjects 
analysed were diagnosed with the BED phenotype and found to 
have either a point mutation or combination of polymorphisms in 
one of the first two genes in their opsin array. A Cys203Arg 
mutation was identified in a protanopic family that was previously 
reported by Michaelides et al. (2005) and so not included in this 
analysis. The Cys203Arg mutation disrupts protein folding and 
stability (Kazmi et al., 1997) and has been identified as causing 
dichromacy (Winderickx et al., 1992c) and BCM (Reyniers et al., 
1995). The cysteine residue at position 203 forms a disulphide 
bridge with the cysteine residue at 126 (Figure 11.14), which the 
substitution of arginine at 203 disrupts (Kazmi et al., 1997).  
 
The rare L exon 3 combinations of LIAVA and LVAVA at sites 153, 
171, 174, 178 and 180, respectively, were identified in all but one 
family with a BED phenotype and are highlighted in Figure 11.12. 
It can be seen that position 153 is on the cytoplasmic side of the 
membrane at the end of helix 3, whilst sites 171, 174, 178 and 
180 are within helix 4. Residues highlighted in black represent 
sites at which amino acids differ between L and M opsins. From 
the positions of the amino acids that make up the LVAVA and 
LIAVA combinations seen in the BED families, it may be that 
these combinations disrupt the transmembrane structure, 
producing a non-functional opsin (causing dichromacy) which 
subsequently leads to degeneration of the cone photoreceptor 
resulting in cone dysfunction (Carroll et al., 2004). The LVAVA 
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and LIAVA combinations were consistently found in BED families 
in the upstream L gene. In one deuteranopic family, an additional 
LIAVA sequence was found downstream in an L3M4 gene, which 
was assumed to be second in the array based on the phenotype. 
However, as the L3M4 hybrid also contains the LIAVA exon 3 
combination, it would be expected that this hybrid opsin would 
also lead to expression of a non-functional opsin. If both genes are 
non-functional then the males of this family would be expected to 
exhibit blue cone monochromocy, but this is not the case. Whilst 
they show apparent deuteranopia, they also revealed 
protanomolous matches made with anomaloscopy, a finding that 
has been previously reported in deuteranopes (Smith et al., 1979). 
It may be that the LIAVA combination in a hybrid L/M opsin has 
more of an effect than in a complete L opsin, leading to these 
patients being deuteranopic with protanomolous matches as 
opposed to being protanopic with deuteranomolous matches. 
 
Another interesting finding is that all the BED families exhibited 
the combination MVVVA at sites 153, 171, 174, 178 and 180, 
respectively, in their downstream M opsin exon 3 sequence. 
Though this combination has been reported in dichromats 
(Sharpe et al., 1998; Ueyama et al., 2004), it is an uncommon 
combination and therefore finding it in all BED families is 
unexpected. The significance of this is unknown but it is 
interesting that sites not commonly polymorphic in dichromats 
exhibit changes in both L and M exon 3 sequences in BED 
families. These exon 3 M amino acids were identified as being in 
linkage disequilibrium with the mutation Trp177Arg in an X-
linked CORD family (Gardner et al., 2010). 
 
One family analysed (Protanopic Family 3) showed neither the 
Cys203Arg missense mutation nor the LVAVA/LIAVA combination 
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of polymorphisms in exon 3. The mother has a normal array of an 
L (LVAIS) and two downstream M (MVAIA) genes. Her second array 
comprises a single complex hybrid of L2M3L4M5, which was 
inherited by her male offspring. This would generate an M 
pigment as amino acids encoded by exon 5 are largely responsible 
for the peak sensitivity, though the presence of L4 might shift the 
wavelength absorption of the opsin. Having just this single gene in 
his X chromosome array would explain the protanopia but not the 
cone dysfunction aspect of the phenotype. Unlike the other 
families analysed, there were no polymorphisms in exon 3 and 
neither was the Cys203Arg substitution present in exon 4, instead 
a novel mutation in exon 2 was identified. This is not thought to 
completely disrupt the opsin function as does the Cys203Arg 
substitution because if this were the case it would be expected 
that the subject would present as a blue cone monochromat but 
he does not. It is therefore suggested that the mutation (Glu41Lys) 
causes a progressive loss of the pigment and, as a result, the 
cones expressing it. Interestingly, the cone mosaic structure of 
this subject was revealed by adaptive optics to present more like 
that of a BCM case than a BED (personal communication, Joseph 
Carroll). This is consistent with the idea that the hybrid L/M 
opsin is expressed but then progressively causes cone loss. The 
residue at site 41 that is changed from the exon 2 nucleotide 
change is shown in Figure 11.12 and lies on the extracellular side 
of the membrane. In the rhodopsin molecule this site is equivalent 
to site 25, which is close to the well known RP mutation caused 
by a Pro23His substitution (Figure 11.13). It is therefore 
unsurprising that such a mutation in the cone opsin gene would 
result in disruption of the opsin and lead to cone dysfunction. 
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Figure 11.12 Schematic diagram taken from Asenjo et al. (1994) 
showing the structure of the human red and green colour vision 
pigments. Highlighted in red are the mutations and variations 
identified in the Bornholm families. 
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11.4.2 Summary 
All the subjects analysed had a BED phenotype and all were 
revealed to have a single sequence variation in exon 2 or 4 or a 
combination of variations in exon 3 of either an L or M gene in 
their X chromosome opsin array. Cys203Arg and LIAVA have been 
previously reported to cause cone dysfunction but here the 
combination LVAVA and Glu41Lys have also been identified. This 
project hypothesised that the opsin gene in which sequence 
variations are present leads to production of a non-functional 
opsin (leading to dichromacy) and causes loss of the cone in which 
it is expressed (cone dysfunction). The data presented suggest the 
hypothesis is correct and that the LIAVA combination of amino 
Figure 11.13 Schematic taken from Ueyama et al. (2002) showing 
the secondary structure of rhodopsin. Rhodopsin mutations are 
highlighted by a bold black outline or a full black circle. Mutations 
in cone opsins are shaded and the mutations from this study 
highlighted in red. The novel Glu41Lys mutation lies near the 
common Pro23His rhodopsin mutation. 
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acids in exon 3 of either an L or hybrid L/M gene cause BED. In 
addition to this, the variants LVAVA and Glu41Lys also appear to 
lead to BED. 
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12. DISCUSSION 
Overall Summary and Discussion 
 
This project has attempted to gain insight into the genetic causes 
of a number of macular dystrophies and a cone dysfunction 
disorder. This type of analysis is conducted in order to gain a 
better understanding of the retina and disease. Discovering 
genetic causes opens the door to investigating new pathways and 
functions in the retina. By identifying disease-causing genetic 
faults the pathology of disorders can also be better understood. A 
better understanding of disease pathology leads to the 
identification of targets for treatment and therapies. Being able to 
offer treatment or therapy for previously untreatable blinding 
disorders can dramatically improve the life of the patients. For the 
disorders investigated here, identifying the genetic cause has been 
somewhat restricted by the number of investigations that were 
attempted. There have been additional issues raised by the 
manner of the analysis conducted but this has not prevented the 
analysis being useful in progressing the identification of the 
genetic causes of the diseases.  
 
This project has largely focused on the use of Affymetrix SNP chip 
technology in refining disease loci in autosomal dominant families 
suffering from a macular disorder. For the disorder North Carolina 
macular dystrophy, scientists have been trying for years to 
uncover the genetic basis of the disease. A new approach was 
attempted here in which affected members from ten unrelated 
families had their genotypes at the disease locus compared in an 
attempt to refine the disease region. This was an incorrect 
approach and failed to provide informative comparisons.  This 
analysis would have benefited greatly had unaffected samples or 
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parents of each proband also been analysed. This would have 
provided a detailed disease haplotype for each family that could 
then be compared. However, given the limited resources of the 
project, it was initially deemed worthwhile to run more affected 
samples from a greater number of families rather than parent-
offspring pairs from half the number of families. This was an error 
and lack of parent-offspring data resulted in genotyping data that 
could not be used to aid in refining the disease locus. At SNPs 
where homozygous calls were given, information from the parent 
would be unnecessary and comparisons of genotypes between all 
families was conducted to provide an indication of regions of allele 
similarities and differences. However, without knowing the phase 
of alleles for SNPs with AB calls, the allele associated with the 
disease haplotype remains unknown. Comparison of 10 unrelated 
HapMap samples showed that the identification of similarities and 
differences between such samples can be achieved from any ten 
samples, highlighting how important determining haplotype is for 
SNP comparisons.  
 
CNV analysis with the MCDR1 families was problematic as the 
samples were analysed on 50K SNP chips, which are not as 
reliable as 250K and SNP 6.0 arrays due to the frequency of the 
SNPs. The 50K chips had initially been chosen instead of the 
250K chips because previous 250K analysis had shown 
interference between SNPs in the genotyping analysis that 
resulted in numerous NoCalls, which reduced the number of 
informative SNPs. However, subsequent MCDR3 comparisons 
revealed that even though the 50K data provided very few NoCalls, 
even with the numerous NoCalls the 250K data still provided a 
greater number of informative SNPs across the genome. In 
hindsight it would therefore seem that use of the 50K was 
unnecessary and that the MCDR1 samples should have been run 
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across the 250K arrays, which would also have allowed for reliable 
CNV analysis. Despite this, the CNV analysis was conducted from 
the MCDR1 50K data and though there are problems with the 
data, seven of the ten families revealed a CN state of three within 
the MCDR1 locus across POU3F2 and FBXL4. This should not be 
ignored and ideally would be further investigated by other 
methods for all samples using SNP 6.0 or QPCR. 
 
For the MCDR3, MCDR4 and PBCRA families studied, the 
Affymetrix analysis method used appears to have been more 
useful in refining the disease regions. By determining the 
inherited disease allele from parent-offspring pairs and then 
comparing these alleles between distant family members, 
exclusions of regions within the disease loci could be made. For 
MCDR3, this refined the region and in doing so reduced the 
candidate gene possibilities. Extensive bioinformatic analysis of 
the candidates within the disease region was conducted and 
primary candidates identified (CCT5, SEMA5A, BASP1, TRIO and 
FBXL7). The CNV analysis conducted using the 250K chip data 
from this family was reliable and valid though no CNVs of interest 
were identified. This was also the case in the MCDR4 and PBCRA 
analysis. 
 
Similar analysis was conducted for the MCDR4 family with the 
genotyping analysis refining the large 14q11.2 locus to a region of 
around 300kb. Extensive bioinformatic analysis of the genes 
within this region was conducted and primary candidates 
identified (TTC5, TEP1, CCN11P1 and TMEM55B). Due to the 
number of diseases investigated in this project, time for screening 
candidate genes was limited. In hindsight the option of reducing 
the number of diseases investigated in order to focus on finding 
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the genetic cause of one or two disorders in particular should 
have been considered.  
 
The genetic analysis of PBCRA was very similar to that of MCDR3 
and MCDR4. Comparison of the genotypes refined the locus, 
deduced that the disease region does directly overlap the MCDR1 
locus. Despite this overlap the data suggested that GRIK2 is an 
interesting candidate for PBCRA.  
 
For these macular disorders, limited screening of candidates was 
conducted due to time limitations. Ideally all the primary 
candidates identified would have been screened but often a 
considerable amount of time is required to optimise PCR 
conditions for all primer sets and samples. The optimisation steps 
and obtaining the correct amplicon from the reaction can be 
problematic as highlighted in this project by the failure to amplify 
POU3F2 and exons of other genes. General PCR conditions were 
first attempted (e.g. gradient BIOTaq PCRs) followed by new 
primer designs, reagents and PCR cycles yet all failed to produce 
the desired amplicon. The time undertaken to screen difficult 
sequences can be significant and with so many disorders and 
candidates within this project, not all were able to be screened. 
Future attempts at the failed screenings could extend to touch-
down and reverse touch-down PCR methods as well as digestion 
of DNA with new primers designed specific to the digestion sites. It 
may also be worthwhile isolating mRNA from non-ocular sources 
for screening purposes, though this would not allow for 
identification of splice site or UTR mutations. A further option 
would be to conduct Next Generation Sequencing over the entire 
disease loci, which would allow screening of all candidates in one 
procedure.  
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In the SHFM and NCMD investigations, both families were small 
with no linkage to a particular locus, which makes the genotyping 
data from the 250K chips of little use other than for checks of 
Mendelian inheritance. These combined with CNV and QPCR 
analyses revealed a region of deletion followed by a duplication in 
the French family at 5p15.33, which lies within the MCDR3 locus. 
The deletion was found consistently in affected members but not 
in the unaffected members of the family, suggesting it may be 
influential in the disease state. No characterised genes lie within 
the area of deletion but the loss of one copy of a novel microRNA 
may lead to a novel disease mechanism.  
 
The MCDR2 analysis did not involve use of Affymetrix data. A 
genetic mutation in PROM1 had been previously identified and 
this gene was screened in a panel of MCDR2 patients to see if 
further variations within this gene occur. Though no new 
variations were found, three new families were identified that 
carry the c1,117C>T mutation in exon 10. These results are 
reported in Michaelides et al. (2010). 
 
Finally, a significant proportion of the project was concerned with 
the analysis of the L/M gene arrays of BED families. Variations in 
these genes were identified as being the cause of the disorder and 
these novel results will be reported and published in the near 
future. Though the QPCR data were acceptable, improvements 
could be made by further optimisation of the reaction conditions 
and sourcing new DNA samples. Additional use of cloned 
plasmids containing known numbers of L or M genes would also 
have been beneficial for use as positive controls. 
 
Overall, the analysis conducted has refined the loci of the 
inherited macular disorders MCDR3, MCDR4 and PBCRA with 
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extensive bioinformatic analysis for each identifying primary 
candidate genes for screening. CNV analysis identified a deletion 
and duplication event that segregates with SHFM and NCMD 
whilst mutation analysis revealed new MCDR2 families with 
PROM1 mutations. Finally, the disease mechanism of Bornholm 
eye disease was determined.  
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13. APPENDICES 
 
13.1 Appendix I 
MCDR1 primers for failed screenings of FBXL4 promoter and exon 
1. 
 
 
Figure 13.1 Primer binding regions for attempts at amplifying the 
FBXL4 promoter and non-coding exon 1. 
 
 
 
 
Table 13.1 Primers used for the attempts at screening FBXL4 
promoter and exon 1.  
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13.2 Appendix II 
MCDR1 6q disease region Affymetrix 50K genotyping data for all 
samples: 
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13.3 Appendix III 
MCDR3 5p15.33-p14.2 region 250K SNP data: 
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13.4 Appendix IV 
Primers for exons 1 and 6 for failed NOVA1 screening. 
 
 
 
 
 
Figure 13.2 Primer positions attempted for amplification of NOVA1 
exons 1 (top) and 6 (bottom). 
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Table 13.2 Primers for NOVA1 exons 1 and 6, screening for which 
failed. 
 
 
 
 
 
13.5 Appendix V 
MCDR4 14q 250K genotyping data plus examples from other 
chromosomes (1, 5 and 16) as examples showing all chromosome 
data had a similar AD exclusion pattern. 
 
Chromosome 14q11.2: 
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Chromosome 1 comparison: 
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Chromosome 5 comparison: 
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Chromosome 16 comparison: 
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13.6 Appendix VI 
All SNPs at the PBCRA 6q disease region: 
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